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4. ABSTRACT
Introduction: There is an ongoing controversy as to which methods in total hip arthro-
plasty (THA) could provide young patients with best long-term results. THA is an espe-
cially demanding operation in patients with severely dysplastic hips. The optimal surgical 
treatment for these patients also remains controversial.
Aims of the present study: The aim of this study was to evaluate the long-term survival of 
THA in young patients (<55 years at the time of the primary operation) on a nation-wide 
level, and to analyze the long-term clinical and radiographical outcome of cementless THA 
in patients with severely dysplastic joints.
Methods: 
1. A total of 4661 primary THAs, performed for primary osteoarthritis (OA) in patients 
under 55 years of age and entered between 1980 and 2001 in the Finnish Arthroplasty 
Register, were subjected to analysis.
2. Survival of uncemented THA designs, which had been used in more than 100 opera-
tions, performed for primary OA in patients under 55 years of age and entered between 
1980–2003 in the Finnish Arthroplasty Register, were analyzed.
3. A total of 2557 primary THAs, performed for rheumatoid arthritis (RA) in patients 
under 55 years of age and entered in the Finnish Arthroplasty Register between 1980–
2003, were analyzed.
4. Between 1989-1994, 68 THAs were performed at Orton Orthopaedic Hospital in 56 
consecutive patients with high congenital hip dislocation. The patients underwent a de-
tailed physical and radiographical evaluation at a mean of 12.3 years postoperatively.
5. Between 1988-1995, 68 THAs were performed at Orton Orthopaedic Hospital in 59 
consecutive patients with severely dysplastic hips and a previous Schanz osteotomy of 
the femur. At a mean of 13.0 years postoperatively, 58 patients (67 hips) were evaluated 
with a detailed physical and radiographical examination.
Results:
1. The risk of stem revision due to aseptic loosening in young patients with primary OA 
was higher for cemented stems than for proximally porous-coated or HA-coated un-
cemented stems implanted over the 1991–2001 period. The risk of revision for all-poly 
cemented-cups implanted during the same period was higher than that for press-fi t 
porous-coated uncemented-cups when aseptic loosening was used as the end point. 
However, there was no longer any difference in the risk between these two design con-
cepts when the end point was defi ned as any revision (including exchange of liner).
2. All uncemented stem designs studied in young patients with primary OA had over 90% 
survival rate at 10 years. The Biomet Bi-Metric stem had a 95% (95% CI 93–97) survival 
rate even at 15 years. The Biomet Universal, the ABG Il and the Harris-Galante II cups 
12
had >90% survival rates at 10 years when aseptic loosening was used as the end point. 
When the end point was defi ned as any revision (incl. exchange of liner), 10 year sur-
vival rates of all cup brands except the Harris-Galante II decreased to less than 80%.
3. In young patients with RA, the risk of stem revision due to aseptic loosening was higher 
with cemented stems than with proximally porous-coated uncemented stems. In con-
trast, the risk of cup revision was signifi cantly higher for all uncemented cup concepts 
than for all-poly cemented cups with any type of cup revision as the end point.
4. In patients with high congenital hip dislocation treated with cementless THA, the Har-
ris hip score increased signifi cantly (p<0.001). There was a negative Trendelenburg sign 
in 92% of hips. There were 12 perioperative complications (18%). With revision be-
cause of aseptic loosening as the end point, the 10 year survival rate was 95% (95% CI 
89–100) for press-fi t, porous-coated acetabular components and 98% (95% CI 97–100) 
for the CDH femoral component.
5. Cementless THA led to a signifi cant increase of the Harris hip score in patients with 
severely dysplastic hips and a previous Schanz osteotomy. There was a negative Tren-
delenburg sign in 88% of hips. There were 15 perioperative complications (22%). The 
10 year survival rate for press-fi t, porous-coated acetabular components was only 69% 
(95% CI, 56–82) with revision of the cup for any reason as the end point. The rate of 
survival for the CDH femoral components, with revision due to aseptic loosening as the 
end point, was 92% (95% CI, 86–99) at 14 years.
Conclusions:
1. For young patients with primary OA, uncemented proximally circumferentially po-
rous- and HA-coated stems are the implants of choice. However, survival rates of mod-
ern uncemented cups are no better than that of all-poly cemented cups.
2. Modern second-generation uncemented stem designs seem to be a good choice for 
young patients with primary OA. Survival rates of uncemented cup designs were unsat-
isfactorily low because of multiple liner revisions.
3. Uncemented proximally circumferentially porous-coated stems and cemented all-poly 
cups are currently the implants of choice for young patients with RA.
4. Uncemented THA, with placement of the cup at the level of the true acetabulum, distal 
advancement of the greater trochanter and femoral shortening osteotomy provided pa-
tients with high congenital hip dislocation good long-term outcomes. Numerous cup 
revisions were secondary to sub-optimal design of the acetabular component used in 
this series.
5. Most of the patients with severely dysplastic hips and a previous Schanz osteotomy 
can be successfully treated with uncemented THA, combined with transposition of the 
greater trochanter and femoral shortening osteotomy. However, the subtrochanteric 
segmental shortening with angular correction gives better leg length correction for the 
patients with a previous low-seated unilateral Schanz osteotomy.
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5. Introduction
Due to higher demands of the population 
and the better long-term results of total 
hip arthroplasty (THA), the proportion of 
younger and more active patients treated 
with this procedure has increased steadily. 
A good long-term outcome (≥90% 10 year 
survival rate) (NICE 2003) has been report-
ed for patients under 55 years of age for ce-
mented (Boeree and Bannister 1993, Joshi et 
al. 1993, Emery et al. 1997, Sochart and Por-
ter 1997b, Sochart and Porter 1997a) and un-
cemented (Fye et al. 1998, Kim et al. 2003b) 
THAs. However, the majority of these re-
ports has originated from highly specialized 
clinics and refer to only one implant brand 
(Joshi et al. 1993, Emery et al. 1997, Sochart 
and Porter 1997b, Sochart and Porter 1997a, 
Kim et al. 2003b). Despite the good results 
obtained for modern uncemented implants 
in these patients, some authors still consider 
the use of uncemented implants in THA as 
experimental (Thanner et al. 1999, Have-
lin et al. 2000). Only a few register-based 
studies have reported the results of THA in 
young patients on a population-based level 
(Havelin et al. 2000, Malchau et al. 2002). 
Most of the previous studies report a higher 
risk of revision in younger patients than in 
older patients (Herberts and Malchau 2000, 
Furnes et al. 2001).
Only a few studies reported the long-
term outcome of THA for young patients 
with rheumatoid arthritis (RA). Good re-
sults were reported for both uncemented 
(Keisu et al. 2001, Lyback et al. 2004) and 
cemented (Lehtimaki et al. 1997, Creighton 
et al. 1998, Lehtimaki et al. 1999) femoral 
components. However, loosening of the ac-
etabular component remains a major long-
term problem after THA in patients with 
RA (Katsimihas et al. 2003). Population-
based results of THA in young patients with 
RA have not been published. 
Published reports of THA in patients 
with congenital hip disease include all three 
subtypes of the disease: dysplasia, low dis-
location, and high dislocation (Harris et al. 
1977, Garvin et al. 1991, DiFazio et al. 2002, 
Perka et al. 2004). These three factors have 
confounded efforts to analyze the results. 
Only three studies have reported the results 
of THA in patients with high congenital hip 
dislocation (Hartofi lakidis et al. 1998, Har-
tofi lakidis and Karachalios 2004, Lai et al. 
2005). Hartofi lakidis et al. (2004) reported 
good long-term results after cemented THA 
in 84 patients.  Lai et al. (2005) reported the 
results of uncemented THA in 56 patients; 
the Harris hip score (HHS) values increased, 
an uncemented stem had a 100% survival 
rate at 12 years, but uncemented cups had 
only a 77% survival rate at 12 years
In 1922, Schanz published the technique 
for subtrochanteric osteotomy of the femur 
of young adults with high congenital hip 
dislocation (Schanz 1922). The purpose of 
the procedure was to reduce the severity of 
limping and to allow greater abduction and 
fl exion. As early attempts to reconstruct the 
hips of adults who had a high congenital 
dislocation were unsuccessful, and some 
authors considered high hip dislocation to 
be a contra-indication to total hip replace-
ment (Charnley and Feagin 1973, Eftekhar 
1978), the Schanz osteotomy was generally 
used at our institution until the 1970’s.
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For high congenital hip dislocation 
THA is a technically demanding operation 
owing to the associated anatomical abnor-
malities encountered (Hartofi lakidis et al. 
1996, Hartofi lakidis and Karachalios 2000). 
However, the anatomy is even more altered 
and variable on both the femoral and pel-
vic sides of the hip after a Schanz osteoto-
my (Paavilainen et al. 1990, Paavilainen et 
al. 1993, Paavilainen 1997). In particular, 
identifi cation and preparation of the true 
acetabulum, preparation of the femoral ca-
nal, and stable reduction of the components 
pose several technical problems.
There are only four previous reports on 
THA in patients who have previously un-
dergone a Schanz osteotomy (Paavilainen et 
al. 1990, Paavilainen et al. 1993, Perka et al. 
2000, Sener et al. 2002). In all of these stud-
ies, those patients with a previous Schanz 
osteotomy have only been a small subgroup 
of the population. To our knowledge, there 
are no reports on THA only, in patients with 
a previous Schanz osteotomy.
The aims of this study were to evaluate 
the long-term survival of THA in young 
patients (<55 years) with primary OA and 
RA on a nation-wide level using the data of 
the Finnish Arthroplasty Register. Further, 
to analyze the long-term clinical and ra-
diographical outcomes of cementless THA 
in young patients with severely dysplastic 
joints operated on in the Orthopaedic Hos-
pital of the Invalid Foundation, Helsinki, 
Finland.
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6. REVIEW OF LITERATURE
6.1 Epidemiology of total 
hip arthroplasty in young 
patients
Most of the patients undergoing THA are 
women and the mean age of the patients 
at the time of the operation is ca. 70 years 
(Havelin et al. 2000, Lucht 2000, Puolakka 
et al. 2001b, Malchau et al. 2002, AOA 2004, 
DHR 2004, Nevalainen 2004, NAR 2005, 
SOS 2005). Primary OA is the most com-
mon indication for THA. It accounts for 
70–90% of primary operations (Havelin et 
al. 2000, Lucht 2000, Puolakka et al. 2001b, 
Malchau et al. 2002, AOA 2004, DHR 2004, 
Nevalainen 2004, NAR 2005, SOS 2005). 
This is followed by femoral neck fractures 
(3–13%), RA (2–7%), and developmen-
tal dysplasia of the hip (DDH) (2–8%) 
(Table 1) (Havelin et al. 2000, Lucht 2000, 
Puolakka et al. 2001b, Malchau et al. 2002, 
AOA 2004, DHR 2004, Nevalainen 2004, 
NAR 2005, SOS 2005). In younger patients, 
commonly referred to as patients less than 
50-60 years of age, the diagnoses profi le 
leading to THA differ in proportion from 
older patients (Table 1). Primary OA is still 
the most common diagnosis. However, RA 
and DDH are clearly more often the reason 
for THA in younger patients than among 
older patients. However, a small propor-
tion of the patients diagnosed with OA may 
in fact have mild DDH in young patients 
(Harris 1986). The proportion of males is 
higher among younger patients undergoing 
THA than among older patients (Table 1) 
(Havelin et al. 2000, Lucht 2000, Puolak-
ka et al. 2001b, Malchau et al. 2002, AOA 
2004, DHR 2004, Nevalainen 2004, NAR 
2005, SOS 2005).
An increase in incidence of THA in 
younger patients during the last 10–15 years 
has been recorded in several national ar-
throplasty registers (DHR 2004, Nevalainen 
2004, NAR 2005, SOS 2005). Over the same 
period there was no change in the incidence 
of hip OA (Danielsson and Lindberg 1997). 
This may refl ect the increase in health ser-
vices capable of offering THA for patients 
in need. Moreover, the inclusion criteria 
for THA may have relaxed, while the tech-
nology associated with THA has developed 
markedly, and expectations of patients have 
also grown.
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Table 1. Epidemiological factors of THA in national arthroplasty registers.
Indication for THA
Country THA incidencea Primary OA RA DDH Women
All patients
  Finland b 93 78% 7% 2% 62%
  Sweden c 125 76% 5% 2% d 61%
  Norway e 120 71% 3% 8% 69%
  Denmark f 110 76% 3% 2% 59%
  Australia g 93 88% 2% 2% 55%
Younger patients h % of all
  Finland i 14% 44% 20% 8% 56%
  Sweden j 5% 54% 17% 14% d NA
  Norway k 17% 42% 6% 29% 62%
  Denmark l 6% 45% 7% NA 43%
  Australia m 15% NA NA NA <50%
a Incidence of primary THA per 100 000 inhabitants. Percentage of younger patients of all patients undergoing THA.
b Diagnoses during 1980 – 2003. Incidence of primary THA in 1999.
c Diagnoses during 1992 – 2004. Incidence of primary THA in 2000.
d Includes all childhood diseases
e During 1987 – 2004.
f During 1995 – 2003. Incidence of THR in 2003 estimated from a diagram.
g Diagnoses during 1999 – 2003. Incidence of primary THA during 2001-2003.
h Percentage of younger patients of all patients undergoing THA.
i Patients under 55 years of age
j Patients under 50 years of age
k Patients aged 60 years or under. Calculated from a table in a published study (Furnes et al. 2001).
l Patients aged 40-49 years. Estimation from a diagram.
m Patients under 50 years of age. Estimated from a diagram (AOA 2004).
OA = osteoarthritis. RA = rheumatoid arthritis. DDH = developmental dysplasia of the hip. NA = not available
6.1.1 Primary osteoarthritis
Osteoarthritis of the hip is a painful disease 
that causes a lot of disability. It has been es-
timated that in the U.S.A., 12% of the popu-
lation aged over 25 years have clinical signs 
and symptoms of hip OA (Lawrence et al. 
1998). Hip OA can result from several dif-
ferent patterns of joint failure. Underlying 
pathological changes due to conditions such 
as osteonecrosis, trauma, sepsis, Paget’s dis-
ease and RA can result in degeneration of 
the joint. Anatomical abnormalities such as 
DDH or slipped capital femoral epiphysis 
can later result in osteoarthritic changes. 
In about 70% of patients undergoing THA, 
neither an anatomical abnormality nor any 
specifi c disease can be identifi ed (Havelin 
et al. 2000, Puolakka et al. 2001b, Malchau 
et al. 2002), and the condition is called pri-
mary OA, a diagnosis made by exclusion of 
the causes mentioned above.
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On the other hand, Harris (1986) origi-
nally hypothesized that the majority of pa-
tients diagnosed with primary OA would 
in fact have mild DDH and/or pistol grip 
deformity of the hip. Recent studies sup-
port this hypothesis. In a systematic review, 
Lievense and colleagues (2004) concluded, 
that there is limited evidence for a posi-
tive association between hip dysplasia and 
hip OA. Similarly, Lane et al. (2000) found 
that acetabular dysplasia, as defi ned by a de-
crease in the center-edge angle, is associated 
with a modestly increased risk of incident 
hip OA in elderly white women. The rela-
tion between DDH and hip OA or hip com-
plaints seems to be much higher in younger 
age groups (Dudkiewicz et al. 2002).
The diagnosis of hip OA is based on hip 
radiographs. In milder cases, conservative 
treatment, i.e. physiotherapy, non-steroidal 
anti-infl ammatory detergents (NSAIDs), al-
leviates the symptoms. In more severe cases, 
THA has been the treatment of choice since 
the 1960s (Charnley 1979).
Several probable risk factors for primary 
OA of the hip have been identifi ed in epi-
demiological studies: older age (Havelin et 
al. 1993), male gender (Havelin et al. 1993), 
high BMI (Oliveria et al. 1999), previous hip 
injury (Cooper et al. 1998), sports activity 
(Lindberg et al. 1993, Vingard et al. 1993) 
and physical activity in work (Vingard et al. 
1991, Croft et al. 1992a, Coggon et al. 1998). 
Results from a sibling study suggested, that 
hip OA has a strong genetic component 
(Lanyon et al. 2000). In a cohort study of 
50 304 patients, Flugsrud and colleagues 
(2002) found that the most important risk 
factors for THA due to primary OA were 
high BMI and intensive physical activity at 
work.
6.1.2 Rheumatoid arthritis
Recent epidemiological studies report the 
incidence of RA at about 50/100 000 inhabit-
ants (Chan et al. 1993, Kaipiainen-Seppanen 
et al. 1996, Wiles et al. 1999). Other studies 
suggest the prevalence of RA is about 1% 
in the adult population (Hazes and Silman 
1990, Hakala et al. 1993), which implies that 
there are about 50 000 patients with RA in 
Finland at the moment (Hakala et al. 1993).
Hip problems are encountered in 20–
40% of patients with RA (Konttinen et al. 
2000), and THA is the most common major 
operation for these patients (Konttinen et al. 
2000). It has been estimated that based on 
data from the Finnish Arthroplasty Register 
the annual need for THA due to RA is 10/100 
000 inhabitants in Finland (Konttinen et al. 
2000). In Norway, the incidence of THA for 
RA has been reported to be about 6/100 000 
and in Sweden 6.5/100 000 (Havelin et al. 
2000, Malchau et al. 2002). The incidence 
of THA for RA decreased by 35% in Finland 
over the 1987–1997 period, whereas the in-
cidence of THA for primary OA increased 
by 67% for the same period (Konttinen et 
al. 2000). The reason for this change may 
be the improved conservative treatment 
for RA. This involves simultaneous therapy 
with multiple disease-modifying anti-rheu-
matic drugs (DMARDs) as well as the use of 
more aggressive treatment measures in the 
early phases of disease, which became more 
common during the 1990’s (Mottonen et al. 
1999a, Mottonen et al. 1999b).
It is typical of RA that the progression 
of the disease varies a lot. A severe form of 
RA can even destroy the hip joint in just a 
few months. In contrast, the pathology of 
joint destruction is slower in primary OA 
and much easier to predict (Konttinen et 
al. 2000). In fi ve years from the onset of RA 
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symptoms, about 10% of the RA patients 
need THA (Poss et al. 1984, Lehtimaki et 
al. 1986, Eberhardt et al. 1990, Havelin et 
al. 1993, Malchau et al. 1993, Eberhardt et 
al. 1995, Lehtimaki et al. 1998). In patients 
with juvenile chronic arthritis (JCA), rap-
idly progressive joint destruction can lead 
to THA at a very young age. In clinical stud-
ies, the mean age range of patients undergo-
ing THA was 28–32 years (Lehtimaki et al. 
1997, Lyback et al. 2004). These factors ex-
plain, why patients undergoing THA for RA 
are younger than patients on whom THA is 
performed for primary OA (AOA 2004, Ne-
valainen 2004, NAR 2005, SOS 2005).
6.1.3 Developmental dysplasia 
of the hip
6.1.3.1 Aetiology and 
epidemiology
The aetiology of DDH is multifactorial, in-
volving both genetic and intrauterine envi-
ronmental factors (Ryöppy 1997). The over-
whelming majority of cases are detectable at 
birth (Hansson et al. 1983, Cates et al. 1993). 
Despite newborn screening programmes, 
some cases are missed. The at-risk group 
of patients includes those with any combi-
nation of the following risk factors: breech 
delivery, oligohydramnios, female gender, 
fi rst born, positive family history or ethnic 
background, persistent hip asymmetry (e.g., 
abduction of one hip and adduction of the 
other), torticollis, and lower-limb deformi-
ty (Weinstein 2001).
Prevalence of DDH varies from 0 to 20% 
in different populations (Ryöppy 1997). At 
the moment, the incidence of DDH is about 
70/1000 in newly born children in Finland 
(Ryöppy 1997).
6.1.3.2 Progression of hip disease 
in untreated patients with 
developmental dysplasia
The natural progression of hip disease in 
untreated complete dislocations depends 
on two factors: the degree of bilateral in-
volvement and the development or lack of 
development of a false acetabulum (Wedge 
and Wasylenko 1978, Weinstein 1987, Har-
tofi lakidis et al. 2000). Patients with bilat-
eral untreated high dislocation without a 
false acetabulum have a good range of mo-
tion and no pain. However, hyperlordosis 
and low back pain develop over time. If the 
completely dislocated femoral head articu-
lates with the ilium and the patient has a 
false acetabulum, secondary degenerative 
arthritis will develop in the false acetabulum 
(Wedge and Wasylenko 1978, Weinstein 
1987, Hartofi lakidis et al. 2000).
Whether a patient with an untreated 
unilateral complete dislocation has pain 
depends on the development or lack of de-
velopment of a false acetabulum. Other as-
sociated problems in such patients include 
limb-length inequality, which can be major 
(up to 10 cm); ipsilateral valgus knee de-
formity with attenuation of the medial col-
lateral ligament; degenerative changes in the 
lateral knee compartment; gait disturbance; 
and secondary scoliosis (Weinstein 1987, 
Hartofi lakidis et al. 2000).
The natural progression of hip disease 
in patients with a low dislocation is clear; 
degenerative joint disease will develop in all 
patients, usually in the third or fourth dec-
ade of life (Weinstein 1987, Hartofi lakidis et 
al. 2000). Moreover, dysplasia usually leads 
to degenerative joint disease in adult age, 
particularly in females (Harris 1986, Sch-
wend et al. 1999). The natural progression 
of hip disease in adults with an untreated 
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dysplasia or a low dislocation is equal to re-
siduals of these conditions after treatment 
in childhood (Weinstein 1987, Hartofi lak-
idis et al. 2000). The reason for degenerative 
changes in dysplastic hips is probably me-
chanical and is possibly related to increased 
contact stress over time (Weinstein 2001).
In a study by Hartofi lakidis et al. (2000), 
the natural progression of hip disease in the 
three types of DDH (dysplasia, low disloca-
tion and high dislocation) were studied in 
157 patients (202 hips: 102 dysplastic, 42 
low dislocation, and 58 high dislocation) 
who had been untreated before the initial 
examination. Average length of follow-up 
was 17 years. In dysplastic hips, the disease 
remained undiagnosed until the onset of 
symptoms at an average age of 34.5 years. 
In patients with a low dislocation, the on-
set of pain was on average 32.5 years due 
to progressive degenerative arthritis within 
the false acetabulum. In patients with a high 
dislocation, in the presence of a false acetab-
ulum, pain started at an average age of 31.2 
years, while in its absence, pain started at 
an average age of 46.4 years due to muscle 
fatigue.
6.1.3.3 Treatment in childhood
If the diagnosis is missed at birth, the natu-
ral progression of dysplasia or dislocation 
can follow one of four scenarios: the hip can 
become normal, it can go on to subluxa-
tion or partial contact, it can go on to com-
plete dislocation, or it can remain located 
but retain dysplastic features (Coleman 
1968). Because it is not possible to predict 
the outcome of dysplasia or dislocation de-
tected in the newborn and because the risk 
of complications of treatment by special-
ists with a device such as a von Rosen cast 
or a Pavlik harness is so low, instability of 
the hip of a newborn has traditionally been 
treated to ensure the highest rate of normal 
outcome (Ryöppy 1997). Nowadays, only 
hips that are found to be dislocated under 
the Ortolan’s test or can be dislocated in 
the Barlow’s test are treated with a cast or 
harness (personal communication, Hele-
nius 2006). Instability alone is no longer 
an indication for cast treatment. The pur-
pose of this modern approach is to avoid 
unnecessary treatments. If treatment with 
these methods is unsuccessful, skin traction 
followed by closed reduction, or even open 
reduction combined with capsulorraphy is 
required (Ryöppy 1997). If the dislocation 
is not diagnosed until the child walks, open 
reduction combined with acetabuloplasty 
and femoral shortening osteotomy must 
be performed (Weinstein et al. 2004). The 
patients who have residual dysplasia after 
these treatments, and the patients who are 
diagnosed with DDH at an older age, may 
require different periacetabular and/or fem-
oral osteotomies to decrease the probability 
of early degenerative OA of the hip (Wein-
stein et al. 2004).
6.1.3.4 Schanz osteotomy of the 
femur
Historically, early attempts to reconstruct 
the hips of adults who had high congeni-
tal dislocation were unsuccessful and some 
authors considered high hip dislocation to 
be a contra-indication to THA (Charnley 
and Feagin 1973, Eftekhar 1978). In con-
sequence, palliative operations, such as the 
Schanz osteotomy were developed (Schanz 
1922).
In his original paper, Schanz gave the 
following reason for his osteotomy: “If a 
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patient with a unilateral dislocation is asked 
to take a step forward with her sound leg, 
she begins to take the step by lifting the heel, 
bending the knee, and dropping the pelvis 
on the sound side (the Trendelenburg phe-
nomenon). The pelvis sinks until the lower 
rim of the pelvic funnel impinges upon the 
femur. Not until this impingement takes 
place is the conversion of the pelvis and 
the femur into a weight-bearing unit com-
plete, and not until then can she raise her 
toes from the ground and advance the foot” 
(Schanz 1922). The goal of the Schanz oste-
otomy is to convert the pelvis and the femur 
into a weight-bearing unit at the moment 
the step begins. This can be accomplished 
by an osteotomy and angulation, in which 
the proximal femur lies against the oblique 
wall of the pelvis, while the distal femur lies 
parallel to the long axis of the body. Accord-
ing to Schanz, osteotomy is carried out at 
the level of the ischial tuberosity, and an an-
gle opening outward is established between 
the fragments (Schanz 1922).
Previously, only a few studies have re-
ported the results of the Schanz osteotomy 
in patients with untreated hip dislocation 
(Hass 1953, Kivilaakso 1959). Hass (1953) 
reported the results of Schanz osteotomy in 
25 patients, with eight bilateral dislocations. 
Of these 80% had good, and 20% poor out-
comes (Hass 1953).
In Finland, untreated congenital hip dis-
location was quite common over 1930’s and 
1940’s. First, owing to the lack of orthopae-
dic hospitals and second, during and after 
the 2nd World War treatment of disabled 
soldiers placed such great demands on lim-
ited medical resources, that very frequently 
patients with hip dislocation did not receive 
any treatment at all or their treatment was 
not completed (Kivilaakso 1959). Thus, 
untreated cases accumulated during those 
years. Treatment of these neglected cases 
was almost exclusively carried out by the 
Orthopaedic Hospital of the Invalid Foun-
dation. Taking these facts into considera-
tion, it is obvious, that the largest published 
study of Schanz osteotomy in patients with 
untreated congenital hip dislocation comes 
from Finland and from the Orthopaedic 
Hospital of the Invalid Foundation (Kivi-
laakso 1959). In that study, Kivilaakso pub-
lished the results of 134 patients (187 hips) 
with congenital hip dislocation treated with 
Schanz osteotomy. In that study, all patients 
diagnosed with congenital hip dislocation 
were either neglected (92 patients) or un-
successfully treated (42 patients). Follow-
up data on 100 patients (131 hips) were 
available (range, 2–12 years): unilateral 
cases showed good or satisfactory results 
in 72% of the hips, whereas only 6% of bi-
lateral cases achieved good outcomes, and 
50% were categorized as poor. Kivilaakso 
recommended the Schanz osteotomy for 
young patients (aged 15–17 years) with uni-
lateral congenital hip dislocation. However, 
for cases of bilateral dislocation, he recom-
mended much more caution should be ex-
ercised (Kivilaakso 1959).
6.1.3.5 Classifi cation in adulthood
Several different classifi cations have been 
devised to describe the different types of 
DDH in adults (Eftekhar 1978, Crowe et al. 
1979, Hartofi lakidis et al. 1996). Tradition-
ally, classifi cations proposed by Eftekhar 
(1978) and Crowe (1979) have been used. 
According to Eftekhar (1978), the height of 
the dislocation is graded into four stages: 
stage A (a slightly elongated and dysplas-
tic acetabulum with some deformity of the 
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head), stage B (an intermediate false acetab-
ulum), stage C (a high false acetabulum), 
or stage D (an old, unreduced dislocation 
with the femoral head never having been in 
contact with the ilium). However, the clas-
sifi cations of Crowe (1979) and Eftekhar 
(1978) refer to the degree of displacement 
of the femoral head but do not accurately 
enough defi ne the acetabular abnormal-
ity. The term ‘subluxation’ is especially 
misleading because it refers to the degree 
of displacement of the femoral head but 
does not defi ne the acetabular abnormality 
(Crowe et al. 1979). Consequently, a new 
classifi cation of acetabular defi ciencies was 
developed by Hartofi lakidis and co-workers 
(Hartofi lakidis et al. 1996). They suggested 
the use of the term congenital hip disease for 
the total spectrum of the deformities and its 
classifi cation into three types on the basis of 
the relationship between the femoral head 
and the true or false acetabulum. These 
types were: dysplasia, low dislocation, and 
high dislocation. With dysplasia, the femo-
ral head is still contained within the original 
acetabulum despite some degree of sub-
luxation. With low dislocation, the femoral 
head articulates with a false acetabulum that 
partially covers the true acetabulum. Under 
radiographical examination, there appear to 
be two overlapping acetabula; the inferior 
part of the false acetabulum is an osteophyte 
that begins at the level of the superior rim 
of the true acetabulum. With high disloca-
tion, the femoral head has migrated supe-
riorly and posteriorly. The true acetabulum 
is inferior and anterior to the hollow in the 
iliac wing with which the femoral head ar-
ticulates, and may have the appearance of a 
false acetabulum.
6.1.3.6 Treatment by total hip 
arthroplasty
The primary indications for THA in adult 
patients with DDH are severe pain and/or 
considerable diffi culty with walking and 
performing daily activities (Charnley and 
Feagin 1973, Harris et al. 1977, Hess and 
Umber 1978, Crowe et al. 1979, Paavilainen 
et al. 1990, Paavilainen et al. 1993, Harto-
fi lakidis et al. 1998, DiFazio et al. 2002, Har-
tofi lakidis and Karachalios 2004, Perka et al. 
2004, Chougle et al. 2005). Secondary indi-
cations for THA are increased low back pain 
and/or progressive valgus deformity of the 
knee (Paavilainen et al. 1990, Paavilainen 
et al. 1993). National arthroplasty registers’ 
data reveal that 2–9% of THAs have been 
performed for DDH (Malchau et al. 1993, 
Havelin et al. 2000, Furnes et al. 2001, AOA 
2004). In younger patients, the proportion 
of patients undergoing THA for DDH has 
been reported to be higher, the indication 
for THA being DDH in 8–29% of cases in 
nation-wide studies (Malchau et al. 1993, 
Havelin et al. 2000, Furnes et al. 2001, AOA 
2004, DHR 2004). However, fi gures in the 
Finnish Arthroplasty Register are not reli-
able because some of the patients registered 
with the diagnosis of primary OA in fact 
have mild dysplasia of the hip.
Total hip arthroplasty for high con-
genital dislocation of the hip presents many 
technical challenges because of associated 
anatomical abnormalities (Hartofi lakidis 
et al. 1996, Hartofi lakidis and Karachalios 
2000). Identifi cation and preparation of the 
true acetabulum, preparation of the femoral 
canal, and stable reduction of the compo-
nents pose several technical problems, espe-
cially in patients with high dislocation.
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In the treatment of high congenital hip 
dislocation with THA, several techniques 
for femoral osteotomy have been pub-
lished (Yasgur et al. 1997, Hartofi lakidis et 
al. 1998, Chareancholvanich et al. 1999a, 
Bruce et al. 2000, Perka et al. 2000, Masonis 
et al. 2003, Hartofi lakidis and Karachalios 
2004). A shortening osteotomy of the femur 
and transposition of the greater trochanter 
has been reported to increase both the ab-
ductor lever arm and the functional length 
of the gluteus medius muscle, creating good 
abduction strength (Paavilainen et al. 1990, 
Paavilainen et al. 1993, Paavilainen 1997). 
However, the long-term effi cacy of this pro-
cedure has not been studied.
Only Paavilainen and his co-workers 
have published studies on hip arthroplasty 
techniques, which can be applied to femora 
with previous Schanz osteotomies at differ-
ent levels. Moreover, a shortening osteotomy 
of the proximal part of the femur with trans-
position of the greater trochanter should be 
performed to correct limb-length discrepan-
cy and facilitate reduction of the prosthesis 
in patients with: hips with a previous unilat-
eral high-seated Schanz osteotomy, or with 
a bilateral low-seated Schanz osteotomy. 
Furthermore, adequate limb-lengthening 
is not possible with the method described 
above for unilateral cases with a previous 
low-seated Schanz osteotomy. Instead, the 
authors recommended metaphyseal segmen-
tal shortening with angular correction to al-
low reduction and the proper lengthening of 
the limb. With segmental metaphyseal oste-
otomy, a step-method is used to stabilize the 
osteotomy against rotation. However, a seg-
mental metaphyseal osteotomy is a laborious 
and time-consuming procedure. Moreover, 
the risk of fracturing the proximal fragment 
is considerable, and the magnitude of func-
tional lengthening of the leg is limited to only 
three centimeters. (Paavilainen et al. 1990, 
Paavilainen et al. 1993, Paavilainen 1997)
Because of technical diffi culties related 
to THA in patients with high congenital 
dislocation, complication rate of this proce-
dure has been reported to be substantially 
higher than that of THA in hips with normal 
anatomy (Woolson and Harris 1983, Paavi-
lainen et al. 1990, Paavilainen et al. 1993, 
Jasty et al. 1995, Paavilainen 1997, Harto-
fi lakidis et al. 1998, Anderson and Harris 
1999, Hartofi lakidis and Karachalios 2004, 
Perka et al. 2004, Klapach et al. 2005, Lai et 
al. 2005). The risk of neurological complica-
tions is especially high (Woolson and Harris 
1983, Paavilainen et al. 1990, Paavilainen et 
al. 1993, Jasty et al. 1995, Paavilainen 1997, 
Hartofi lakidis et al. 1998, Anderson and 
Harris 1999, Hartofi lakidis and Karachalios 
2004, Perka et al. 2004, Klapach et al. 2005, 
Lai et al. 2005) and with subtrochanter-
ic osteotomies, the risk of fracturing the 
proximal part of the femur is also increased 
(Paavilainen et al. 1990, Paavilainen et al. 
1993, Paavilainen 1997, Bruce et al. 2000, 
Perka et al. 2000, Sener et al. 2002).
6.2 Arthroplasty registers
A national joint replacement register was 
fi rst set up in Sweden in 1979 (Ahnfelt et 
al. 1990). Similar registers were then estab-
lished in Finland in 1980 (Paavolainen et 
al. 1991), Norway in 1987 (Havelin et al. 
1993), Denmark in 1995 (Lucht 2000) and 
in Australia in 2000 (AOA 2004).
The most important purpose of the reg-
isters is to identify inferior implants and 
methods used in THA as soon as possible. 
In Norway, poor results regarding some 
inferior THRs and a cement brand used 
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in THA has been detected after only three 
years of use (Havelin et al. 1995b, Havelin 
et al. 1995a, Havelin et al. 1995c, Furnes et 
al. 1997). Naturally, only very inferior im-
plants and methods can be detected that 
early. Larger numbers of patients and lon-
ger follow-ups enable smaller differences 
between implants and methods to be de-
tected and assessed.
With the aid of arthroplasty registers, ep-
idemiological trends of THA (Paavolainen 
et al. 1991, Havelin et al. 2000, Lucht 2000, 
Puolakka et al. 2001b, Malchau et al. 2002) 
and mortality associated with THA (Lie et 
al. 2000, Paavolainen et al. 2002) can also 
be analyzed on a nation-wide level. In addi-
tion, other issues such as cancer risk associ-
ated with THA can be analyzed by matching 
data from arthroplasty and cancer registers 
(Visuri et al. 1996). The future need for 
THA can also be predicted using national 
registry data (Ostendorf et al. 2002).
Results from observational, register-
based studies are often regarded as being 
less conclusive than those from comparable 
randomized trials. However, recent studies 
have indicated that properly conducted large 
prospective observational reviews may give 
results which are similar to those of large 
randomized trials (Benson and Hartz 2000, 
Concato et al. 2000). Furthermore, patients 
who participate in randomized studies are 
frequently atypical, and specifi c exclusion 
criteria may be so restrictive that only a small 
proportion of patients treated in regular 
clinical practice are represented. Therefore, 
it has been suggested, that the effectiveness 
of a widely used surgical techniques, such as 
THA, would be better evaluated by observa-
tional approaches, such as in a register-based 
study, rather than in randomized studies 
(Herberts and Malchau 2000).
6.3 Causal mechanisms 
of failure of total hip 
replacements
6.3.1 Aseptic loosening
Loosening of the components is the most 
common reason for revision of THA both in 
younger and in older patients (Paavolainen 
et al. 1991, Havelin et al. 2000, Puolakka et al. 
2001b, Malchau et al. 2002, AOA 2004, DHR 
2004, NAR 2005, SOS 2005). The process of 
hip implant loosening is often multifactorial. 
Primary stability of the implant is crucial for 
long-term success (Mjoberg 1994). Adequate 
primary stability is acquired for cementless 
implants to obtain osseointegration (Pilliar 
et al. 1986). With cemented implants, a suf-
fi cient bone-cement interface is required to 
gain adequate primary stability and long-
lasting fi xation (Havelin et al. 1995b). Ade-
quate acetabular and femoral fi xation can be 
achieved both with bone cement (Charnley 
1979, Maloney et al. 1989, Malcolm 1993) 
and with various cementless surfaces (Bau-
er et al. 1991, Bauer et al. 1993, Engh et al. 
1995, Tonino et al. 1999, Bohm et al. 2001, 
Coathup et al. 2001, Tonino et al. 2001). An-
other important factor of implant loosening 
is wear debris induced osteolysis. It has been 
established that the local reaction to particu-
late wear debris initiates the formation of a 
granulomatous tissue that ultimately invades 
the bone-implant interface and results in 
aseptic loosening (Schmalzried et al. 1992b). 
Cement mantle defects (Kawate et al. 1998), 
non-circumferential porous coatings (Bobyn 
et al. 1995), and screw holes (Sumner et al. 
1993) of the acetabular component can serve 
as preferential access pathways for the pro-
gression of this granulomatous process lead-
ing to implant loosening.
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6.3.2 Wear and osteolysis
6.3.2.1 Wear
Wear arises from the breaking away of ma-
terial, which occurs as a result of friction 
and motion between two surfaces under 
load. Wear of hip replacement articula-
tions depends on several factors, such as 
the surface fi nish, the material hardness, 
the type of lubricant, the femoral head di-
ameter, the joint pressure and the number 
of gait or motion cycles (Ritter et al. 1996, 
Schmalzried et al. 2000). Many types of 
polymers have been used as bearing surfaces 
in THA; all but conventional polyethylene 
(PE) based designs have been abandoned 
due to excessive wear (Charnley 1979, Hav-
elin et al. 1986). PE that has been modifi ed 
into ultra-high molecular weight polyeth-
ylene (UHMWPE) has become the most 
common type of articular surface on the 
acetabular component. Mean annual wear 
rates of ca. 0.1–0.2 mm for UHMWPE have 
been commonly reported (Charnley and 
Halley 1975, Livermore et al. 1990, Sochart 
1999, Kim et al. 2003b). In practice, this 
leads to the release of enormous numbers 
of submicron particles at the joint (McKel-
lop et al. 1995). Substantial reductions in 
volumetric wear on fi rst- and second-gen-
eration metal-on-metal implants have been 
shown in comparison with conventional 
metal-on-UHMWPE articulation surface 
couples (McKellop et al. 1996, Schmidt et 
al. 1996). Retrieval studies on ceramic bear-
ing surfaces have generally concluded that 
these materials also generate a markedly 
lower volume of debris in comparison with 
conventional metal-on-UHMWPE couples 
(Dorlot et al. 1989, Mittelmeier and Heisel 
1992, Boehler et al. 1994). The most modern 
form of PE, i.e. highly cross-linked polyeth-
ylene, has been more resistant to abrasives 
in hip simulator studies (McKellop et al. 
1999, Muratoglu et al. 2001a, Muratoglu et 
al. 2001b). In a recent clinical study with a 
minimum follow-up of fi ve years, the annu-
al linear wear rate of the highly cross-linked 
polyethylene was 45% of that seen with the 
conventional PE liner (Dorr et al. 2005).
The causes of PE wear can be divided 
into endogenous and exogenous factors 
(Lewis 1997). Factors, which are related to 
the material, are termed endogenous and 
other factors exogenous. The quality of PE 
is infl uenced by the manufacturing process 
(Bankston et al. 1995, Tanner et al. 1995, 
Lewis 1997) and the sterilizing method 
(Premnath et al. 1996, Kurtz et al. 1999a, 
Ries et al. 2001). Poor design of the acetabu-
lar component can lead to excessively thin 
PE liners, which lead to increased stress and 
wear (Bartel et al. 1986, Jasty et al. 1997, 
Lee et al. 1999). Modularity of the acetabu-
lar component leads to varying amounts of 
wear on the attachment surface (backside 
wear), as there is always some motion be-
tween the modular liner and the metal shell 
(Williams et al. 1997, Fehring et al. 1999); 
non-conformity between the liner and the 
metal shell increases this motion and re-
sults in backside wear (Kurtz et al. 1998). 
The presence of screw holes does not sub-
stantially increase abrasive backside wear 
when compared with the effects of backside 
non-conformity (Kurtz et al. 1999b). How-
ever, screw holes may facilitate transport 
of particles to the bone-implant interface 
(Huk et al. 1994). The volumetric wear is 
directly linked to the size of the femoral 
head; i.e. smaller heads produce less wear 
debris (Livermore et al. 1990, Kesteris et al. 
1996, Hall et al. 1998). Cementless metal-
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backed liners have had higher wear rates 
than cemented all-polyethylene cups in 
retrieval studies (Sychterz et al. 1996, Jasty 
et al. 1997). In one clinical study, lateraliza-
tion of the femoral component more closely 
restored preoperative hip biomechanics and 
signifi cantly decreased polyethylene wear 
(Sakalkale et al. 2001). In cementless THAs, 
increased abduction angle of the cup seems 
to increase PE wear (Kennedy et al. 1998). 
Looseness of the artifi cial hip joint may also 
increase wear through telescopic move-
ment between the bearings (Lombardi et al. 
2000). Wear has been shown to be a func-
tion of use, not of time; in a clinical study 
patient activity, assessed by a pedometer, a 
step activity monitor and by a simple visual 
analog scale, strongly correlated to wear 
(Schmalzried et al. 2000). This may partly 
explain the higher wear rates observed in 
younger patients (Shih et al. 1997) and in 
males (Schmalzried et al. 2000). The effect 
of male gender on wear may also be attrib-
utable to differences in behaviour, i.e. the 
types and patterns of activity.
6.3.2.2 Osteolysis
Periprosthetic osteolysis is bone resorption, 
which occurs in association with a foreign-
body such as in response to particulate de-
bris from a prosthetic joint (Amstutz et al. 
1992). Histological evaluations of tissues 
around failed primary arthroplasties have 
revealed metal, cement, and PE particles 
(Nasser et al. 1990, Buly et al. 1992, Schmal-
zried et al. 1992a). It is generally believed 
that PE wear debris is the main cause of os-
teolysis (Hirakawa et al. 1996b).
Wear-mediated periprosthetic osteolysis 
is unlikely to be caused solely by one par-
ticular cell type or particulate species, rather 
it is the cumulative consequence of a num-
ber of biological reactions. Recent fi ndings 
suggest three novel mechanisms of particle 
bioreactivity that may contribute to oste-
olysis (Santavirta et al. 1998, Wang et al. 
2004, Konttinen et al. 2005): (1) exacerbat-
ed infl ammation caused by elevated reactive 
oxygen species production resulting from 
activated macrophages and osteoclasts, (2) 
impaired periprosthetic bone formation 
secondary to disrupted osteogenesis, and 
(3) compromised bone regeneration result-
ing from increased cytotoxic response of 
mesenchymal osteoprogenitor cells.
Large numbers of particles have been 
recognized in periprosthetic tissues, with 
the highest concentration of particles in the 
proximal femoral interfacial membranes. 
Lesser concentrations of particles were seen 
in the acetabular interfacial membranes and 
the joint pseudocapsule (Hirakawa et al. 
1996a, Hirakawa et al. 1996b, Hirakawa et 
al. 1997). These fi ndings are are consistent 
with the concept of the effective joint space 
in which joint fl uid, laden with wear debris 
primarily generated at the articular surfaces 
has widespread access to the periprosthetic 
tissues (Schmalzried et al. 1992b).
Although PE is the dominant particle 
material in most retrieval studies, this is 
not the case when ceramic-on-ceramic or 
metal-on-metal wear couples are involved. 
Ceramic-on-ceramic bearings have been 
shown to yield particles that, though typi-
cally less in number than PE particles, are 
comparable in size (Yoon et al. 1998) and 
bioactivity (Catelas et al. 1998, Catelas et 
al. 1999). In contrast, tissues retrieved from 
patients with metal-on-metal bearings have 
particles that are an order of magnitude 
smaller than either PE or ceramic particles 
(Doorn et al. 1998). Even though tissues as-
26
sociated with metal-on-metal bearings may 
have a milder infl ammatory reaction over-
all (Doorn et al. 1996), there is at least one 
report of early osteolysis following second-
generation metal-on-metal hip replacement 
indicative of a delayed-type hypersensitivity 
response (Park et al. 2005).
It has been suggested that there is a 
critical wear rate threshold above which 
the risk of osteolysis is disproportionately 
increased; this threshold is 0.1–0.2 mm/yr 
(Sochart 1999, Dowd et al. 2000, Orishimo 
et al. 2003). On the other hand, Wilkinson 
and co-workers (2005) recently found, that 
the incidence of osteolysis increased in a 
linear manner with each quintile increase 
in wear rate throughout the range 0.01–0.54 
mm/year. They suggested that the associa-
tion of osteolysis with PE wear rate repre-
sents a continuous positive use–response 
relationship, a fi nding which does not sup-
port the concept of a discrete critical wear 
rate threshold.
The clinical consequences of wear de-
bris cover a broad spectrum from a radio-
lucence to massive osteolysis and implant 
failure. Osteolysis is a major complication. 
It is often asymptomatic and therefore con-
tinuous radiographical follow-up is neces-
sary (Harris 2001) to enable revision to be 
performed before severe bone destruction 
has occurred. The clinical importance of 
this phenomenon in young patients has 
been reported by Sochart (1999): in a study 
on 235 Charnley low-friction arthroplasties 
(Charnley LFAs) in patients aged less than 
40 years the author found, that there was 
signifi cantly less osteolysis in patients with 
mean annual wear rate of <0.1 mm than in 
patients who had a mean wear rate of >0.25 
mm /yr (9 % vs. 35 %). What is more, the 
20 year survival rates were 92 % for the low-
wear group but only 12 % for the high-wear 
group, respectively.
6.4 Results of THA in young 
patients
Results of modern THA are excellent in 
older (>60 years of age) patients; >95% 10 
year survival rates have been reported from 
several sources, even at a nation-wide level 
(Havelin et al. 2000, Herberts and Mal-
chau 2000, Furnes et al. 2001, Malchau et 
al. 2002, AOA 2004, DHR 2004, NAR 2005, 
SOS 2005). Good long-term results have 
also been reported in young patients, but 
those studies either have originated from 
specialized centers (Boeree and Bannister 
1993, Joshi et al. 1993, Emery et al. 1997, 
Sochart and Porter 1997b, Sochart and 
Porter 1997a, Fye et al. 1998, Sochart and 
Porter 1998) or they report an individual 
surgeon’s results (Keener et al. 2003, Kim 
et al. 2003b). Therefore, caution is needed 
for interpreting these results. However, in 
register-based studies, the outcome of THA 
has been poorer in younger than in older 
patients (Havelin et al. 2000, Malchau et 
al. 2002, DHR 2004). As early as 1979 the 
pioneer of modern THA, Sir John Charnley, 
stated: “The challenge comes when patients 
between 45 and 50 years of age are to be 
considered for the operation, because then 
every advance in technical detail must be 
used if there is to be a reasonable chance of 
20 and more years of trouble-free activity” 
[sic] (Charnley 1979). Nowadays almost 
three decades later the ultimate challenge 
for the orthopaedic surgeon performing 
THA is still the younger patients, whose life 
expectancy is well into the eighth decade, 
and who put a great demand on their artifi -
cial hip joints.
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Relatively few patients who are younger 
than 55 years old need THA, and operations 
on large numbers of such patients have, 
mostly been performed in specialized cent-
ers. Many of the previous studies have limi-
tations including an insuffi cient number 
of patients for reliable statistical analysis 
(Collis 1991, Barrack et al. 1992, Boeree and 
Bannister 1993, Ballard et al. 1994, Emery 
et al. 1997, Kobayashi et al. 1997, Sochart 
and Porter 1997b, Sochart and Porter 1998, 
Keener et al. 2003), different THR designs 
have been used in a single series (Collis 1991, 
Barrack et al. 1992, Boeree and Bannister 
1993, Ballard et al. 1994), or they describe 
the results of THA in the hands of single 
surgeons in specialized centers (Barrack et 
al. 1992, Wroblewski and Siney 1992, Bal-
lard et al. 1994, Keener et al. 2003, Kim et al. 
2003b, Kim et al. 2004). It has also been re-
ported, that the outcome of THA in young-
er patients may depend on the pathology of 
the hip joint (Joshi et al. 1993, Sochart and 
Porter 1997a). Despite this young patients 
with different hip diseases are included in 
most studies in an attempt to increase the 
total number of patients (Halley and Wrob-
lewski 1986, Barrack et al. 1992, Wroblewski 
and Siney 1992, Boeree and Bannister 1993, 
Ballard et al. 1994, Devitt et al. 1997, Emery 
et al. 1997, Kobayashi et al. 1997, Sochart 
and Porter 1998, Keener et al. 2003). The 
results of different diagnostic subgroups 
are reported separately in only a few studies 
(Joshi et al. 1993, Sochart and Porter 1997b, 
Sochart and Porter 1997a).
6.4.1 Clinical evaluation
Several different scoring systems have 
been used in evaluating the results of THA 
(D’Aubigne and Postel 1954, Harris 1969, 
Kavanagh and Fitzgerald 1985). They typi-
cally describe pain, motion and walking 
ability of the patients who have undergone 
a THA. The most commonly used scoring 
system is the HHS, which was introduced in 
1969 and included both daily living activities 
and the type and extent of deformity (Har-
ris 1969). This scoring system had originally 
been designed to evaluate the outcome after 
an acetabular fracture. Since then the HHS 
has been widely used to evaluate the clinical 
results after a THA. Specifi c pain drawings 
and visual analogue scales can also be used 
in describing pain (Huskisson 1974).
Performance of the abductors deter-
mines hip function (Inman 1947). Thus, it 
is essential to evaluate the abduction func-
tion of the hip joint after THA particularly 
in patients who have a severe limp before 
the operation; e.g. patients with a high con-
genital hip dislocation (Paavilainen et al. 
1990, Paavilainen et al. 1993, Paavilainen 
1997, Hartofi lakidis et al. 1998, Hartofi lak-
idis et al. 2000). The abduction strength of 
the hip can be measured by several meth-
ods. The range of active abduction can be 
assessed with the patient lying in the lateral 
decubitus position and elevating the affect-
ed extremity against gravity, with the knee 
in extension. This method has been report-
ed to be sensitive in evaluating the hip ab-
duction function. Another method is to ask 
the patient to elevate the affected extremity 
against resistance by the physician’s hand, 
and the strength of abduction of the hip 
is graded according to the standard Medi-
cal Research Council scale (MRC grades 0 
through 5) (Seddon 1954). The Trendelen-
burg test is also a widely accepted screening 
method to measure abduction function.
When the results of a THA series are 
evaluated, it is essential that the observer is 
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independent, i.e. the surgeon must not be 
involved. The clinical outcome parameters 
of THA are blunt instruments to detect im-
plant failures, as complications from the 
implant (e.g. wear and osteolysis) will rarely 
cause any pain in the early phase. Thus, 
long-term radiographical examination fol-
low-up is always needed to detect clinical 
failures of THA.
Various statistical methods are used to 
calculate the survival rates of implants. Sur-
vival rate analyses of different hip implants 
are usually determined by the Kaplan-Mei-
er method (Kaplan and Meier 1958) or the 
Cox regression analysis (Cox 1972). The 
Kaplan-Meier survival analysis was origi-
nally developed for other research areas but 
it has also become very commonly used for 
evaluating the survival of THAs. The defi ni-
tion of a failure is a very important issue, 
as the defi nition per se may have a marked 
effect on the results. Failure of a THA may 
be defi ned in different ways: the decision to 
perform a revision operation, an actual re-
vision operation, or early signs of loosening 
as determined by radiography can all be de-
fi ned as a failure. Indications and resources 
to perform revisions vary, as do the defi ni-
tions of loosening under radiographical ex-
amination. Thus, the end-point criteria of 
failure are critical in survival analyses. In 
addition, the number of patients at risk de-
creases with time in survival analyses. Thus, 
survival rates should always be presented 
with confi dence intervals. Furthermore, 
when survival curves are calculated, they 
should not be presented beyond a point, 
where less than 15–20 patients are still at 
risk. Moreover, the 95% confi dence inter-
val of the estimated survival curve should 
always be presented for the last follow-up 
period for which the survival curve is being 
drawn (Dorey 2004). When survival rates of 
different implant design concepts or designs 
are compared, one should either select sub-
groups of patients who are homogeneous as 
regards age, gender and diagnosis, or adjust 
for these and other confounding factors us-
ing a Cox regression model (Havelin et al. 
2000, Furnes et al. 2001).
Observational studies based on data 
obtained from national arthroplasty reg-
isters provide valuable insight into the use 
of the THA procedure in a certain patient-
group. Such an approach has an advantage 
over clinical studies from single centres in 
that the number of arthroplasties studied is 
substantially larger. The results can also be 
compared between other Nordic arthroplas-
ty registers, which gives a broad perspective 
on the results for both single implants and 
the methods applied in THA (Havelin et 
al. 2000, Puolakka et al. 2001b, Malchau et 
al. 2002). In Sweden, results of THA have 
improved due to long-term registration of 
THAs (Herberts and Malchau 2000). Sub-
jective outcome measurements, e.g. HHS 
or disease-specifi c quality of life measure-
ments, cannot usually be reported in regis-
ter-based studies. Moreover, it is not pos-
sible to conduct radiographical analyses in 
register-based analyses involving thousands 
of patients. Thus, only revision operations 
can be used as the end point for failure in 
register-based studies.
There is usually a long time lag between 
implantation and failure of a THA. In prac-
tice, a large number of patients must be 
treated with a new THA or surgical tech-
nique, before the true effi cacy of the proce-
dure can be evaluated. It has been suggested, 
that new THA design concepts should fi rst 
be tested with radiostereometric analysis 
(RSA) in a small group of patients and then 
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in multi-center prospective clinical studies, 
before they are widely introduced in hospi-
tals (Kärrholm 2003). Thus, the number of 
patients exposed to the potential hazards of 
a new technique can be minimized.
6.4.2 Radiographical evaluation
Certain standardized methods are com-
monly used in radiographical evaluation 
of hips after THA. An anteroposterior ra-
diograph is usually taken with the patient 
bearing weight and the feet parallel with 
each other (Turula et al. 1985). To obtain 
consistent and comparable radiographs, the 
x-ray beam should be centered on the sym-
physis pubis. The fi lm-focus distance and 
the exposure rate should also be as highly 
standardized as possible to allow compari-
sons between examinations done at increas-
ing time intervals after implantation. The 
lateral frog-leg radiograph is usually taken 
with the patient supine. Uncemented femo-
ral and acetabular components are com-
monly assessed by the method described 
by Johnston et al. (1990). The stability of 
an uncemented femoral component is clas-
sifi ed as bone-ingrown, fi brous stable, or 
unstable according to the system of Engh 
et al. (1987). The femoral stem interface 
is analyzed in seven regions of the frontal 
plane and seven regions of the sagittal plane 
(Gruen et al. 1979). On the acetabular side, 
radiolucent lines with a width of >1 mm at 
the component-bone interface are recorded 
for the three zones defi ned by DeLee and 
Charnley (1976). Osteolytic lesions are simi-
larly counted, classifi ed and documented by 
size and location (DeLee and Charnley 1976, 
Gruen et al. 1979). It is generally accepted 
that loosening of the femoral component is 
defi ned as a change in position of >3 mm, 
and loosening of the acetabular component 
is defi ned as a change in alignment of >2° or 
a change in position of 2 mm. Heterotopic 
ossifi cation is generally classifi ed into four 
grades (Brooker et al. 1973).
The extent of linear wear of the PE liner 
can be estimated from plain radiographs. 
Several different methods that evaluate wear 
have been published (Charnley and Cupic 
1973, Charnley and Halley 1975, Russe 
1988, Livermore et al. 1990, Devane et al. 
1995a, Devane et al. 1995b, Krismer et al. 
1995). The classic uni-radiographical tech-
nique of Charnley and Cupic measures only 
vertical linear wear. This is done by measur-
ing the width of the narrowest part of the 
socket in the weight-bearing area and the 
width of the widest part in the non-weight-
bearing area and the difference between 
them is halved (Charnley and Cupic 1973). 
In 1975, Charnley and Halley introduced 
a duoradiographical comparative method: 
the most recent radiographs are compared 
to early postoperative radiographs, in which 
the distance between a radiographical 
marker and the outline of the femoral head 
is assessed (Charnley and Halley 1975). In 
a method described by Livermore in 1990, 
the thinnest part of the PE should be meas-
ured and compared with the postoperative 
radiograph (Livermore et al. 1990). Both of 
these duoradiographical methods use the 
opening face of the socket as a reference and 
wear is calculated as the change in position 
of the femoral head relative to this acetab-
ular face reference line. All these methods 
have been found to correlate with direct 
assessment of the internal deformity of 28 
retrieved sockets (Ohlin and Selvik 1993). 
However, PE wear in these two-dimen-
sional techniques may be underestimated, 
as multiple wear factors are actually in-
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volved (Yamaguchi et al. 1997). Since this 
method was fi rst described, more-accurate 
three-dimensional computerized methods 
have been developed (Devane et al. 1995a, 
Devane et al. 1995b, Ilchmann 1997, Shih et 
al. 1997, Chen and Shih-Shyn Wu 2002). It 
should be noted that two- and three-dimen-
sional measurements have been found to 
give more or less equal estimates in 95% of 
the cases (Sychterz et al. 1999). The most ac-
curate method of measuring both migration 
and wear is radiostereometric analysis (RSA) 
(Aronson et al. 1974), which can only be used 
in prospective studies, as tantalum markers 
must be implanted intraoperatively.
6.4.3 Special aspects regarding 
THA in young patients
6.4.3.1 Reasons for failure of THA 
in young patients
In general, the most common reason for 
revision of THA is aseptic loosening, which 
accounts for 50–79 % of all revisions in 
nationwide studies (Malchau et al. 1993, 
Havelin et al. 2000, Lucht 2000, Puolakka et 
al. 2001b, Malchau et al. 2002, AOA 2004, 
DHR 2004, NAR 2005, SOS 2005). This is 
followed by prosthesis dislocation (6–15%), 
deep infection (5–11%), periprosthetic 
fracture (4–8%), technical errors (2–6%), 
implant failure (2–5%), osteolysis with-
out loosening (2–10%), exchange of worn 
liner (1–5%), and pain (0–7%) (Malchau 
et al. 1993, Havelin et al. 2000, Lucht 2000, 
Puolakka et al. 2001b, Malchau et al. 2002, 
AOA 2004, DHR 2004, NAR 2005, SOS 
2005).
Most of the early revisions (<1 year after 
THA) are performed because of dislocation 
and deep infection (AOA 2004, SOS 2005), 
whereas later on loosening is the main rea-
son for revision (Malchau et al. 1993, Have-
lin et al. 2000, Lucht 2000, Puolakka et al. 
2001b, Malchau et al. 2002, AOA 2004, 
DHR 2004, NAR 2005, SOS 2005). In Aus-
tralia 33% of revisions performed during 
the fi rst postoperative year were due to dis-
location (AOA 2004). Data from the Swed-
ish arthroplasty register reveal that during 
the fi rst three postoperative years 19% of 
revisions were performed for deep infection 
and 17% for dislocation. At the same time, 
over 80% of revisions performed more than 
four years after primary THA were due to 
aseptic loosening (SOS 2005). However, 
risk of revision secondary to deep infection 
as a whole has decreased both in Sweden 
and in Norway. This can be attributed to 
the wide-spread use of systemic antibiotics 
combined with antibiotic-containing bone 
cement (Espehaug et al. 1997, Herberts and 
Malchau 2000). In Sweden, a trend towards 
an increasing risk of revision due to disloca-
tion has been obtained recently (SOS 2005). 
In Norway, an increase in the incidence of 
revisions secondary to osteolysis and wear 
has been observed for the 1996–2004 period 
(NAR 2005).
Population-based data giving reasons 
for THA revisions in younger patients have 
not been published. However, reasons for 
revision obtained from clinical studies from 
single centers in younger and in older pa-
tients have been similar (Barrack et al. 1992, 
Wroblewski and Siney 1992, Boeree and 
Bannister 1993, Joshi et al. 1993, Ballard et 
al. 1994, Neumann et al. 1996, Berger et al. 
1997, Devitt et al. 1997, Emery et al. 1997, 
Kobayashi et al. 1997, Sochart and Porter 
1997b, Sochart and Porter 1997a, Fye et al. 
1998, Sochart and Porter 1998, McLaughlin 
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and Lee 2000, Smith et al. 2000, Chiu et al. 
2001a, Chiu et al. 2001b, Duffy et al. 2001, 
Aldinger et al. 2003, Capello et al. 2003, 
Keener et al. 2003, Kim et al. 2003a, Kim 
et al. 2003b, Kim et al. 2004, Lyback et al. 
2004).
The probability of revision of the ac-
etabular component in young patients has 
been consistently higher than that of the 
femoral component, both with cemented 
(Barrack et al. 1992, Wroblewski and Siney 
1992, Boeree and Bannister 1993, Joshi et 
al. 1993, Ballard et al. 1994, Neumann et al. 
1996, Emery et al. 1997, Sochart and Porter 
1997b, Sochart and Porter 1997a, Sochart 
and Porter 1998, Smith et al. 2000, Chiu 
et al. 2001a, Keener et al. 2003) and unce-
mented THAs (Berger et al. 1997, Fye et al. 
1998, McLaughlin and Lee 2000, Chiu et 
al. 2001b, Duffy et al. 2001, Aldinger et al. 
2003, Capello et al. 2003, Kim et al. 2003a, 
Kim et al. 2003b, Kim et al. 2004, Lyback et 
al. 2004). There were only a few exceptions 
to this fi nding (Devitt et al. 1997, Kobayashi 
et al. 1997).
6.4.3.2 Results of different THA 
fi xation concepts in young patients
6.4.3.2.1 Cemented THA
The long-term results of cemented THA in 
younger patients are dominated by a few 
implants and methods (Table 2). First, re-
garding studies on long-term results of ce-
mented THA in younger patients, Charnley 
LFA has been used either solely (Wroblews-
ki and Siney 1992, Joshi et al. 1993, Devitt 
et al. 1997, Kobayashi et al. 1997, Sochart 
and Porter 1997a, Sochart and Porter 1998, 
Keener et al. 2003) or at least in a clear ma-
jority of the cases (Collis 1991, Barrack et al. 
1992, Boeree and Bannister 1993, Ballard et 
al. 1994). There was only one exception to 
this reported in the literature (Emery et al. 
1997). Second, long-term results of modern 
second-generation cementing techniques 
have only been reported in three studies 
(Ballard et al. 1994, Emery et al. 1997, Koba-
yashi et al. 1997) and results of third-gener-
ation cementing techniques in younger pa-
tients have not been published so far. 10 year 
survival rates ranging from 79 to 93% have 
been reported for the whole THA, 92–97% 
for the femoral component and 83–98% 
for the acetabular component (Collis 1991, 
Barrack et al. 1992, Wroblewski and Siney 
1992, Boeree and Bannister 1993, Joshi et al. 
1993, Ballard et al. 1994, Devitt et al. 1997, 
Emery et al. 1997, Kobayashi et al. 1997, So-
chart and Porter 1997b, Sochart and Porter 
1997a, Sochart and Porter 1998, Keener et 
al. 2003). At 20 years, survival rate range of 
cemented THAs was 67– 75% (Joshi et al. 
1993, Devitt et al. 1997, Sochart and Porter 
1997b, Sochart and Porter 1997a, Sochart 
and Porter 1998, Keener et al. 2003); that 
of femoral components was 76–86% and 
that of acetabular components 70–84%. 
However, a study of young (<40 years old) 
Chinese patients, by Chiu and colleagues 
(2001a) found a 27% survival rate for the 
acetabular component of the Charnley LFA 
at 15 years. What is more, survival rates of 
cemented THA clearly declined in those 
studies in which radiographic loosening of 
the THR were taken into account in surviv-
al analyses, (Ballard et al. 1994, Kobayashi 
et al. 1997, Chiu et al. 2001a, Keener et al. 
2003).
Reported mean annual rates of linear 
wear for cemented THA have ranged from 
0.08 to 0.14 mm (Ballard et al. 1994, Devitt 
et al. 1997, Emery et al. 1997, Kobayashi et 
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al. 1997, Sochart and Porter 1997b, Sochart 
and Porter 1997a, Sochart and Porter 1998, 
Keener et al. 2003). Substantially higher 
wear rates have been found in revised 
THAs compared with unrevised THAs (So-
chart and Porter 1997b, Sochart and Porter 
1997a, Sochart 1999). In addition, varying 
wear rates have been reported for different 
hip diseases (Sochart and Porter 1997a, So-
chart and Porter 1998). There are two stud-
ies in which wear rates of THAs were higher 
in patients with degenerative OA compared 
with patients with RA (Sochart and Porter 
1997a, Sochart and Porter 1998). Although 
the incidence of osteolysis in cemented 
THAs has been reported to be lower than 
in uncemented THAs in younger patients 
(Harris and Maloney 1989, Schmalzried and 
Harris 1993, Ballard et al. 1994, Berger et al. 
1997, Devitt et al. 1997, Emery et al. 1997, 
Kobayashi et al. 1997, Sochart and Porter 
1997b, Sochart and Porter 1997a, Fye et al. 
1998, Sochart and Porter 1998, McLaugh-
lin and Lee 2000, Chiu et al. 2001b, Duffy et 
al. 2001, Aldinger et al. 2003, Capello et al. 
2003, Keener et al. 2003, Kim et al. 2003a, 
Kim et al. 2003b, Kim et al. 2004, Lyback 
et al. 2004), Smith and co-workers reported 
a 51% incidence of acetabular osteolysis 
and a 32% incidence of femoral osteolysis 
in young patients after a cemented THA at 
a mean follow-up of 18 years (Smith et al. 
2000).
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6.4.3.2.2 Uncemented THA
Results of uncemented THA are shown in 
table 3. First reports on cemented THAs re-
vealed high failure rates in young patients 
(Chandler et al. 1981, Sharp and Porter 1985, 
White 1988, Dorr et al. 1990). Later on, im-
proved results were obtained with the use of 
Charnley LFA (Joshi et al. 1993, Neumann 
et al. 1996, Devitt et al. 1997, Callaghan et 
al. 1998), or with improved cementing tech-
niques used on the femoral side (Barrack et 
al. 1992, Ballard et al. 1994, Wroblewski et 
al. 1998). However, the problem of acetab-
ular loosening of cemented cups was not 
substantially alleviated by contemporary 
cementing techniques such as pressuriza-
tion and centrifugation (Wroblewski 1986, 
Barrack et al. 1992, Schulte et al. 1993, Sul-
livan et al. 1994). Harris and co-workers 
(1976) reported extensive non-linear oste-
olysis in the proximal femur after cemented 
THA. This phenomenon was believed to be 
due to ‘cement disease’, and poor results 
of cemented THAs were considered to be 
associated with the use of bone cement. 
Thus, cementless THAs were developed in a 
search for an optimal solution for the young 
patients, and they gave good short-term re-
sults (D’Antonio et al. 1992, Schmalzried 
and Harris 1992, Heekin et al. 1993).
Regarding the long-term results of unce-
mented THA, none of the published studies 
reported 15 or 20 year survival rates (Berg-
er et al. 1997, Fye et al. 1998, McLaughlin 
and Lee 2000, Chiu et al. 2001b, Duffy et 
al. 2001, Aldinger et al. 2003, Capello et al. 
2003, Kim et al. 2003a, Kim et al. 2003b, 
Kim et al. 2004, Lyback et al. 2004): 10 year 
survival rates of uncemented THAs have 
ranged from 67 to 100 %. However, dura-
bility of the femoral component has been 
superior to that of the acetabular compo-
nent in all studies (Berger et al. 1997, Fye et 
al. 1998, McLaughlin and Lee 2000, Chiu et 
al. 2001b, Duffy et al. 2001, Aldinger et al. 
2003, Capello et al. 2003, Kim et al. 2003a, 
Kim et al. 2003b, Kim et al. 2004, Lyback 
et al. 2004). Furthermore, 10 year survival 
rates ranging from 85 to 100% and from 
49 to 100% were reported for uncemented 
stems and cups, respectively. What is more, 
wear rates and incidence of periprosthetic 
osteolysis have been higher in uncemented 
than in cemented THAs in younger patients 
(Ballard et al. 1994, Berger et al. 1997, Devitt 
et al. 1997, Emery et al. 1997, Kobayashi et 
al. 1997, Sochart and Porter 1997b, Sochart 
and Porter 1997a, Fye et al. 1998, Sochart 
and Porter 1998, McLaughlin and Lee 2000, 
Chiu et al. 2001b, Duffy et al. 2001, Aldinger 
et al. 2003, Capello et al. 2003, Keener et al. 
2003, Kim et al. 2003a, Kim et al. 2003b, 
Kim et al. 2004, Lyback et al. 2004).
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6.4.3.2.3 Hybrid THA
As the loosening of the acetabular compo-
nent of the cemented THA continued to be 
a problem in young patients, hybrid THR 
consisting of a cementless acetabular com-
ponent and a cemented femoral component 
was developed in an effort to maximize 
the durability of fi xation and the longev-
ity of the prosthesis (Harris and Maloney 
1989, Schmalzried and Harris 1993). The 
so called “reverse hybrid” fi xation concept 
consists of a cemented acetabular compo-
nent and an uncemented femoral com-
ponent (Alho et al. 2000). Reverse hybrid 
THAs have been implanted into patients in 
Finland and in Norway (Nevalainen 2004, 
NAR 2005).
Long-term results of THA in young pa-
tients using a hybrid THA have only been re-
ported in one single study (Kim et al. 2002). 
In that study, Kim and co-workers reported 
a 98% survival rate for a hybrid THA at 10 
years with any revision as the end point. Us-
ing third-generation cementing techniques, 
they had no revisions for aseptic loosening 
of the cemented stem. None of the modern 
third-generation acetabular components 
were revised for aseptic loosening either. 
The authors reported a 0.096 mm annual 
linear wear rate, and a 9% incidence of oste-
olysis in the calcar 
femorale. No osteolysis was observed 
around the acetabular component. Long-
term results of the reverse hybrid THA have 
not been published so far.
6.4.3.3 Results from arthroplasty 
registers
Data from the Swedish Arthroplasty Regis-
ter revealed that in general THAs in younger 
patients (<55 years of age) had poorer sur-
vival than in older patients (Malchau et al. 
2002). However, there were no results from 
that study comparing design concepts be-
tween age groups. In the cohort of patients 
who were younger than 55 years old at the 
time of the index operation, there was no 
signifi cant difference between cemented, 
uncemented, and hybrid implants, though 
there was a trend towards higher survival 
rates for the uncemented and hybrid THAs. 
In another register-based study using data 
of the Norwegian Arthroplasty Register, 
Havelin and co-workers (2000) found that 
in younger patients (<60 years of age), the 
uncemented circumferentially porous-or 
hydroxyapatite (HA)-coated femoral stems 
had higher survival rates than the cemented 
types. They also found that cemented cups 
had better survival than uncemented po-
rous-coated cups. They attributed this to 
higher rates of revision from wear and os-
teolysis among the latter. In Denmark, the 
risk of revision was reported to be higher 
with cemented than with uncemented im-
plants in patients under 50 years of age (all 
diagnosis groups) (DHR 2004). In young 
patients, register-based results of different 
THR design concepts or designs have not 
been published so far.
6.4.3.4 Results in primary OA
There is only one published study that re-
ports long-term results of cemented THA 
in young patients with primary OA (Devitt 
et al. 1997). In that study, Devitt and co-
workers found a 64% survival rate for the 
Charnley LFA at 20 years. Survival of THAs 
was considerably poorer in patients with 
primary OA than in patients with RA (80% 
at 20 years). No one has published long-
term results of uncemented THA in young 
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patients with primary OA. Furthermore, 
there are no register-based studies of THA 
in young patients with primary OA.
6.4.3.5 Results in RA
There are only a few published studies re-
porting long-term results of THA in young 
patients with RA (Joshi et al. 1993, Devitt 
et al. 1997, Lehtimaki et al. 1997, Sochart 
and Porter 1997a, Lehtimaki et al. 1999, 
Lyback et al. 2004) (Table 4). Long-term 
results of cemented THA have only been 
published on the Charnley LFA, and sur-
vival rates have ranged from 91 to 99% at 
10 years and from 77 to 96% at 20 years 
(Joshi et al. 1993, Devitt et al. 1997, Sochart 
and Porter 1997a). Long-term results of 
modern cemented THA concepts or mod-
ern third-generation cementing techniques 
have not been published for young patients 
with RA so far. Furthermore, there is only 
one published study on long-term results of 
uncemented THA in such patients (Lyback 
et al. 2004). In that study, Lybäck and col-
leagues reported a 97% survival rate at 10 
years for the uncemented proximally po-
rous-coated Bi-Metric stem (Biomet, War-
saw, In., USA): In contrast, 10 year survival 
rate of the uncemented smooth-threaded 
T-Tap cup (Biomet) was only 49% and that 
of the uncemented combination cup (po-
rous-coated threaded) Romanus (Biomet) 
only 78%. Register-based studies of THA in 
young patients with RA have not been pub-
lished.
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6.4.3.6 Results in developmental 
dysplasia of the hip
6.4.3.6.1 High congenital hip dislocation
Published reports of THA in patients with 
DDH have included all three subtypes of the 
disease: dysplasia, low dislocation and high 
dislocation (Tronzo and Okin 1975, Harris 
et al. 1977, Lund and Termansen 1985, Har-
ley and Wilkinson 1987, Garvin et al. 1991, 
Morscher 1995, DiFazio et al. 2002, Perka 
et al. 2004, Klapach et al. 2005). Confusion 
has thus arisen in efforts to analyze these 
results. There are only three earlier reports 
presenting the long-term results of THA in 
patients with high congenital dislocation 
(Hartofi lakidis et al. 1998, Hartofi lakidis 
and Karachalios 2004, Lai et al. 2005).
In a study of 84 consecutive THAs in 
patients with a high congenital dislocation, 
Hartofi lakidis and Karachalios (2004) re-
ported an 86.1% (±7.4%) survival rate for 
the acetabular component (both uncement-
ed and cemented) at 15 years. However, the 
combined frequency of probable loosening 
as determined by radiographical examina-
tion plus actual revision of the acetabular 
component was 17.5%. Lai and co-workers 
(2005) reported the results of uncemented 
THA in 56 patients with a high congeni-
tal dislocation. In their study, uncemented 
cups had a 77% survival rate at 12 years. 
These authors reported that four of the nine 
cup revisions were performed because of 
excessive wear of the PE and fi ve for aseptic 
loosening.
As most of the patients with a high con-
genital dislocation have a limp and poor 
abduction strength, it is important to re-
port the effect of THA on these signs, which 
should also be measured objectively. In the 
largest available study of THA in congenital 
hip disease, Hartofi lakidis and Karachalios 
(2004) did not report the proportion of pa-
tients limping nor did they report on the 
presence or absence of the Trendelenburg 
sign postoperatively. Bruce et al. (2000) 
published a   study of a small number of 
congenitally dislocated hips operated on 
with a subtrochanteric segmental shorten-
ing osteotomy with the prosthesis in situ. 
They found all osteotomies united, but six 
of the eight patients had a positive Trende-
lenburg sign postoperatively. In a study of 
21 THAs in severely dysplastic hips, Ma-
sonis et al. (2003) reported that only 17% 
of the patients could walk without a limp 
and 61% walked with a single cane after the 
operation. Other studies on femoral osteot-
omy in THA of severely dysplastic hips have 
included only a small number of patients 
with short-term to mid-term follow-up, 
and rarely have reported any data on abduc-
tion strength of the operated hips (Yasgur 
et al. 1997, Chareancholvanich et al. 1999b, 
Perka et al. 2000). In one paper, by Lai et al. 
(2005), the authors used preoperatively ili-
ofemoral distraction with an external fi xa-
tor for 8–17 days in 56 patients with uni-
lateral high dislocation. With this method, 
shortening osteotomy of the femur was not 
required perioperatively. However, the au-
thors did not provide any data on abduc-
tion strength of the hips postoperatively.
Paavilainen and co-workers have pos-
tulated, that a shortening osteotomy of the 
femur and transposition of the greater tro-
chanter would be a safe surgical method for 
treating these patients (Paavilainen et al. 
1990, Paavilainen et al. 1993, Paavilainen 
1997). In the short-term, the authors re-
ported excellent functional results and radi-
ographical union rates with this procedure 
(Paavilainen et al. 1990, Paavilainen et al. 
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1993, Paavilainen 1997). Hartofi lakidis and 
Karachalios (2004) published a large study 
of 229 primary THAs in 168 patients with 
DDH. In this study, osteotomy of the great-
er trochanter was performed on all hips ex-
cept for three with dysplasia, but femoral 
shortening osteotomy was not used for any 
hip. Fibrous union of the greater trochanter 
occurred in 22% of the hips that had a high 
dislocation, but non-union with migration 
of the greater trochanter in only one case 
(2%).
There is only one previous report by 
Hartofi lakidis and Karachalios (2004) that 
presents the long-term survival rates of ce-
mented femoral components in hips with a 
high congenital dislocation. They reported 
an 89.1% survival rate for cemented femo-
ral components at 10 years and an 82.5% 
survival rate at 15 years. Similarly, long-
term results of uncemented stems in the 
same patients have been published in one 
single study by Lai and co-workers (2005), 
who reported a 100% survival rate for a 
straight uncemented femoral component at 
12 years.
6.4.3.6.2 Hips with a previous Schanz 
osteotomy of the femur
Only four previous reports on THA include 
patients, who have previously undergone a 
Schanz osteotomy (Paavilainen et al. 1990, 
Paavilainen et al. 1993, Perka et al. 2000, 
Sener et al. 2002). In all of these studies, 
most of the patients had DDH. However, 
only a small minority of them had been 
previously treated with a Schanz osteotomy 
and no one has reported the results of THA 
only in patients with a previous Schanz os-
teotomy. 
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7. Aims of the present study
The main of purpose of this study was to 
evaluate the long-term survival of THA in 
young patients (<55 years at the time of pri-
mary THA) on a nation-wide level as well as 
the long-term outcome of cementless THA 
in young patients with severely dysplastic 
joints.
The specifi c aims of the studies were to 
assess:
1) The population-based survival of THA 
concepts in young patients with prima-
ry osteoarthritis and the factors affect-
ing survival rates.
2) The population-based survival of mod-
ern uncemented THA designs in young 
patients with primary OA.
3) The population-based survival of THA 
concepts in young patients with rheu-
matoid arthritis and the factors affect-
ing survival rates.
4) The long-term clinical and radiographi-
cal outcome of uncemented THA com-
bined with distal advancement of the 
greater trochanter and femoral shorten-
ing osteotomy, in young patients with 
high congenital hip dislocation.
5) The long-term clinical and radiographi-
cal outcome of uncemented THA in 
young patients with severely dysplastic 
hips and a previous Schanz osteotomy 
of the femur.
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8. PATIENTS AND METHODS
8.1 Patients
8.1.1 Register-based studies
(I, II and III)
Between 1980 and 2001, a total of 74 492 
THAs were recorded in the Finnish Arthro-
plasty Register. Of these operations, 4661 
were performed for primary OA in 3657 pa-
tients under 55 years of age. For this reason, 
these 4661 THAs were included in the fi nal 
analysis in study I. Between 1980–2003, in-
formation on 92 083 primary THAs were 
entered in the Finnish Arthroplasty Register. 
Of these operations, 5607 were performed 
for primary OA (II) and 2557 performed for 
RA (III) in patients under 55 years of age. 
Consequently, these were included in the 
fi nal analysis. (Table 5)
Table 5. Summary of study design, type of data, patients and follow-up time.
Study I II III IV V
Study design
Prospective,
observational
Prospective,
observational
Prospective,
observational
Partially 
prospective
Partially 
prospective
Type of data Register-based Register-based Register-based
Clinical and 
radiographical
Clinical and 
radiographical
Patients (hips) 3657 (4661) 4884 (5607) 1893 (2557) 56 (68) e 59 (68) e
Females (%) 48% 47% 74% 88% 92%
Age a 49 (16 – 54) 49 (16 – 54) 43 (14 – 54) 54 (29-74) 51 (29 – 69)
Follow-up (%) - - - 95% 97%
Clinical f - - - 52 (64) 58 (67)
Radiographic and
telephone f
- - - 3 (3) 1 (1)
Telephone only f - - - 1 (1) 0
Mean b 6.9 (0 – 22) 7.0 (0 – 24) 9.7 (0 – 24) 12.3 (9 – 15) 13.0 (9 – 18)
a Mean age in years, range in parentheses.
b Mean follow-up in years, range in parentheses.
c Mean height in cm, range in parentheses.
d Mean weight in kilograms, range in parentheses.
e 28 patients (34 hips) were included both in study IV and in study V.
f Patients who participated at the last follow-up examination, hips in parentheses.
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8.1.2 Clinical studies (IV and V)
Patients who had undergone THA at Orton 
Orthopaedic Hospital were included in the 
present study (IV and V) for the following 
conditions: Between January 1989 and De-
cember 1994, 75 primary THAs had been 
performed in 63 consecutive patients who 
had a high congenital dislocation of the hip 
according to the classifi cation of Harto-
fi lakidis et al. (1996) (IV). Between January 
1988 and December 1995, 75 primary THAs 
had been performed in 65 consecutive pa-
tients with severely dysplastic hips, who had 
previously undergone a Schanz osteotomy 
(Schanz 1922) of the femur (V). Twenty-
eight of these patients (34 hips) were in-
cluded in both studies. (Table 5)
In study IV, all patients had a high con-
genital hip dislocation. Similarly, 55 (95%) 
patients (64 hips) had developmental dys-
plasia of the hip, three patients had a previ-
ous tuberculous arthritis of the hip, and one 
patient had congenital coxa vara in study V. 
(Table 6)
Table 6. Classifi cation of the hips according to Eftekhar (1978) and Hartofi lakidis et al. (1996).
Eftekhar classifi cation (n)
Hip disease a n A B C D
Study IV
  DDH 63
  High dislocation 63 24 47
Study V
  DDH 63
  Dysplasia 4 4
  Low dislocationb 9 9
  High dislocation 51 18 33
  Tuberculosis b 3
  Dysplasia 1 1
  High dislocation 2 1 1
  Coxa vara b 1
  Dysplasia 1 1
n = number of hips. DDH = developmental dysplasia of the hip.
a Classifi cation of dysplasia according to Hartofi lakidis et al7
b Hips with previous tuberculous coxarthritis or coxa vara were classifi ed with the same methods.
The indications for arthroplasty were 
severe pain and/or considerable diffi culty 
in walking and performing daily activities. 
Four patients in both studies died postoper-
atively from causes unrelated to the proce-
dure. None of the deceased patients in study 
IV had undergone revision surgery, but two 
of the four deceased patients in study V had 
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undergone cup revision because of aseptic 
loosening of the cementless smooth-thread-
ed acetabular component (3.3 and 4.4 years 
postoperatively). All of the remaining pa-
tients (59 in study IV and 61 in study V) 
were asked to participate in this follow-up 
study: 56 of the patients (95%) in study IV 
and 59 of patients (97%) in study V agreed 
to do so. The patients who declined to par-
ticipate gave a lack of interest as their rea-
son; none of the patients in study IV had 
undergone revision surgery, whereas two 
patients in study V had undergone revision 
of the femoral component.
8.2 Methods
8.2.1 Register-based studies
(I, II and III)
The numbers and percentages of different 
implants used in the operations and the 
fi xation method of each component (ce-
mented or uncemented) were evaluated. (I 
and III)
The success rates of different implant 
design concepts were analyzed. In study I, 
stems were divided into fi ve groups whereas 
the cups were divided into four groups for 
statistical comparisons. In study III, stems 
and cups were divided into four groups 
each, whereas the THRs were classifi ed 
into three groups. Stems were classifi ed as 
uncemented proximally circumferentially 
porous-coated, uncemented proximally cir-
cumferentially HA-coated, uncemented un-
coated (including isoelastic, grit-blasted and 
sand-blasted uncemented stems), cemented 
(including polished, grit-blasted and sand-
blasted cemented stems). In study I, unce-
mented extended porous-coated (porous-
coating on more than half of the stem length) 
were also included in the design concept 
analysis. Cups were classifi ed and grouped 
as uncemented porous-coated press-fi t, un-
cemented HA-coated press-fi t, uncemented 
smooth threaded and cemented all-poly. In 
study III, THRs were classifi ed as press-fi t 
porous-coated uncemented (proximally 
porous-coated uncemented stem and press-
fi t porous-coated uncemented cup), press-
fi t HA-coated uncemented (proximally 
HA-coated uncemented stem and press-fi t 
HA-coated uncemented cup) and cemented 
(cemented stem and cemented all-polyeth-
ylene cup). Only implant designs used in 10 
or more operations over the whole study 
period were included in the design concept 
analysis (I and III).
Epidemiological trends of THA in young 
patients with primary OA were analyzed for 
three time periods: 1980–1981, 1990–1991, 
and 2000–2001. In study I, the effects of im-
plant fi xation (cemented vs. uncemented) 
and implant concept on the survival of THA 
were analyzed separately for the whole study 
period and also for the decades 1980–1990 
and 1991–2001.
The revision burden (expressed as a per-
centage by dividing the number of revisions 
done over a certain time period by the total 
number of primary and revision THAs per-
formed over the same period) (Malchau et 
al. 2002) and indications for revision were 
analyzed (I and III).
Uncemented femoral and acetabular 
components that had been used in more 
than 100 operations during the study period 
were subjected to analysis. Only stem designs 
with a mean follow-up of more than fi ve 
years, and more than 20 patients at risk at 10 
years were included in the analysis. The un-
cemented isoelastic Mathys stem (RM Ma-
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thys AG, Bettlach, Switzerland) which had 
previously given poor results was excluded 
from the study (Niinimaki et al. 1994). On 
the acetabular side, only press-fi t cup de-
signs with porous- or HA-coating were in-
cluded; the Biomet Romanus cup common-
ly used in Finland, with porous-coating and 
screw-ring design, was also included. New 
cup brands, so called “second-generation” 
of modern press-fi t porous- or HA-coated 
uncemented cups with short-term follow-
up (mean follow-up <5 years) were also in-
cluded in the study in order to determine 
whether the preliminary results of the new 
cup brands would differ from those of the 
older types. Similarly, stem and cup com-
binations used in more than 100 operations 
during the study period, including new de-
signs with a short follow-up time, were in-
cluded in the study. Uncemented smooth-
threaded cups with well-documented poor 
results (Engh et al. 1990, Tallroth et al. 1993, 
Simank et al. 1997) were excluded. Accord-
ing to these inclusion and exclusion criteria, 
seven uncemented stem designs (Table 7a), 
10 uncemented cup designs (Table 7b) and 
eight cup-stem combinations were included 
in the study (II).
Table 7a. Design, surface and material of the femoral components in the study. 
Stem design Material Surface Design
ABG I Titanium alloy Prox. HA-coating Anatomic
Anatomic Mesh Titanium alloy Prox. porous-coating Anatomic
Bi-Metric Titanium alloy Prox. porous-coating Straight
Lord Madréporique Cobalt-chromium Full porous-coating Straight
PCA Std Cobalt-chromium Prox. porous-coating Anatomic
Profi le Porous Titanium alloy Prox. porous-coating Anatomic
Spotorno Titanium alloy Grit-blasted Straight, proximal fi ns
Table 7b. Design, surface and material of the acetabular components in the study.
Cup design Material Surface Design Screw-holes
ABG I Titanium alloy HA-coating Hemispherical Open
ABG II Titanium alloy HA-coating Hemispherical Closed
Biomet Mallory Titanium alloy Porous-coating Hemispherical Open
Biomet Romanus Titanium alloy Porous-coating Screw-ring Open
Biomet Universal Titanium alloy Porous-coating Hemispherical Open
Biomet Vision Titanium alloy Porous-coating Hemispherical Closed
Harris-Galante II Titanium alloy Porous-coating Hemispherical Open
Metasul Press-Fit Tantalum Trabecular Hemispherical No screw-holes
PCA Pegged Cobalt-chromium Porous-coating Hemispherical Open
Profi le Duraloc Titanium alloy Porous-coating Hemispherical Open
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The effect of hospital type on THA 
survival was also studied by dividing the 
hospitals into subgroups according to the 
number of operations performed annually 
for primary OA in patients under 55 years 
of age, i.e., more than 10 operations or 10 
operations or less (I).
8.2.2 Clinical studies (IV and V)
8.2.2.1 Clinical evaluation
The patients underwent detailed physi-
cal examination between August 2003 and 
December 2005. In addition to questions 
soliciting demographic data, they were also 
asked to assess their opinion on the result 
of the treatment on an arbitrary scale with 
fi ve grades: 1 (very satisfi ed), 2 (satisfi ed), 
3 (unsatisfi ed), 4 (very unsatisfi ed), and 5 
(no opinion). The HHS was recorded (Har-
ris 1969). The abduction strength of the 
hip was measured by three methods. First, 
the range of active abduction was assessed 
with the patient lying in the lateral decubi-
tus position and elevating her or his affected 
extremity against gravity with the knee in 
extension. Second, the patient was asked to 
elevate her or his affected extremity against 
resistance by the physician’s hand and the 
strength of abduction of the hip was graded 
according to the standard Medical Research 
Council scale (Seddon 1954) (MRC grades 
zero to fi ve). Third, abduction strength was 
assessed by the Trendelenburg test. The ex-
tent of functional leg length discrepancy, if 
any, was measured by using wooden blocks 
under the shorter leg.
8.2.2.2 Operation technique
8.2.2.2.1 Preparation of the femur
The appropriate operative method was se-
lected according to the possible presence 
and the anatomical level of the Schanz 
osteotomy, and performed according to 
the methods described by Paavilainen et 
al (Paavilainen et al. 1990, Paavilainen et 
al. 1993, Paavilainen 1997). First, in cases 
of untreated high dislocation, a previous 
high-seated Schanz osteotomy or a bilat-
eral low-seated osteotomy, a shortening 
osteotomy of the proximal part of the fe-
mur with transposition of the greater tro-
chanter was performed (Figures 1 and 2). 
Second, in cases of unilateral low-seated 
Schanz osteotomy an angular correction 
and shortening osteotomy was performed 
at the level of the Schanz angle, and the 
stem was used as an intramedullary nail to 
stabilize the osteotomy site (Figure 1, C).
The fi rst method was used in 61 hips 
(90%) in study IV and in 59 hips (87%) in 
study V. In this method a modifi ed pos-
terior approach was used with the patient 
in the lateral position. The proximal part 
of the vastus lateralis muscle was divided, 
and the posterior half was detached from 
the base of the greater trochanter to fa-
cilitate identifi cation of the Schanz angle, 
at which level the femur was cut. The re-
leased proximal femur was split by an os-
cillating saw. The medial half of the femur 
containing the rudimentary or deformed 
femoral head and medial metaphysic was 
removed. The lateral half, containing the 
greater trochanter with intact attachments 
of the gluteus medius and anterior half of 
the vastus lateralis muscles was retracted 
anteriorly providing excellent access for 
preparing the acetabulum. Finally, after 
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reduction of the prosthesis the greater 
trochanter was advanced and fi xed by two 
or three screws (Duo-Drive Head Corti-
cal Screws®, 3.6 mm Self-Tapping (How-
medica, Limerick, Ireland)) with the hip 
in wide abduction. Laxity of the vastus 
lateralis due to the femoral shortening 
osteotomy was corrected by advancing 
the posterior half of the muscle to a more 
proximal insertion in the greater trochant-
er, and the loose anterior half was dupli-
cated. If the medullary canal was found to 
be too narrow even for the smallest stem, 
the femur was split anteriorly and pos-
teriorly for 8 to 10 cm with an opening 
wedge osteotomy, after which rasping was 
completed (Figure 1, D) (Paavilainen et 
al. 1993).
The second method was used only in 
unilateral cases with a previous low-seat-
ed Schanz osteotomy (4 hips in study IV 
and 8 hips in study V) because adequate 
limb-lengthening was not possible with 
the method described above. Metaphyseal 
segmental shortening with angular cor-
rection was performed in these hips to al-
low reduction and proper lengthening of 
the limb (Figure 1, C). A step-method was 
used to stabilize the osteotomy against 
rotation (Paavilainen et al. 1990). This 
operation was performed using a modi-
fi ed anterolateral approach described 
by Hardinge (Hardinge 1982) because it 
provides better access for the corrective 
osteotomy. The procedure was tedious, 
especially in the early cases, when rasping 
of the medullary canal had to be exact for 
both the proximal fragment and the distal 
femur. Moreover, the step-method of the 
osteotomy was time consuming.
8.2.2.2.2 Preparation of the acetabulum
Preparation of the acetabulum was similar 
for both techniques. The proximal parts 
of the pubic and ischial bones and the 
tear-drop were exposed for identifi cation 
of the true acetabulum and evaluation of 
the bone stock. The new acetabulum was 
created at the anatomical level between 
the pubic and ischial bone. If the sagittal 
diameter was too small at this level, the 
cup was placed in a more inferior posi-
tion. An anterolateral bony prominence 
close to the junction of the pubic and iliac 
bones (anterior inferior iliac spine) offers 
reliable anterosuperior support, and the 
junction of the ischium to the ilium gives 
excellent posterosuperior support for the 
acetabular component. The superolateral 
rim between these is often concave and 
defective. However, it can be reinforced 
with a bulk bone graft from the removed 
femoral head or resected medial femoral 
metaphysis (Paavilainen 1997). The graft 
was fi xed by screws. This was performed 
in 29 (43%) hips in study IV and in 42 
hips (62%) in study V.
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Reliable fi xation of the cup, i.e. at least 80% 
host bone coverage of the cup (Wolfgang 
1990), was always achieved without bone 
grafting of the superolateral rim. Bone graft-
ing was performed only to increase bone 
stock in the event of future revisions, not 
for primary fi xation. In six (9%) hips, the 
pelvic bone was so thin that less than 80% 
host bone coverage of the cup was achieved; 
thus, the cup could not be reliably fi xed in 
the remolded shallow acetabulum. In such 
cases, the central part of the medial wall was 
intentionally fractured and pushed medi-
ally while its periosteal attachments were 
preserved. The new medial wall was then 
augmented with cancellous bone (Hess and 
Umber 1978) and the acetabular compo-
nent was impacted against the new medial 
wall. With this protrusion socket technique 
(Hess and Umber 1978), over 80% cover-
age of the cup was also achieved in the re-
maining six hips without superolateral bone 
grafting.
Fig. 1. Diagrams of the osteotomies used for various deformities of the femur. The femoral shaft is 
usually transected below the lesser trochanter, shown as transverse solid lines in A and B. A dotted 
line demonstrates the lowest level of possible osteotomy. A: Proximal shortening osteotomy with dis-
tal advancement of the greater trochanter (vertical solid line) for high congenital dislocations. B: Site 
of shortening osteotomy in hips with previous proximal Schanz osteotomy. C: Segmental shortening 
with angular correction for hips with a previous, more distal Schanz osteotomy. D: The femoral shaft 
is split both anteriorly and posteriorly if it is too narrow for the smallest stem.
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Fig. 2-B An AP pelvic radiograph taken 12 years after an uncemented total 
hip arthroplasty of the right hip, and 11 years after a similar procedure on the 
left hip. Both hips underwent femoral shortening and advancement of the 
greater trochanter. The pelvis is level. The resultant bilateral femoral shorten-
ing was 3.5 centimeters. There are no radiographic signs of loosening of the 
components and no signs of polyethylene wear.
Fig. 2-A and 2-B A 52-year-old woman who had high congenital dislocation 
of both hips. Fig. 2-A Preoperative anteroposterior radiograph of both hips.
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In only a few hips (3 in study IV and 
4 in study V) was THA possible without 
transposition of the greater trochanter 
or performing a metaphyseal step oste-
otomy.
The mean durations of the operations 
were 210 min (range, 95–340 min) and 
215 min (range, 110– 340 min) in stud-
ies IV and V, respectively. Similarly, the 
mean perioperative blood losses were 
2580 ml (range, 650–10000 ml) and 2411 
ml (range, 450–10000 ml).
8.2.2.2.3 Prosthetic components 
The prosthetic components used in stud-
ies IV and V are shown in Table 8. Collared 
CDH (Biomet) stems were used since 1988 
(n=46) and, beginning in 1993, collarless 
CDH stems (n=17) were used as well. The 
stem was chosen according to the anatomy 
of the proximal femur beyond the resection 
level. In study IV, a HexLocTM polyethylene 
liner was used in all of the Biomet cups, and 
in study V it was used for the fi rst 60 (88%) 
acetabular components, and a RingLocTM 
liner was used in the last eight (Biomet Vi-
sion) cups. The mean outer diameter of the 
acetabular components was 46 mm (range, 
40–56 mm). The outer diameter of the cup 
was ≤44 mm in 15 of the 68 hips in both 
studies (IV and V); and with these only 22 
mm heads were available. In the larger cups, 
28 mm heads were used.
Table 8. Prosthetic components used in studies 
IV and V.
Design Study IV Study V
Stem
Lord Madréporique a 1 1
Biomet CDH b 63 63
Biomet Head-Neck c 4 2
Biomet Bi-Metric d 0 2
Cup
Lord e 1 0
Biomet T-Tap e 8 18 f
Biomet Mallory g 34 18
Biomet Universal h 25 24
Biomet Vision i 0 8 j
a Extended porous-coated uncemented stem.
b Proximally circumferentially porous-coated stem, which 
has been specifi cally planned to dysplastic femora.
c Proximally circumferentially porous-coated stem with 
a …
d Proximally circumferentially porous-coated uncemented 
stem.
e Uncemented smooth-threaded cup.
f Biomet T-Tap cup was used in the fi rst 18 hips in study 
V.
g A press-fi t, porous-coated spherical uncemented cup 
with multiple open screw-holes and two? fi ns.
h A press-fi t, porous-coated spherical uncemented cup 
with multiple open screw-holes.
i A press-fi t, porous-coated spherical uncemented cup 
with multiple closed screw-holes and a RingLocTM liner.
j Biomet Vision cup with RingLocTM liner was used since 
1994 (the last 8 hips in study V).
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8.2.2.3 Radiographical evaluation 
(IV and V)
8.2.2.3.1 Preoperative
The height of the dislocation was assessed by 
two methods. First, the three-stage grading 
proposed by Hartofi lakidis et al. (1996) was 
applied. Second, the hips were also graded 
according to the four-stage Eftekhar classi-
fi cation (Eftekhar 1978).
All patients in study IV had a high con-
genital dislocation according to the grading 
proposed by Hartofi lakidis et al. (1996). In 
21 hips (31%), the congenital dislocation 
was graded as Eftekhar C and in 47 hips 
(69%) as Eftekhar D (Eftekhar 1978). In 
study V, in 6 hips (9%) congenital disloca-
tion was classifi ed as dysplastic (Eftekhar 
A) in six hips (9%), as low dislocation 
(Eftekhar B) in 9 hips (13%), and as high 
dislocation (19 Eftekhar C and 34 Eftekhar 
D) in 53 hips (78%).
8.2.2.3.2 Postoperative
Anteroposterior and frog-leg view (Lau-
enstein) radiographs were evaluated by an 
independent observer. An anteroposte-
rior radiograph was taken with the patient 
bearing weight and the feet parallel to each 
other (Turula et al. 1985). To obtain con-
sistent and comparable radiographs, the 
x-ray beam was centered on the symphysis 
pubis. A lateral frog-leg radiograph was tak-
en with the patient supine. The femoral and 
acetabular components were assessed by the 
method described by Johnston et al. (1990). 
The femoral components were classifi ed as 
bone-ingrown, fi brous stable, or unstable 
according to the system described by Engh 
et al. (1987). Subsidence of the femoral 
component was defi ned as a change in posi-
tion of >3 mm, and loosening of the acetab-
ular component was defi ned as a change in 
alignment of >2° or a change in position of 
≥2 mm. Radiolucent lines with a width of 
>1 mm at the component-bone interface 
were recorded in the three zones defi ned 
by DeLee and Charnley (1976). Osteolytic 
lesions were documented and classifi ed by 
size and location (Gruen et al. 1979). Het-
erotopic ossifi cation was classifi ed accord-
ing to the system of Brooker et al. (1973). 
The thickness of the PE liner was assessed 
using a magnifying glass and millimeter pa-
per according to the method described by 
Charnley and Cupic (1973).
8.2.3 Statistical methods
(I, II, III, IV and V)
Associations between categorical variables 
were analyzed by the Chi-square -test or the 
Fisher’s exact –test, whichever was appropri-
ate. Differences between two groups with re-
spect to discrete quantitative variables were 
tested using the Mann-Whitney U-test. The 
normality of distributions was established 
by the Kolmogoroff-Smirnoff goodness-of-
fi t test with the Lilliefors method of signifi -
cance correction. The independent samples 
t-test was applied for comparisons between 
two normally distributed groups. When the 
distributions were skewed, the Mann-Whit-
ney U-test was applied (I and IV). 
Preoperative and postoperative Harris 
hip scores were compared by the Wilcoxon 
signed rank-sum test (IV and V).
The end point criteria for survival were 
defi ned as revision when either one compo-
nent or the whole implant was removed or 
exchanged. The end point for survival was 
defi ned as either revision (removal or ex-
change of one component or the whole im-
plant) for any reason (including exchange 
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of liner), or as revision because of aseptic 
loosening. Kaplan-Meier survival data were 
used to calculate the survival probabilities 
of implants at different time points (Kap-
lan and Meier 1958). The survival data ob-
tained in the Kaplan-Meier analysis were 
compared by the log-rank test (I, II, III IV 
and V).
The Cox multiple-regression model was 
used to evaluate differences between groups 
and to adjust for potential confounding fac-
tors (Cox 1972). The factors studied with 
the Cox model were as follows: implant 
fi xation concepts (I), implant design con-
cepts (I and III), implant designs (II), hos-
pital THA volume (I), age group (I and III) 
and gender (I and III). All models included 
adjustment for differences in age (<46 and 
46–54 years) and gender. When the effects 
of age, gender and hospital volume on the 
survival of implants were analyzed using 
the Cox regression model, adjustment was 
also made for implant design concepts (I 
and III). Cox regression analyses provided 
estimates of survival probabilities and revi-
sion risk ratios (RR) for different factors. 
Estimates from Cox analyses were used to 
calculate adjusted survival curves at mean 
values of the risk factors. The Wald test was 
used to calculate p-values for data obtained 
from the Cox multiple regression analysis.
Differences between groups were con-
sidered statistically signifi cant, if the p-val-
ues were less than 0.05 in a two-tailed test (I, 
II, III, IV and V).
The statistical analyses were conducted 
with SPSS (versions 11.0 and 12.0) statisti-
cal software (SPSS Inc, Chicago, Ill., U.S.A.) 
for (I, II, III, IV and V).
8.2.4 Ethical considerations
Informed consent was obtained from all 
participants (IV and V). The authors ob-
tained permission to perform these studies 
from the ethical committee of the hospital 
district in which the studies were conducted 
(I, II, III, IV and V).
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9. Results
9.1 Register-based studies
(I, II and III)
9.1.2 Primary operation
9.1.2.1 Patient characteristics
Of the THAs, 82% in study I (n=3811) and 
51% (n=1293) in study III were performed 
in patients aged 46–54 years. The rest were 
performed on patients aged <46 years. 
Moreover, 54% (n=2508) of THAs in study 
I and 52% (n=1331) in study III were per-
formed on the right hip.
The number of hospitals performing 
THAs for primary OA in young patients (I) 
increased over the study period, from 30 at 
the beginning of the period (1980-1981) 
to 49 at the beginning of the next decade 
(1990-1991). This fi gure rose to 64 at the 
end of the study period (2000-2001). Simi-
larly, the number of hospitals performing 
THAs for RA in young patients (III) rose 
from 19 at the beginning of the study pe-
riod (1980–1981) to 32 at the beginning of 
the next decade (1991-1992), and remained 
at this level to the end of the study period 
(2002-2003). Over the whole study period, 
only 5 hospitals in Finland (3 university 
hospitals, one hospital run by a private 
foundation and one central hospital) per-
formed more than 10 THAs annually for 
primary OA (I), and only one hospital (run 
by a private foundation) performed more 
than 20 THAs annually for RA (III) on pa-
tients under 55 years of age. During the last 
time-period (2000–2001) analyzed in study 
I, 52 of the 64 hospitals studied, performed 
fewer than 10 THAs annually for primary 
OA in young patients. Similarly, only 6 of 
the 32 hospitals studied performed more 
than 20 THAs annually for RA in young pa-
tients during 2002–2003 (III).
9.1.2.2 Femoral components
Uncemented femoral components were 
used in a majority of the THAs performed 
in young patients both with primary OA (I) 
and RA (III) in Finland during the study pe-
riod (Table 9). At the end of the study peri-
od (2000–2001 for OA, 2002-2003 for RA), 
the 3 most common stem brands (Bi-Met-
ric, ABG II and Exeter Universal) accounted 
for 72% and 70% of all stems in patients 
with OA (I) and RA (III), respectively. The 
proportion of uncemented stems implanted 
in patients of both groups rose dramatically 
from the beginning of the study to the early 
1990s.
9.1.2.3 Acetabular components
Uncemented acetabular components were 
used in a majority of the THAs performed in 
young patients both with primary OA (I) and 
RA (III) in Finland during the study period 
(Table 9). At the end of the study periods 
(2000–2001 for OA and 2002–2003 for RA), 
the 3 most common cup brands accounted 
for 64% of all cups implanted for OA (I) and 
46% of all cups implanted for RA (III). The 
proportion of uncemented cups also rose 
markedly from the beginning of the study 
period to the early 1990s. However, since the 
beginning of the 21st century the use of ce-
mented cups appears to have become more 
popular for both patient groups. A majority 
of the femoral and acetabular components 
were used in less than 20 operations during 
the whole study period.
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Table 9. Femoral and acetabular components used in young patients with primary OA and RA in Finland 
over the study period a.
Femoral components Acetabular components
N b Uncem. < 20 operationsc N b Uncem. < 20 operationsc
Primary OA (study I) 73 78% 69% 79 82% 59%
RA (study III) 71 60% 73% 83 82% 72%
a Study period was 1980-2001 in patients with primary OA and 1980-2003 in patients with RA.
b Number of different implant designs used over the study period.
c Number of implant designs used in less than 20 operations over the whole study period.
OA = osteoarthritis. RA = rheumatoid arthritis.
9.1.3 Revision operation
Aseptic loosening was the most common 
reason for revision both in young patients 
with primary OA (I) and in patients with 
RA (III) (Table 10). The revision bur-
den was higher in patients with RA than 
in patients with primary OA (19.1% vs. 
13.2%).
Reasons for revisions of uncemented 
implant designs are presented in Tables 
11a and 11b (II). Over the study period 
90% (37/39) of the revisions of the PCA 
Pegged cups were performed due to asep-
tic loosening. In contrast, 52% (23/44) of 
the Biomet Romanus and 67% (14/21) of 
the Biomet Mallory cups revised were due 
to other reasons (including exchange of 
liner).
Table 10. THA revisions in patients with diagnoses of primary osteoarthritis or rheumatoid 
arthritis and aged <55 years at the time of the primary operation in Finland a.
Primary OA (study I) RA (study III)
Follow-up b 6.9 (0 - 22) 9.7 (0 - 24)
Total number of revisions 709 605
Revision burden c 13.2% 19.1%
Reasons for revision
Aseptic loosening 82% 82%
Dislocation 2.7% 3.3%
Infection 2.7% 2.8%
Malposition 2.3% 1.0%
Fracture of implant 3.0% 1.2%
Periprosthetic fracture 1.1% 1.8%
Other (incl. exchange of liner) 6.3% 8.3%
a Study period was 1980-2001 in patients with primary OA and 1980-2003 in patients with RA.
b Mean follow-up in years, range in parentheses.
c Expressed as a percentage by dividing the number of revisions done over a certain period by the 
total number of primary and revision THAs performed over the same period.
OA = osteoarthritis. RA = rheumatoid arthritis.
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Table 11a. Reasons for revision of femoral components in study II.
N of revisions (revision burden %)
Stem brand
Opera-
tions (n)
Aseptic 
loosening
Infec-
tion
Disloca-
tion
Malposi-
tion of 
stem
Fracture 
of stem
Fracture 
of bone
Total
ABG I 390 2 (0.5) - 4 (1.0) - - - 6 (1.5)
Anatomic Mesh 135 13 (8.5) - - 1 (0.7) 4 (2.6) - 18 (11.8)
Bi-Metric 1982 37 (1.8) 7 (0.3) 15 (0.7) 12 (0.6) - 2 (0.1) 73 (3.6)
Lord Madréporique 286 26 (8.3) 1 (0.3) 2 (0.6) 29 (9.2)
PCA Std 111 9 (7.4) 1 (0.8) - - 1 (0.8) - 11 (9.0)
Profi le Porous 115 - 1 (0.8) 4 (3.2) 2 (1.6) 2 (1.6) - 9 (7.3)
Spotorno 108 1 (0.9) - 1 (0.9) - 1 (0.9) 1 (0.9) 4 (3.6)
Table 11b. Reasons for revision of acetabular components in study II.
N of revisions (revision burden%)
Cup brand
Opera-
tions (n)
Aseptic 
loosening
Infec-
tion
Disloca-
tion
Malposi-
tion of the 
cup
Other 
reasons a
Total
ABG I 108 4 (3.1) 0 4 (3.1) 0 14 (10.8) 22 (16.9)
ABG II 473 1 (0.2) 1 (0.2) 0 0 0 2 (0.4)
Biomet Mallory 110 5 (3.8) 0 1 (0.8) 1 (0.8) 14 (10.7) 21 (16.0)
Biomet Romanus 114 18 (11.4) 1 (0.6) 2 (1.3) 0 23 (14.6) 44 (27.8)
Biomet Universal 898 34 (3.4) 2 (0.2) 12 (11.9) 8 (0.8) 58 (5.7) 114 (11.3)
Biomet Vision 418 0 1 (2.4) 1 (2.4) 1 (2.4) 1 (2.4) 4 (0.9)
Harris-Galante II 277 16 (5.1) 2 (0.6) 3 (1.0) 1 (0.3) 15 (4.8) 37 (11.8)
Morscher Press-Fit 136 2 (1.4) 0 1 (0.7) 0 0 3 (2.2)
PCA Pegged 122 37 (23.0) 1 (0.6) 0 0 1 (0.6) 39 (24.2)
Profi le Duraloc 145 1 (0.7) 0 3 (2.0) 1 (0.7) 3 (2.0) 8 (5.2)
a Including exchange of liner.
9.1.4 Follow-up results for all 
primary operations
9.1.4.1 Stem fi xation (I)
In young patients with primary OA, Kap-
lan-Meier analysis of the total data showed 
that the survival of uncemented stems was 
signifi cantly higher than that of cemented 
stems (p<0.001; all revisions; p<0.001, asep-
tic loosening). The Cox regression analysis, 
with or without adjustment for age and 
gender, gave similar results.
Kaplan-Meier analysis of stems im-
planted during the fi rst decade (1980–1990) 
of the study period showed that survival 
of uncemented stems was notably better 
than that of cemented stems (p=0.002, all 
revisions; p<0.001, aseptic loosening). In 
Kaplan-Meier analysis of the last decade, 
there was a signifi cant difference in over-
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all survival in favour of uncemented stems, 
when aseptic loosening was used as the end 
point (p<0.001). However, the difference 
in survival rates between uncemented and 
cemented stems was not statistically sig-
nifi cant when the end point was defi ned as 
any revision (p=0.2). Similar results were 
obtained from the Cox regression analysis, 
both with and without adjustment for age 
and gender.
9.1.4.2 Stem design concepts (I, 
and III)
9.1.4.2.1 Whole study period
Data for the stem design concepts for the 
whole study period are shown in Tables 
12 and 13.
When the whole study period was ana-
lyzed, all stem design concepts had a >90% 
survival rates at 7 years when aseptic loos-
ening was taken as the end point, both in 
patients with primary OA (I) and in patients 
with RA (III) (Table 12). For patients with 
primary OA (I), only proximally porous-
coated uncemented stems had >95% sur-
vival rate at 10 years. Moreover, for patients 
with RA (III), the survival rate for proximally 
porous-coated stems was 89% (95% CI 83–
94), and that of cemented stems 84% (95% 
CI 81–87) at 15 years. However, the survival 
rate of uncoated stems had declined to 71% 
(95% CI 63–79) over the same period. Cox 
regression analysis (with adjustment for age 
and gender) revealed that both proximally 
porous-coated, extended porous-coated 
and proximally HA-coated uncemented 
stems had a signifi cantly lower risk of revi-
sion than cemented stems in patients with 
OA (I) (Figure 3 and Table 12). Further-
more, proximally porous-coated unce-
mented stems had a signifi cantly (p<0.001) 
lower risk of revision than cemented stems 
in patients with RA (III) (Figure 4 and Ta-
ble 12). In contrast, uncoated uncemented 
stems had an increased risk of revision as 
compared to cemented stems in patients 
with RA (III) (Figure 4 and Table 12). The 
Cox regression model indicated that the 
survival of proximally porous-coated unce-
mented stems was already better than that 
of cemented stems during the fi rst 7 years of 
follow-up. Even after 7 years of follow-up, 
there was a trend for porous-coated stems 
to perform better than cemented ones.
Fig 3. Cox-adjusted survival curves of 4315 stems 
in young patients with primary OA, with stem 
design concept as the strata factor. The end point 
defi ned as stem revision due to aseptic loosening. 
Adjustment made for age and gender.
With any stem revision taken as the end 
point, only proximally porous-coated unce-
mented stems had a >90% survival rate at 
10 years in both patient groups (I and III) 
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(Table 13). In patients with primary OA 
(I), both proximally and extended porous-
coated uncemented stems had better overall 
survival than cemented stems (Table 13). 
There was also a trend towards better sur-
vival of HA-coated uncemented stems than 
for cemented stems, but the difference just 
failed to be statistically signifi cant (p=0.05). 
In the Cox model of patients with RA (III), 
proximally porous-coated uncemented 
stems were found to have a decreased risk 
of stem revision and uncoated uncemented 
stems an increased risk of stem revision as 
compared to cemented stems (Table 13).
Fig 4. Cox-adjusted survival curves of 2232 stems 
in young patients with RA, with stem design con-
cept as the strata factor. The end point defi ned as 
stem revision due to aseptic loosening. Adjust-
ment made for age and gender.
9.1.4.2.2 Primary OA, period 1980–1990 (I)
Only proximally and extended porous-
coated uncemented stems had >90% sur-
vival rates in patients with primary OA at 10 
years. In the Cox regression analysis, both 
proximally and extended porous-coated 
uncemented stems had a lower risk of re-
vision  than cemented stems when aseptic 
loosening was taken as the end point (Fig-
ure 5 and Table 14). With any stem revision 
as the end point, 10 year survival rates of all 
concepts declined to less than 90%. Moreo-
ver, the Cox analysis revealed that extended 
porous-coated uncemented stems still had 
a signifi cantly lower risk of revision than 
cemented stems. It should be noted that 
HA-coated uncemented stems were not im-
planted during the 1980s.
9.1.4.2.3 Primary OA, period 1991–2001 (I)
When stems implanted over the 1991–2001 
period were analyzed, only proximally po-
rous-coated uncemented stems had >95% 
survival rates at 10 years when aseptic loos-
ening was taken as the end point (Figure 
6, Table 14). Using the Cox regression 
analysis, both proximally porous-coated 
and HA-coated uncemented stems were 
found to have lower risks of revision than 
cemented stems. In contrast, uncoated 
uncemented stems had a signifi cantly in-
creased risk of revision as compared to ce-
mented stems. With all revisions taken as 
the end point, there were non-signifi cant 
trends towards a lower risk of revision for 
proximally porous-coated (p=0.09) and 
HA-coated uncemented stems (p=0.07) as 
compared to cemented stems.
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9.1.4.2.4 Cohort effect among stem 
design concepts (I and III)
In patients with primary OA (I), the Cox 
regression analysis showed that proximally 
porous-coated uncemented stems implant-
ed during 1991–2001 had a signifi cantly 
lower risk of revision than stems of the 
same design concept implanted during the 
fi rst decade (1980–1990) of the study pe-
riod when all revisions (p<0.001) or aseptic 
loosening (p<0.001) were taken as the end 
points (Table 14). There were no signifi cant 
differences in survival between the cohorts 
of 1980–1990 and 1991–2001 for cemented 
and uncoated uncemented stems.
The Cox regression analysis did not re-
veal any differences in stem design concept 
survival between the cohorts of 1980–1991 
and 1992–2003 for patients with RA (III).
Fig 6. Cox-adjusted survival curves calculated for 3240 stems 
implanted during 1990-2001, with stem design concept as 
the strata factor. The end point defi ned as stem revision due 
to aseptic loosening. Adjustment made for age and gender. 
Only 31 extended porous-coated stems were implanted dur-
ing 1991-2001; they are not included in the analysis.
Fig 5. Cox-adjusted survival curves calculated for 
1421 stems implanted during 1980-1990, with 
stem design concept as the strata factor. The end 
point defi ned as stem revision due to aseptic loos-
ening. Adjustment made for age and gender.
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9.1.4.3 Uncemented stem designs 
(II)
The Bi-Metric, the CLS Spotorno, the ABG I 
and also the Profi le Porous stems had >95% 
survival rates at 10 years when aseptic loos-
ening was taken as the end point (Table 15). 
At 15 years, survival rate of the Bi-Metric 
stem was still 95% (95% CI 93–97), and that 
of the PCA Std stem 90% (95% CI 84–97), 
whereas the 15 year survival rate of the ex-
tended porous-coated Lord Madréporique 
stem was 91% (95% CI 88–94). Survival 
of the other stem brands were compared 
with the Bi-Metric stem (reference stem): 
Cox regression analysis (adjusting for age 
and gender) indicated that both the Lord 
Madréporique stem (RR 2.2, 95% CI 1.3–
3.7; p=0.004) and the Anatomic Mesh stem 
(RR 2.8, 95% CI 1.5–5.4; p=0.002) had sig-
nifi cantly higher risks of revision than the 
Bi-Metric stem (Figure 7).
 
Fig 7. Cox-adjusted survival curves of 3127 stems 
in patients under 55 years of age, with stem de-
sign as the strata factor. The end point defi ned 
as stem revision due to aseptic loosening. Ad-
justment made for age and gender. Curve of the 
Profi le Porous stem is not displayed, as it had a 
100% survival rate at 10 years.
All stem brands had >90% survival 
rates at 10 years, using stem revision for 
any reason as the end point (Table 15). 
The Bi-Metric stem had a 92% (95% CI 
90–94) survival rate at 15 years. Using the 
Cox model, the Anatomic Mesh stem was 
found to have a 2.2-fold (95% CI 1.3–3.7; 
p=0.004) increased risk of stem revision 
as compared to the Bi-Metric stem.
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9.1.4.4 Cup fi xation (I)
We found no differences in survival rates 
between cemented and uncemented cups 
in young patients with primary OA, using 
either the Kaplan-Meier analysis or the Cox 
regression model to analyse the whole study 
period.
The Kaplan-Meier analysis of cups im-
planted during the fi rst decade (1980–1990) 
revealed that overall survival of cemented 
cups was signifi cantly better than that of un-
cemented cups (all revisions, p=0.01; asep-
tic loosening, p=0.02). Conformation of 
this was obtained using the Cox regression 
analysis, which gave similar results (with or 
without adjustment for age and gender).
Neither the Kaplan-Meier analysis nor 
the Cox regression method revealed any 
differences in survival rates between ce-
mented and uncemented cups implanted 
during 1991–2001 using either all revisions, 
or aseptic loosening as the end point.
9.1.4.5 Cup design concepts 
(I and III)
9.1.4.5.1 Whole study period (I and III)
In young patients with primary OA (I), 
only press-fi t porous- and HA-coated 
uncemented cups showed >95% survival 
rates at 7 year follow-up with aseptic loos-
ening as the end point (Table 16). At 10 
years, only porous-coated uncemented 
cups had >90% survival rate. In young pa-
tients with RA (III), all cup concepts except 
smooth-threaded uncemented cups had > 
95% survival rates at 7 years (Table 16). 
However, survival rates of all cup concepts 
declined below 85% at 15 years. In the Cox 
regression analysis of patients with pri-
mary OA (I), both press-fi t uncemented 
cup concepts had a decreased risk of re-
vision as compared to all-poly cemented 
cups, whereas smooth-threaded cups had 
an increased risk of revision (Figure 8 and 
Table 16). Smooth-threaded cups had a 
signifi cantly higher risk of revision than 
all-poly cemented cups in patients with 
RA (III) (Figure 9 and Table 16).
Using any cup revision as the end 
point, all cup design concepts except 
smooth-threaded uncemented cups in 
young patients with primary OA (I), had 
>90% survival rates at 7 years (Table 
17). However, survival rates for all cup 
concepts at 10 years had declined <90%. 
Moreover, smooth-threaded uncemented 
cups had only a 69% survival rate at 10 
years. In young patients with RA (III), 
only press-fi t porous-coated uncement-
ed cups and all-poly cemented cups had 
Fig 8. Cox-adjusted survival curves of 4217 cups 
in young patients with primary OA, with cup de-
sign concept as the strata factor. The end point 
defi ned as cup revision due to aseptic loosening. 
Adjustment made for age and gender.
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>90% survival rates at 7 years (Table 17). 
The 15-year survival rate for press-fi t 
porous-coated cups declined to <70%. 
Smooth-threaded uncemented cups had 
a catastrophic survival rate of only 53% 
at 15 years. Using the Cox regression 
analysis smooth-threaded cups had an 
increased risk of revision as compared to 
cemented cups in patients with primary 
OA (I) (Figure 10 and Table 17). All un-
cemented cup concepts had an increased 
risk of revision as compared to all-poly 
cemented cups in patients with RA (III) 
(Figure 11 and Table 17). Whereas the 
survival of porous-coated uncemented 
cups started to decline after 7 years fol-
low-up, the survival of HA-coated unce-
mented cups was already poorer than that 
of all-poly cemented cups during the fi rst 
7 years of follow-up in patients with RA.
Fig 9. Cox-adjusted survival curves of 2151 cups 
in young patients with RA, with cup design con-
cept as the strata factor. The end point defi ned 
as cup revision due to aseptic loosening. Adjust-
ment made for age and gender.
Fig 10. Cox-adjusted survival curves of 4217 
cups in young patients with primary OA, with 
cup design concept as the strata factor. The end 
point defi ned as any cup revision (including ex-
change of liner). Adjustment made for age and 
gender.
Fig 11. Cox-adjusted survival curves of 2151 
cups in young patients with RA, with cup design 
concept as the strata factor. The end point de-
fi ned as any cup revision (including exchange of 
liner). Adjustment made for age and gender.
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9.1.4.5.2 Primary OA, period 1980–1990 (I)
In patients with primary OA, only press-
fi t porous-coated uncemented cups had a 
>90% survival rate at 10 years with revi-
sion for aseptic loosening of the cup as 
the end point (Table 18). However, using 
the Cox regression analysis, there was not 
any difference in revision risks between 
porous-coated uncemented and all-poly 
cemented cups (Figure 12and Table 18). 
Smooth-threaded uncemented cups were 
found to have an increased risk of revision 
as compared to all-poly cemented cups. 
With any cup revision as the end point, 
10 year survival rates of all concepts ex-
cept all-poly cemented cups declined to < 
85%. Smooth-threaded uncemented cups 
had a signifi cantly higher risk of revision 
than all-poly cemented cups as estimated 
by the Cox regression analysis. In addi-
tion, there was a trend for increased risk 
of revision  for press-fi t porous-coated 
uncemented cups as compared to all-poly 
cemented cups, but the difference was not 
statistically signifi cant (p=0.07) (Figure 
13 and Table 18).
9.1.4.5.3 Primary OA, period 1991–2001 (I)
Only press-fi t porous-coated uncemented 
cups had >95% survival rate at 10 years 
when revision for aseptic loosening of the 
cup was taken as the end point for patients 
with primary OA (Table 18). Using the Cox 
regression analysis, press-fi t porous-coat-
ed cups had a decreased risk of revision as 
compared to all-poly cemented cups (Fig-
ure 14 and Table 18). Furthermore, there 
was a trend towards a decreased risk of re-
vision for press-fi t HA-coated uncemented 
cups as compared to all-poly cemented 
Fig 13. Cox-adjusted survival curves calculated 
for 1262 cups implanted in young patients with 
primary OA over 1980-1990, with cup design 
concept as the strata factor. The end point de-
fi ned as any cup revision (including exchange of 
liner). Adjustment made for age and gender.
Fig 12. Cox-adjusted survival curves calculated 
for 1262 cups implanted in young patients with 
primary OA over 1980-1990, with cup design 
concept as the strata factor. The end point de-
fi ned as revision due to aseptic loosening of the 
cup. Adjustment made for age and gender.
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cups, but the difference lacked statistical 
signifi cance (p=0.07). With any cup revi-
sion taken as the end point, the 10 year sur-
vival rates of press-fi t porous-coated unce-
mented cups and all-poly cemented cups 
were still >90%. Using the Cox regression 
analysis, no differences were found for risk 
of revision between uncemented and all-
poly cemented cup concepts (Figure 15 
and Table 18).
9.1.4.5.4 Cohort effect among cup design 
concepts (I and III)
The Cox regression analysis indicated that 
press-fi t porous-coated uncemented cups 
implanted into patients with primary OA 
(I) during 1991–2001 had signifi cantly low-
er risk of revision than cups of the same de-
sign concept implanted during the fi rst dec-
ade (1980–1990) of the study period when 
either all revisions or aseptic loosening was 
taken as the end point (p<0.001 for both 
comparisons; Table 18). The cohort effect 
was also apparent for smooth threaded un-
cemented cups. Such cups implanted dur-
ing the 1991–2001 period had a signifi cantly 
lower risk of revision than the same type of 
cups implanted during 1980–1990 (all revi-
sions, p=0.02; aseptic loosening, p=0.003; 
Table 18). There was no difference in surviv-
al rates for all-poly cemented cups between 
the cohorts of 1980–1990 and 1991–2001. 
Cox regression analysis of patients with RA 
(III), revealed that press-fi t porous-coated 
uncemented cups implanted during 1992–
2003 had a signifi cantly decreased risk of 
revision as compared to cups of the same 
concept implanted during 1980–1991 with 
either aseptic loosening (p<0.001) or all re-
visions (p=0.03) as the end point.
Fig 14. Cox-adjusted survival curves calculated 
for 2946 cups implanted in young patients with 
primary OA over 1991-2001, with cup design 
concept as the strata factor. The end point de-
fi ned as revision due to aseptic loosening of the 
cup. Adjustment made for age and gender.
Fig 15. Cox-adjusted survival curves calculated 
for 2946 cups implanted in young patients with 
primary OA over 1991-2001, with cup design 
concept as the strata factor. The end point de-
fi ned as any cup revision (including exchange of 
liner). Adjustment made for age and gender.
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9.1.4.6 Uncemented cup designs (II)
Only three of the nine uncemented cup de-
signs studied (the ABG I, the Biomet Uni-
versal and the Harris-Galante II) had >90% 
survival rates at 10 years in young patients 
with primary OA, when aseptic loosening 
was taken as the end point (Table 19). Sur-
vival rates of the Biomet Universal and the 
Harris-Galante II cups remained at around 
90%, even at 13 years follow-up. The most 
recently introduced uncemented cup de-
signs had good survival rates at fi ve years, 
but 10 year survival data are still not yet 
available for these designs. However, there 
was no difference between survival rates of 
these new designs and the reference cup (Bi-
omet Universal) at fi ve years. The Biomet 
Romanus (p=0.009) and the PCA Pegged 
(p<0.001) cups had a signifi cantly higher 
risk of revision than the Biomet Universal 
cup after fi ve years of follow-up using the 
Cox regression analysis (Figure 16 and Ta-
ble 19). There were no other differences in 
survival rates between the cup designs.
Fig 16. Cox-adjusted survival curves calculated 
for 2801 cups, with cup design as the strata fac-
tor. The end point defi ned as revision due to 
aseptic loosening of the cup. Adjustment made 
for age and gender. Curve of the Biomet Vision 
cup is not shown as it had a 100% survival rate 
at 5 years.
With any cup revision taken as the end 
point, only the Harris-Galante II cup had 
over 80% survival rate at 10 years (Table 
19). The 13 year survival rates of cups with 
long-term follow-up (the Biomet Universal, 
the Harris-Galante II and the PCA Pegged) 
declined to <80%. The ABG I (RR 0.3, 95% 
CI 0.1–0.8; p=0.02) and the ABG II cups 
(RR 0.2, 95% CI 0.0 - 0.7; p=0.02) had a 
lower risk of revision than the Biomet Uni-
versal cup before fi ve years of follow-up had 
elapsed, when analysed by the Cox regres-
sion method (Figure 17 and Table 19). How-
ever, the difference between the ABG I and 
the Biomet Universal cups disappeared after 
5 years of follow-up. The Harris-Galante II 
cup was found to have a 0.7-fold (95% CI 
0.5–1.0; p=0.04) decreased risk of revision 
as compared to the Biomet Universal cup. 
The Biomet Romanus cup had a 1.9-fold 
(95% CI 1.3–2.7; p<0.001) increased risk of 
revision as compared to the reference cup 
(Biomet Universal).
74
Fig 17. Cox-adjusted survival curves calculated 
for 2801 cups, with cup design as the strata fac-
tor. The end point defi ned as any cup revision. 
Adjustment made for age and gender. Curves of 
the ABG II and the Biomet Vision cups are not 
shown as they had a 100% survival rate.
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9.1.4.7 Total hip replacement 
designs (II)
The Biomet Bi-Metric – Universal (the ref-
erence design), the ABG I – ABG I and the 
Anatomic Mesh – Harris-Galante (HG) II 
cup-stem combinations all had >95% sur-
vival rates at 10 years with aseptic loosen-
ing of the stem and/or the cup as the end 
point in young patients with primary OA 
(Table 20). The Cox regression analysis re-
vealed, that the Bi-Metric – Romanus and 
the PCA Std – PCA Pegged prostheses had 
signifi cantly higher risk of revision than the 
Bi-Metric – Universal combination (Figure 
18 and Table 20).
Fig 18. Cox-adjusted survival curves calculated 
for 2061 THRs, with THR design as the strata 
factor. The end point defi ned as revision due to 
aseptic loosening of the stem and/or the cup. 
Adjustment made for age and gender. The curve 
of the Bi-Metric – Vision THR is not shown as it 
had a 100% survival rate at 5 years.
When the end point was defi ned as any 
cup and/or stem revision, survival rates of 
most designs declined markedly. Only the 
Anatomic Mesh – HG II prosthesis had 
>80% survival rate at 10 years (Table 20). 
The Bi-Metric – Romanus prosthesis had 
an increased risk of revision as compared to 
the reference brand (the Bi-Metric – Uni-
versal prosthesis) when analysed by the Cox 
regression method (Figure 19 and Table 
20). The ABG I – ABG II combination had 
a lower risk of revision than the reference 
design.
Fig 19. Cox-adjusted survival curves calculated 
for 2061 THRs, with THR design as the strata 
factor. The end point defi ned as any revision. 
Adjustment made for age and gender.
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9.1.4.8 Gender and age as risk 
factors (I and III)
9.1.4.8.1 Primary osteoarthritis (I)
Cox regression analysis of the total data re-
vealed that in young patients with primary 
OA, females had a higher risk of revision 
than males with either all revisions (RR 1.2, 
95% CI 1.0–1.4; p=0.02) or aseptic loosening 
(RR 1.2, 95% CI 1.0–1.4; p=0.02) as the end 
point. When the risk of stem revision was 
analyzed using the Cox regression method, 
there was no signifi cant difference in risk of 
revision between the genders when either 
all revisions or aseptic loosening was used 
as the end point. However, females had a 
higher risk of cup revision than males when 
either all revisions (RR 1.2, 95% CI 1.1–1.5; 
p=0.01) or aseptic loosening (RR 1.3, 95% 
CI 1.1–1.5; p=0.009) was chosen as the end 
point. Results were similar after adjustment 
for age and cup design concepts.
With any revision as the end point, 
younger patients (<46 years) were found 
to have a 1.2-fold (95% CI 1.0–1.5; p=0.03) 
increased risk of revision as compared to 
older patients (46–54 years). However, 
after adjustment for gender and implant 
concepts the difference disappeared. With 
aseptic loosening as the end point, the risk 
of revision in the younger age group (<46 
years) was 1.3 (95% CI 1.1–1.6; p=0.005) 
times as high as that in the older age group 
(46–54 years). Adjustment for gender and 
implant concepts using the Cox regression 
method gave similar results. When the risk 
of stem revision was analyzed there was no 
difference in risk of revision between the 
age groups with either all revisions or asep-
tic loosening as the end point (with or with-
out adjustment for gender and stem con-
cepts). However, the younger age group had 
a higher risk of cup revision than the older 
age group when either all revisions (RR 1.2, 
95% CI 1.1–1.5; p=0.01) or aseptic loos-
ening (RR 1.3, 95% CI 1.1–1.5; p=0.009) 
served as the end point. Adjustment for 
gender and cup design concepts in the Cox 
model gave similar results.
9.1.4.8.2 Rheumatoid arthritis (III)
The Cox regression analysis of the total data 
did not reveal any difference in risk of revi-
sion between the genders of young patients 
with RA when either all revisions or aseptic 
loosening was taken as the end point (with 
or without adjustment for age and implant 
concepts). When the risk of stem revision 
was analyzed using the Cox regression 
method, there was a trend towards a greater 
risk of stem revision in males as compared 
to females with adjustment for age and stem 
concepts (aseptic loosening, p=0.06; any 
stem revision, p=0.05). Analysis of cup revi-
sions suggested that there was no difference 
in risk of revision between the genders when 
either all cup revisions or aseptic loosening 
served as the end point (with or without ad-
justment for age and cup design concepts).
With aseptic loosening taken as the end 
point, there was no difference in revision 
risk between the age groups (with or with-
out adjustment for gender and stem con-
cepts). With any revision as the end point, 
younger patients (<46 years) were found to 
have a 1.2-fold (95% CI 1.0–1.5; p=0.03) in-
creased risk of revision as compared to old-
er patients (46–54 years) (with adjustment 
for gender and implant design concepts). 
When the risk of stem revision was analyzed 
by the Cox model, there was no signifi cant 
difference in risk of revision between the age 
groups using either all revisions or aseptic 
loosening as the end point (with or without 
79
adjustment for gender and stem design con-
cepts). However, the younger age group had 
a higher risk of cup revision than the older 
age group when either all revisions (RR 1.3, 
95% CI 1.1–1.6; p=0.005) or aseptic loosen-
ing (RR 1.3, 95% CI 1.1–1.7; p=0.008) was 
chosen as the end point (with adjustment 
for gender and cup design concepts).
9.1.4.9 Hospital volume and 
survival of implants (I)
Neither the Kaplan-Meier analysis nor the 
Cox multiple-regression model found any 
difference in risk of revision between hos-
pitals performing more than 10 and those 
performing 10 or fewer THAs annually in 
young patients with primary OA irrespec-
tive of whether the end point was defi ned 
as revision due to any reason or as aseptic 
loosening.
9.2 Clinical studies (IV and V)
9.2.1 Clinical results
9.2.1.1 Functional results
9.2.1.1.1 Patients with high congenital 
dislocation (IV)
The Harris hip score (HHS) averaged 54.2 
points (range, 13– 85) preoperatively, 86.5 
points (range, 48–100 ) at the one-year 
follow-up examination, and 83.9 points 
(range, 34–100 ) at the fi nal follow-up eval-
uation (p<0.001 for both comparisons). 
The mean HHS for hip pain increased from 
22.1 points (range, 0–40) preoperatively to 
41.5 points (range, 0–44) at the one-year 
follow-up evaluation (p<0.001). At the 
time of fi nal follow-up, 45 of the 68 hips 
(66%) (37 patients) were totally pain-free. 
Pain was slight, occasional in 16 hips (24%), 
mild in three, moderate in one, marked in 
three, and for one hip there was severe rest 
pain. The patient with severe rest pain had 
a completely worn liner in the painful hip 
at the time of the last follow-up; only three 
weeks earlier the hip had been painless; the 
patient was urgently scheduled for a liner 
revision. In total, 43 (67%) of 64 hips (33 
of 52 patients) had a good or excellent HHS 
(>80 points). In all, 44 of the 56 patients 
(79%) subjectively reported good satisfac-
tion at their last follow-up visit, seven pa-
tients (12%) were unsatisfi ed with the out-
come, and fi ve patients had no opinion on 
the outcome.
All patients had a limp preoperatively, 
and the Trendelenburg sign was positive in 
57 (84%) of the 68 hips (Table 5). At the 
time of fi nal follow-up, there was a posi-
tive Trendelenburg sign in only fi ve of the 
64 hips (78%). In 59 (92%) of 64 hips, the 
abduction strength of the hip was graded as 
good or slightly decreased (Seddon 1954) 
(Table 21). Elements of the HHS for func-
tion are summarized in Table 22. A total of 
32 (57%) patients were able to walk without 
a limp; 17 (53%) had an unlimited walking 
distance. Moreover, 31 (55%) patients were 
able to walk without support; 23 had an 
unlimited walking distance. Nine patients 
used a single cane for long walks, eight pa-
tients used a single cane most of the time, 
fi ve patients used two canes, and three pa-
tients used two crutches. A total of 24 (43%) 
patients had a limp, which was moderate in 
four and slight in 20 (compare abduction 
strength). The median distance that the pa-
tient could walk increased from 100–500 
meters to 1000–1500 meters (p<0.001). In 
all, 26 (46%) patients were able to walk an 
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unlimited distance at the time of their last 
follow-up visit. The range of motion in-
creased signifi cantly in extension and fl ex-
ion, abduction, and internal rotation after 
THA, as did the mean HHS for the range of 
motion (Table 23).
Table 21. Abduction strength of the hips at fi nal follow-up.
Abduction strength N (%)
Active
ROM*
Trendelen-
burg (+/-)
Active contraction without movement (1) 1 (2%) 0  1 / 0
Active movement against gravity (no resistance from
physician) (3)
4 (6%) 4 +/- 8 2 / 2
Active movement against gravity and resistance (4) 21 (33%) 25 +/- 10 2 / 19
Normal strength (5) 38 (59%) 36 +/- 9 0 / 38
*The values are given, in degrees, as the mean and standard deviation. The abduction strength was graded from zero 
(no active contraction) to fi ve (normal strength) according to MRC scale.
Table 22. Harris Hip Score for function* at fi nal follow-up.
Elements Preoperative At fi nal follow-up p-value
Limp 1.2 (0 - 5) 8.3 (0 - 11) <0.001
Support 8.2 (0 - 11) 8.1 (0 - 11) 0.74
Walking distance 6.2 (2 - 11) 8.3 (2 - 11) <0.001
Stairs 1.7 (0 - 4) 2.3 (1 - 4) 0.004
Shoes and socks 2.4 (0 - 4) 2.8 (0 - 4) 0.11
*The values are given as the mean (range).
Table 23. Range of Motion *
Movement Preoperative Final Follow-Up P-value
Extension 2 +/- 8 8 +/- 6 <0.001
Flexion 95 +/- 24 106 +/- 10 <0.001
Abduction 31 +/- 15 38 +/- 10 0.001
Adduction 26 +/- 13 27 +/- 7 0.35
Internal Rotation 33 +/- 23 40 +/- 17 0.026
External Rotation 38 +/- 26 35 +/- 16 0.58
HHS for range of motion 4.5 (1.0 - 5.0) 4.9 (4.6 - 5.0) <0.001
HHS for absence of deformity 1.9 (0 - 4) 3.9 (0 - 4) <0.001
* The values are given, in degrees, as the mean and standard deviation.
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The mean functional leg-length discrep-
ancy decreased from 3.5 cm (range, 0–10.0 
cm) before surgery to 1.2 cm (range, 0–6.0 
cm) at the time of the fi nal follow-up evalu-
ation (p<0.001).
A total of 29 of the 68 hips (43%, in 25 
patients) required revision during the fol-
low-up period. With revision for any reason 
as the end point, the survival rate was 73% 
(95% CI 63–84) at 10 years.
9.2.1.1.2 Patients with a previous Schanz 
osteotomy of the femur (V)
The HHS averaged 52.3 points (range, 
13–85) preoperatively, 86.7 points (range, 
63–100) at the one-year follow-up exami-
nation, and 88.8 points (range, 49–100) 
at the fi nal follow-up evaluation (p<0.001 
for both comparisons with the preopera-
tive value). The mean HHS  for hip pain 
increased from 20.2 points (range, 0–40) 
preoperatively to 42.1 points (range, 0–44) 
at the one-year follow-up (p<0.001). Of the 
68 hips, 51 (75%) in 44 patients were totally 
pain-free at the time of fi nal follow-up. Pain 
was slight and occasional in 13 hips (19%), 
mild in two, and marked in two. One patient 
with marked pain in the hip had undergone 
two cup-revisions in another hospital, and 
after the last revision she had had persist-
ent neuropathic pain in the lower limb. The 
other patient with marked pain had under-
gone a liner revision in another hospital fi ve 
months earlier, and still had marked pain in 
the hip. As many as 55 (82%) of the 67 hips 
(46 of the 58 patients) who were examined 
by us at the time of fi nal follow-up) had a 
good or excellent HHS (>80 points). Forty-
fi ve (76%) of the 59 patients subjectively 
reported good satisfaction at the time of 
the last follow-up visit, seven patients had 
no opinion on outcome, and seven patients 
(12%) were dissatisfi ed with the outcome.
Preoperatively, all patients had a limp 
and the Trendelenburg sign was positive in 
52 (76%) of the 68 hips (Table 5). At the 
time of fi nal follow-up, there was a positive 
Trendelenburg sign in only fi ve (8%) of the 
59 hips operated with shortening osteotomy 
and distal advancement of the greater tro-
chanter, and in two of the eight hips treated 
with segmental shortening and angular cor-
rection (p=0.21). The abduction strength of 
59 (88%) of the 67 hips was graded as good 
or slightly decreased (Seddon 1954) (Table 
24). Elements of the HHS for function are 
summarized in Table 25. There was a trend 
towards a better HHS for limp in patients 
treated with distal advancement of the 
greater trochanter than in patients operated 
on with segmental shortening with angular 
correction. However, the difference was on 
the borderline of being statistically signifi -
cant (9.3 vs. 6.8 points, p=0.05).
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Table 24. Abduction strength of the hips at fi nal follow-up.
Abduction strength N (%)
Active
abduction
Trendelen-
burg (+/-)
No active contraction (0) 1 (1%) 0 1 / 0
Active contraction without movement (1) 3 (4%) 0 3 / 0
Active movement against gravity (no resistance from 
physician) (3)
4 (6%) 8 +/- 8 3 / 1
Active movement against gravity and resistance (4) 17 (25%) 21 +/- 10 0 / 17
Normal strength (5) 42 (63%) 33 +/- 9 0 / 42
*The values are given, in degrees, as the mean and standard deviation. The abduction strength was graded from zero 
(no active contraction) to fi ve (normal strength) according to MRC scale.
Table 25. Harris Hip Score for function* at fi nal follow-up.
Elements Preoperative At fi nal follow-up p-value
Limp 1.4 (0 – 11) 8.8 (0 - 11) <0.001
Support 8.6 (2 - 11) 9.0 (0 - 11) 0.41
Walking distance 6.3 (2 - 11) 9.0 (2 - 11) <0.001
Stairs 1.9 (1 - 4) 2.5 (1 - 4) 0.003
Shoes and socks 2.3 (0 - 4) 3.2 (0 - 4) 0.008
*The values are given as the mean (range).
A total of 24 (43%) patients were able to 
walk without a limp, and 22 (88%) of them 
were able to walk an unlimited distance. In 
total, 23 (50%) of the 46 patients treated 
with distal advancement of the greater tro-
chanter and six of the eight patients treated 
with segmental shortening osteotomy had 
a limp (p=0.26). As many as 38 patients 
(64%) were able to walk without support, 
and 32 (84%) of them were able to walk an 
unlimited distance. Nine patients used a 
single cane for long walks, six patients used 
a single cane most of the time, fi ve patients 
used two canes, and one patient used two 
crutches. As many as 34 (57%) patients had 
a limp, which was severe in six and slight in 
28 cases. (Compare abduction strength). 
The median distance that the patients could 
walk increased from two to three blocks 
preoperatively to unlimited walking dis-
tance at the time of follow-up (p< 0.001). 
As many as 35 (59%) patients could walk an 
unlimited distance at the time of their last 
follow-up visit.
The range of motion increased signifi -
cantly in extension and fl exion, abduction, 
and internal rotation after THA, as did the 
mean HHS for range of motion and for ab-
sence of deformity (Table 26). Patients who 
had been treated with distal advancement 
of the greater trochanter had signifi cantly 
better extension than those patients who 
had undergone a segmental shortening os-
teotomy with angular correction (9° vs. 4°, 
p=0.03). There were no other signifi cant 
differences in the range of movements be-
tween these two groups.
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Table 26. Range of Motion *
Movement Preoperative Final Follow-Up P-value
Extension 2 +/- 9 8 +/- 6 <0.001
Flexion 83 +/- 29 104 +/- 11 <0.001
Abduction 27 +/- 17 39 +/- 11 0.001
Adduction 23 +/- 14 24 +/- 8 0.55
Internal Rotation 26 +/- 29 41 +/- 18 0.01
External Rotation 32 +/- 30 34 +/- 18 0.80
HHS for range of motion 4.1 (1.1 - 5.0) 4.9 (4.1 - 5.0) <0.001
HHS for absence of deformity 1.7 (0 - 4) 3.8 (0 - 4) <0.001
* The values are given, in degrees, as the mean and standard deviation.
The mean functional leg-length discrep-
ancy decreased from 4.6 cm (range, 1.0–
10.0 cm) before surgery to 1.9 cm (range, 
0–7.0 cm) at the time of the fi nal follow-up 
(p< 0.001). In eight patients (eight hips) 
with a metaphyseal shortening osteotomy 
and angular correction, the mean leg-length 
discrepancy decreased from 5.6 cm (range, 
3.0–8.0 cm) preoperatively to 1.8 cm (range, 
0–3.0 cm) at the time of fi nal follow-up 
(p=0.02). For those patients with a transpo-
sition of the greater trochanter and femoral 
shortening osteotomy, the corresponding 
fi gures were 4.5 cm (1.0–10.0 cm) preop-
eratively, and 1.9 cm (0–7.0 cm) at the fi nal 
follow-up (p<0.001).
Of the 68 hips, 42 (62%), in 37 patients, 
required revision during the follow-up peri-
od. With revision for any reason being cho-
sen as the end point, the survival rate was 
52% (95% CI 40–63) at 10 years.
9.2.2 Prosthetic components
9.2.2.1 Prosthetic components 
in patients with high congenital 
dislocation (IV)
The revision rate of the acetabular compo-
nent was 44%. Aseptic loosening was evident 
both clinically and radiographically in eight 
threaded (seven Biomet T-Tap cups and one 
Lord cup) and four press-fi t, porous-coated 
uncemented (two Biomet Universal and 
two Biomet Mallory cups) acetabular com-
ponents. In addition, 14 hips underwent or 
were scheduled to undergo revision of failed 
liners because of excessive wear (Table 27).
Three patients (three hips) had multiple 
cup revisions; all were performed for aseptic 
loosening of the acetabular component.
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Table 27. Revisions of the acetabular components.
Brand N Reason for revision n Component used in revision n
Lord 1 Aseptic loosening 1 Biomet Vision 1
Biomet T-Tap 8 Aseptic loosening 7
Biomet Universal 6
Biomet SHP (cemented) 1
Biomet Universal 25
Aseptic loosening 2
Biomet Universal 1
Ogee (cemented) 1
Broken augment 1 Lubinus IP (cemented) 1
Excessive liner wear 7* New PE liner cemented inside the shell 4*
Biomet Mallory 34
Aseptic loosening 2 Biomet Universal 2
Liner wear + granulomas 1 Elite (cem.) + Kerboul antiprotrusion 1
Excessive liner wear 7* New liner cemented inside the shell 2*
* Eight hips were scheduled for liner revision at the fi nal follow-up examination (three Universal and fi ve Mallory 
cups). All cemented cup revisions were performed in other hospitals. N = number of primary operations. n = number 
of revisions. PE = polyethylene.
The 10 year survival rate for press-fi t, 
porous-coated acetabular components 
(Biomet Universal and Biomet Mallory) 
was 95% (95% CI 89–100) with aseptic 
loosening as the end point (Figure 20) and 
88% (95% CI 81–95) with revision of the 
cup for any reason as the end point (Fig-
ure 21). The overall survival rate of press-
fi t, porous-coated cups was signifi cantly 
better than that of smooth-threaded cups 
(p<0.001). Eight of the nine threaded 
acetabular components were revised, and 
the remaining one was found to be loose 
under radiographical examination at the 
time of fi nal follow-up. The patient with 
the loose cup was not able to attend the fi -
nal follow-up examination in person ow-
ing to poor general health and to medical 
conditions unrelated to her hip disease. 
However, she was interviewed by tele-
phone and her hip was, painless, therefore 
revision of the cup was not proposed.
The liner was revised in six hips (fi ve 
patients; four Universal and two Mallory 
cups), due to excessive PE wear. In each 
of these re-operations a new liner (Biomet 
Vision) was cemented inside the well-fi xed 
metallic shell. In addition, eight hips (seven 
patients; three Universal and fi ve Mallory 
cups) were scheduled for liner revision at 
the fi nal follow-up examination.
Recurrent dislocation occurred in one 
hip, which had a well-oriented acetabular 
component. The patient was treated with 
wall augmentation of the acetabular com-
ponent using a semilunar piece of liner rim 
fi xed by three screws. The outcome was suc-
cessful.
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Fig 20. Kaplan-Meier survival curve of press-fi t porous-coated acetabular components with aseptic 
loosening as the end point.
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Fig 21. Kaplan-Meier survival curve of press-fi t porous-coated acetabular components with any cup 
revision (including exchange of liner) as the end point.
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The revision rate of the femoral com-
ponent was 7%. One Biomet CDH stem 
was revised for aseptic loosening 3.3 years 
after the primary operation. Another Bi-
omet CDH stem was undersized, and was 
revised with a larger Biomet CDH stem fi ve 
months after the primary operation. One 
Lord Madréporique stem and two Biomet 
CDH stems were revised because of malpo-
sitioning (see Complications section 9.2.4.) 
with Biomet CDH stems at a mean of 16 
days (range, 8–28 days) after the primary 
operation. The survival rate of the Biomet 
CDH stem was 98% (95% CI 97–100) at 
10 years using aseptic loosening as the end 
point. When the end point was defi ned as 
stem revision for any reason, the 10-year 
survival rate for the Biomet CDH stem was 
94% (95% CI 88–100) (Figure 22).
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Radiographical examination revealed 
evidence of fi brous union of the transposed 
trochanter in three of the 68 hips studied. 
One patient with bilateral fi brous unions of 
the greater trochanter had no limp, his hips 
were also painless, the Trendelenburg sign 
was negative, and the abduction strength of 
both hips was strong at the time of fi nal fol-
low-up.
9.2.2.2 Prosthetic components in 
patients with a previous Schanz 
osteotomy of the femur (V)
The revision rate of the acetabular compo-
nent was 59%. Aseptic loosening was evi-
dent both under clinical and radiographi-
cal examination for 18 threaded (Biomet 
T-Tap) and one press-fi t, porous-coated 
Fig 22. Kaplan-Meier survival curve of the CDH stem with stem revision for any reason 
as the end point.
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uncemented (Biomet Universal) acetabular 
components. In addition, 16 hips under-
went or were scheduled to undergo revision 
of failed liners due to excessive PE wear (Ta-
ble 28).
Of the four deceased patients (four 
hips), one had been scheduled and two had 
already undergone cup revision for aseptic 
loosening of the threaded acetabular com-
ponent.
In total, 10 patients (ten hips) had mul-
tiple cup revisions: three hips for aseptic 
loosening of the acetabular component, 
two hips for liner wear and recurrent dislo-
cation, and three hips for aseptic loosening 
and liner wear. Moreover, one hip had two 
revisions for liner wear, and for one hip a 
fi rst revision was performed for technical 
error and a second revision for liner wear.
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The 10 year survival rate for press-fi t, 
porous-coated acetabular components (Bi-
omet Universal, Biomet Mallory and Biom-
et Vision) was 98% (95% CI 94–100) with 
aseptic loosening as the end point (Figure 
23), and 69% (95% CI 56–82) with revi-
sion of the cup for any reason as the end 
point (Figure 24). The overall survival rate 
of press-fi t, porous-coated cups was sig-
nifi cantly higher than that of the smooth-
threaded cups (p<0.001). As many as 16 
of the 18 threaded acetabular components 
were revised, and the remaining two were 
found to be loose under radiographical ex-
amination at the time of fi nal follow-up. 
Consequently, these were scheduled for cup 
revision.
Fig. 23. Kaplan-Meier survival curve for the press-fi t, porous-coated acetabular components, with 
revision because of aseptic loosening as the end point. CI = confi dence interval.
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For 14 hips (12 patients; 10 Universal 
and four Mallory cups), the liner was re-
vised due to excessive PE wear. In each of 
these revisions a new liner (Biomet Vision) 
was cemented inside the well-fi xed metallic 
shell. Two hips (two patients; two Mallory 
cups) were scheduled for liner revision at 
the fi nal follow-up examination. In addi-
tion, in three hips with well-fi xed acetabular 
Fig. 24. Kaplan-Meier survival curve for the press-fi t, porous-coated acetabular components, with 
cup revision for any reason as the end point. CI = confi dence interval.
components (three patients, one Universal 
and two Mallory cups) severe liner wear 
had lead to the widespread proliferation 
of granulomas. Consequently, cups had to 
be removed, granulomas were excised and 
replaced with allogeneous bone grafts, and 
acetabular reconstruction was performed 
with antiprotrusion devices and cemented 
cups (Table 28).
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Table 28. Revisions of the acetabular components.
Brand N Reason for revision n Component used in revision n
Biomet T-Tap 18 Aseptic loosening 18
Biomet Universal 12
Lubinus IP (cemented)1 2
Biomet SHP (cemented)1 1
Exeter (cemented) 1
Scheduled for revision 2
Biomet Universal 32
Aseptic loosening 1 Biomet Universal 1
Technical error2 1 Biomet Universal 1
Recurrent dislocation 1 Acetabular augmentation 1
Liner wear + granulomas1 1 Ogee (cem.) + Howmedica support mesh1 1
Excessive liner wear 10 New PE liner cemented inside the shell 10
Biomet Mallory 18
Liner wear + granulomas 1 Exeter (cem.) + Ganz antiprotrusion 1
Liner wear + granulomas1 1 Elite (cem.) + Kerboul antiprotrusion1 1
Excessive liner wear 63 New PE liner cemented inside the shell3 43
1 Cup revision performed in another hospital.
2 The cup was placed too medially. In the postoperative radiographs, the cup had turned horizontally and protruded 
medially. It was revised with a larger Universal cup, that was placed on a more lateral and cranial position.
3 Two hips were scheduled for liner revision at the fi nal follow-up examination (two Mallory cups).
N = number of primary operations. n = number of revisions. PE = polyethylene.
Recurrent dislocation occurred in one 
hip with a well-oriented acetabular com-
ponent. The patient was treated by aug-
mentation of the wall of the acetabular 
component with a semilunar piece of lin-
er rim fi xed by three screws. The outcome 
was successful.
The rate of revision of the femoral com-
ponent was 11%. Four Biomet CDH stems 
were revised for aseptic loosening, at a mean 
of 3.8 years (range, 3.3–4.9 years) after the 
primary operation. Two of these four stems 
were clearly undersized, and in another two 
cases the greater trochanter had been de-
tached so far distally, that lateral support 
and rotational stability of the stem was defi -
cient. All four stems were revised with larg-
er Biomet CDH stems. Two Biomet CDH 
stems were revised because of malposition-
ing (see Complications section 9.2.4); they 
were replaced with a Biomet CDH stem at 
eight and 12 days after the primary opera-
tion. The survival rate of the Biomet CDH 
stem was 92% (95% CI 86–99) at 14 years 
using aseptic loosening as the end point. 
When the end point was defi ned as stem re-
vision for any reason, the 14-year survival 
rate for the Biomet CDH stem was 88% 
(95% CI 81–96) (Figure 25).
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The two patients who declined to partic-
ipate in the study, had both undergone stem 
revision. One patient underwent revision 
because of aseptic loosening of a clearly un-
dersized Biomet CDH stem 3.8 years after 
the primary operation; the loose CDH stem 
was replaced with a Head-Neck (Biomet) 
stem. The second patient underwent revi-
CDH stems - all revisions
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0 2 4 6 8 10 12 14
Years postoperatively
C
um
ul
at
iv
e 
su
rv
iv
al
Survival
95% CI upper
95% CI lower
Censored
sion only three months after the primary 
operation, as the Biomet CDH stem had 
subsided, turned into retroversion and frac-
tured the medial femoral cortex; the loose 
stem was replaced with a larger CDH stem. 
None of the four deceased patients (four 
hips) had undergone stem revision.
Radiographical evidence of fi brous un-
ion of the transposed trochanter was noted 
in two of the 68 hips. The patient with bilat-
eral fi brous unions of the greater trochanter 
had no limp, his hips were painless, the 
Trendelenburg sign was negative, and the 
abduction strength of both hips was strong 
at the time of fi nal follow-up.
Fig. 25. Kaplan-Meier survival curve for the CDH stems, with stem revision for any reason as the end 
point. CI = confi dence interval.
9.2.3 Radiographical results
9.2.3.1 Radiographical results in 
patients with high congenital 
dislocation (IV)
Heterotopic ossifi cation was observed in 
three of the 68 hips; the ossifi cation was 
Brooker class I in two hips, and class II in 
one hip.
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9.2.3.1.1 Femoral component
Alignment of the femoral component was 
classifi ed as neutral in 62 hips (97%), val-
gus in one, and varus in one. All cementless 
femoral components provided evidence of 
bone ingrowth under radiographical exam-
ination at the last follow-up. One hip had 
femoral osteolysis measuring 110 mm2 in 
zone 1, but there was no distal osteolysis.
9.2.3.1.2 Acetabular component
The mean acetabular cup angle was 49° 
(range, 34° –74°). At the time of fi nal fol-
low-up, one hip exhibited both migration 
of the acetabular component and a 4-mm 
thick radiolucent line in zone 1. Two hips 
with unrevised cups had periacetabular os-
teolysis, the osteolytic lesion measuring 431 
mm2 in all three zones in one hip and 450 
mm2 in zone 3 in the other hip. None of the 
14 patients who underwent cup revisions 
had radiolucent lines or migration of the 
revised acetabular component at the time of 
fi nal follow-up. All bone grafts used to re-
inforce the acetabular roof united and the 
centralized medial walls of the acetabulum 
healed without complications.
At the time of the fi nal follow-up evalu-
ation, 15 of the 67 hips (22%) had linear 
wear of the PE liner measuring from one to 
fi ve millimeters in depth. Two of these hips 
had periacetabular osteolysis. Seven patients 
(eight hips) were scheduled for liner revi-
sion at the fi nal follow-up examination.
9.2.3.2 Radiographical results in 
patients with a previous Schanz 
osteotomy of the femur (V)
Heterotopic ossifi cation was observed in 
four of the 68 hips; the ossifi cation was 
Brooker class I in two hips, class II in one 
hip and class III in the other hip.
9.2.3.2.1 Femoral component
Alignment of the femoral component was 
classifi ed as neutral in 67 hips (99%), and 
valgus in one. All cementless femoral com-
ponents provided radiographical evidence 
of bone ingrowth at the last follow-up eval-
uation. Three hips had femoral osteolysis in 
zone 1, measuring 32 mm2 in one hip, 110 
mm2 in the second hip, and 338 mm2 in the 
third hip. There was no distal osteolysis in 
any of these hips.
9.2.3.2.2 Acetabular component
The mean acetabular cup angle was 50° 
(range, 30°–71°). All bone grafts used to re-
inforce the acetabular roof united and the 
centralized medial walls of the acetabulum 
healed without complications. At the time 
of fi nal follow-up, one hip exhibited both 
migration of the socket and 2-mm thick 
radiolucent lines in zones 1 and 2 and a 
12 mm thick line in zone 3. The patient 
was scheduled for revision of the threaded 
acetabular component. Another hip ex-
hibited both migration of the socket and a 
4 mm thick radiolucent line in zone 3; she 
was already scheduled for cup revision in 
another hospital. One hip with an unre-
vised cup had a periacetabular osteolytic 
lesion, which measured 450 mm2 and was 
in zone 3; this hip manifested a 3 mm deep 
linear wear of the PE liner; the patient was 
scheduled for liner revision and bone graft-
ing of the osteolytic lesion. One hip with a 
previous cup revision (Biomet T-Tap cup 
revised to a cemented Exeter cup) exhibited 
both migration of the socket and a 2 mm 
thick radiolucent line in zone 3. The patient 
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was scheduled for a second revision of the 
acetabular component. One hip with a re-
vised cup (Biomet T-Tap cup revised to a 
Universal cup) had periacetabular osteoly-
sis, the osteolytic lesion measuring 800 mm2 
in zone 1. In addition, this patient had lin-
ear wear of the PE liner measuring 3 mm in 
depth, and was scheduled for liner revision 
and bone grafting of the osteolytic lesions. 
None of the other 36 patients who under-
went cup revisions had radiolucent lines or 
migration of the revised acetabular compo-
nent at the time of fi nal follow-up.
At the time of the fi nal follow-up evalu-
ation, nine of the 68 hips (13%) had linear 
wear of the PE liner with the depth of the 
wear ranging from 0.5–3 mm. Two of these 
hips had periacetabular osteolysis. Two pa-
tients (two hips) with original acetabular 
components and one patient (one hip) with 
a revised cup were scheduled for liner revi-
sion at the fi nal follow-up examination.
9.2.4 Complications (IV and V)
9.2.4.1 Complications in patients 
with high congenital dislocation, 
without a previous Schanz 
osteotomy
When patients with high congenital hip 
dislocation, but without a previous Schanz 
osteotomy (28 patients, 34 hips), were ana-
lyzed separately, there were 10 periopera-
tive complications (29%): three instances 
of peroneal nerve palsy, one femoral nerve 
palsy, one superior gluteal nerve palsy, four 
non-displaced fractures of the proximal part 
of the femur, and one early dislocation sec-
ondary to malpositioning of the stem. None 
of the femoral fractures occurred secondary 
to the femoral splitting osteotomies. There 
was one proximal femur fracture identifi ed 
during canal rasping and three fractures 
identifi ed during stem insertion. Two of the 
fractures were fi xed using Parham bands, 
one was fi xed by the same lag screws used 
to secure the transposed greater trochanter, 
and one was fi xed with Dall-Miles cables 
(Howmedica International, Rutherford, NJ, 
U.S.A.) combined with autologous cancel-
lous bone grafting. All healed without af-
fecting the fi nal outcome of the operation.
One patient who presented with peroneal 
nerve palsy on the fi rst postoperative day, 
had a clinically apparent haematoma in the 
buttock; in addition, the leg had been length-
ened by fi ve centimeters. The haematoma 
was evacuated urgently, and the femur was 
shortened by one centimeter; the palsy fully 
resolved in six months. A second patient 
also presented with peroneal nerve palsy on 
the fi rst postoperative day. However, this 
patient’s buttock was soft, and the leg had 
been lengthened by only three centimeters. 
She was kept under observation and the pal-
sy fully resolved itself in six months. A third 
patient presented with peroneal nerve palsy 
two months postoperatively. Even though 
electroneuromyography revealed a lesion in 
the fi fth lumbar nerve root, clinical exami-
nation revealed tenderness in the peroneal 
nerve at the level of the knee. We explored 
the peroneal nerve, which was found to be 
entrapped under the sharp fi brous edge of 
the peroneus longus origin. Consequently, 
the nerve was released around the fi bular 
neck. Despite decompression, this palsy did 
not fully resolve, and the patient had a per-
manent incomplete drop foot at the time of 
the last follow-up examination. 
The femoral nerve palsy did not fully re-
solve, although quadriceps function gradu-
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ally returned, and there was 80% force (as 
demonstrated by subjective manual test-
ing) compared with that on the unaffected 
side 11.9 years after the primary operation. 
The patient with the superior gluteal nerve 
palsy had a spontaneous recovery within six 
months.
The only early dislocation was secondary 
to malpositioning of the stem. The patient 
with a malpositioned Lord Madréporique 
stem underwent a re-operation to replace it 
with a CDH stem on the 28th postoperative 
day.
A fracture of the greater trochanter was 
diagnosed in one patient who had fallen 1.2 
years after the operation. The trochanter 
was re-attached by screws and augmented 
with a hook plate; it healed well.
One early stem revision (fi ve months 
postoperatively) was due to the insertion of 
too small a stem originally, which resulted 
in incomplete osseointegration and the ear-
ly loosening of the stem.
9.2.4.2 Complications in patients 
with a previous Schanz osteotomy 
of the femur (V)
Fifteen perioperative complications (22%) 
occurred in patients with a previous Schanz 
osteotomy: two instances of peroneal nerve 
palsy, two femoral nerve palsies, one ob-
turatorius nerve palsy, fi ve non-displaced 
fractures of the proximal part of the fe-
mur, one malpositioned stem perforating 
the posteromedial cortex of the femur, one 
malpositioned cup perforating the acetabu-
lum and lying horizontally, one superfi cial 
wound infection, one pulmonary embo-
lism, and one early dislocation secondary to 
malpositioning of the stem.
None of the femoral fractures occurred 
secondary to the femoral splitting osteoto-
mies. There was one proximal femur frac-
ture identifi ed during canal rasping and 
four fractures identifi ed during stem inser-
tion. Three of the fractures were fi xed with 
Parham bands and two were fi xed with 
Dall-Miles cables (Howmedica Interna-
tional, Rutherford, NJ, U.S.A.) combined 
with autologous cancellous bone grafting. 
Two of these fractures occurred in hips with 
metaphyseal segmental angular correction 
and shortening osteotomy. All healed with-
out affecting the fi nal outcome of the opera-
tion.
One patient who presented with pero-
neal nerve palsy on the second postoperative 
day, had a clinically apparent haematoma in 
the buttock. This haematoma was massive 
and locally compressed the sciatic nerve, 
thus it was evacuated urgently. The sciatic 
nerve was found to be macroscopically nor-
mal. Despite decompression the palsy did 
not resolve and the patient presented with 
a permanent complete drop foot at the time 
of the last follow-up examination. Another 
peroneal nerve palsy was observed on the 
fi rst postoperative day and compression of 
the sciatic nerve by haematoma was sus-
pected. The hip was explored, but there 
was no haematoma in the locality of the 
sciatic nerve. Instead, the sciatic nerve was 
found to impinge on the posterior wall of 
the acetabular component when the hip was 
in fl exion. The femoral head was exchanged 
to a shorter one, and the impingement was 
relieved. However, the palsy did not resolve, 
and at the time of the last follow-up ex-
amination this patient also presented with 
a permanent complete drop foot. The two 
patients who presented with femoral nerve 
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palsy postoperatively (on the fi fth and on 
the fi rst postoperative day) had each a clini-
cally apparent haematoma in the groin. The 
haematoma was evacuated urgently in both 
patients and bleeding arteries were electro-
coagulated. The palsy of the fi rst patient ful-
ly resolved within three months. The motor 
paresis of the second patient fully resolved 
within six months, but at the time of the fi -
nal follow-up the patient presented with a 
permanent sensory defi cit in the thigh. One 
patient had a superior gluteal nerve palsy, 
and another patient presented with an ob-
turatorius nerve palsy. Both patients recov-
ered spontaneously within six months. 
In one patient, a CDH stem was inserted 
in excessive anteversion causing an early 
dislocation. Consequently, a re-operation 
to insert the malrotated stem in correct 
rotation was performed on the 12th post-
operative day. During insertion one CDH 
stem perforated the posteromedial cortex of 
the femur. The malpositioning was evident 
in the postoperative radiographs, and the 
stem was revised on the eighth postopera-
tive day. For one patient, the cup was placed 
too medially. In the immediate postopera-
tive radiographs, the cup had perforated the 
medial wall of the acetabulum and turned 
horizontally. A re-operation was performed 
on the second postoperative day; a new cup 
was placed in a more lateral and cranial po-
sition and autogenous bone grafting was 
performed to augment the lower medial 
wall of the acetabulum. The revised cup was 
found to be radiographically well-fi xed at 
the time of the fi nal follow-up.
One patient was diagnosed with pul-
monary embolism postoperatively. She 
was treated with peroral warfarin for three 
months, and experienced no residual symp-
toms.
A superfi cial wound infection, caused 
by Staphylococcus aureus, in one patient 
was treated with oral antibiotics and healed 
well.
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10 Discussion
10.1 Validity of the data
Certain limiting factors and selection bias 
are inherent in most clinical studies and this 
is also true of our studies.
10.1.1 Register-based studies
(I, II and III)
Register-based studies provide valuable in-
sight into the use of the THA procedure in a 
certain patient-group, as the number of ar-
throplasties studied is substantially larger in 
register-based studies than in clinical stud-
ies from single centers (Kim et al. 2002). In 
addition, such nationwide studies enable 
trends in THAs to be shown more clearly 
and on a larger scale. Further, the results can 
be compared with those of other Nordic ar-
throplasty registers giving a broad perspec-
tive on the results for both single implants 
and the methods applied in respect of THA. 
The statistical methods used in our study 
were valid, as we applied not only the Kap-
lan-Meier survival analysis but also the Cox 
multiple regression analysis to take account 
of confounding factors. The importance 
of considering confounding factors in the 
survival analysis of hip implants has been 
shown previously (Furnes et al. 2001).
Nevertheless, we acknowledge that the 
current register-based studies have certain 
limitations. For instance, we were not able 
to report any subjective outcome measure-
ments such as that found in the HHS or dis-
ease-specifi c quality of life measurements. 
Moreover, in register-based analyses com-
prising thousands of patients, it is not possi-
ble to conduct radiographical examinations 
with the consequence that silent osteolysis 
inter alia cannot be detected. A register-
based study such as ours may also have di-
agnostic pitfalls regarding young patients, 
in that a small proportion of the patients 
(females in particular) diagnosed with pri-
mary osteoarthritis may in fact have mild 
developmental dysplasia (Harris 1986). It 
has been reported that patients with devel-
opmental dysplasia of the hip have poorer 
outcomes to THA than other patient groups 
(Furnes et al. 2001).
There is some heterogeneity in the de-
sign concept groups in study I; fi rst, the 
concept of uncemented uncoated stems in-
cluded both failed designs and designs with 
reported good results. Second, concepts of 
proximally HA-coated and extended po-
rous-coated uncemented stems each in-
cluded only two designs. However, major 
design concept groups (i.e. cemented stems 
and proximally porous-coated uncemented 
stems; all-poly cemented cups and press-fi t 
porous-coated uncemented cups) included 
a lot of brands, none of which have previ-
ously been reported as failures.
In study II, the most frequently used 
components were implanted between 8–15 
times more often than the most infrequent-
ly used implants. It is notable, that this may 
cause some bias in the results; e.g. rarely 
used designs may only have been implanted 
in one centre, and if the surgical technique 
of the centre has been suboptimal, results of 
the particular implant will not refl ect its true 
performance. On the other hand, results of 
a THR may be unrealistically good, if it they 
have been implanted in a single specialized 
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center by an orthopaedic surgeon of excep-
tional expertise at THA. As Biomet’s endo-
prostheses were so commonly used, their 
benefi ts and pitfalls may be overemphasized 
in this study.
When survival rates of hip implants are 
evaluated, it is important to analyze and re-
port both the independent survival rates of 
femoral and acetabular components and the 
survival rate of the whole prosthesis. Simi-
larly, both aseptic loosening and all revisions 
should serve as end points separately. A good 
example is the Biomet Bi-Metric – Universal 
prosthesis; if we look at the 13-year survival 
rate of the Bi-Metric – Mallory THR (74%) 
in study II, it seems that this uncemented 
THR has an unacceptably poor perform-
ance. However, more accurate analysis re-
vealed, that the Bi-Metric stem per se has a 
very good survival rate. On the other hand, 
the Universal cup with a HexLocTM liner had 
a satisfactory survival rate of 93% at 10 years 
with aseptic loosening as the end point, but 
other revisions (including exchange of the 
PE liner in particular) markedly impaired its 
results. This is in agreement with a previous 
report by Puolakka and colleagues (1999) on 
the (non age-dependent) data taken from 
the same register.
10.1.2 Clinical studies (IV and V)
We retrospectively analyzed the results of 
uncemented THA in patients with high 
congenital hip dislocation and those of pa-
tients with severely dysplastic hips that had 
been previously treated with a Schanz oste-
otomy of the femur. The follow-up time was 
>10 years for 86% (50/56) of the patients in 
study IV and 92% (54/59) of the patients 
in study V, respectively. The participation 
rates for studies IV and V were 95% and 
97%, respectively. Active abduction was 
selected as a measure of abduction muscle 
function because of its reported sensitivity 
(Mallory 1974) and its relative functional 
signifi cance when compared with passive 
abduction (Charnley and Ferreiraade 1964). 
However, abduction strength was measured 
preoperatively by only the Trendelenburg’s 
test. Survival of THA was analyzed by the 
Kaplan-Meier method, and valid principles 
of hip implant survival analysis were fol-
lowed (Dorey 2004).
10.2 General discussion
10.2.1 THA in young patients –
in the light of a national register
10.2.1.1 Gender distribution and 
effect on prosthesis survival
(I and III)
In study I, the majority of the younger pa-
tients who underwent THA for primary OA 
were males. This gender distribution differs 
from that of patients aged 65 years or older 
when undergoing THA for primary OA 
over the same study period: of which 65% 
(n=19 701) were females and 35% (n=10 
622) males (p<0.001) (Nevalainen 2004). 
The reason for the different gender distri-
bution among young OA patients is un-
clear. Earlier studies have shown that THAs 
are performed more frequently in females 
than in males, even among younger pa-
tients (Paavolainen et al. 1991, Havelin et al. 
2000, Puolakka et al. 2001b, Malchau et al. 
2002). However, the data of the Danish and 
Australian hip registers show that >50% of 
younger patients undergoing THA (all diag-
noses) were males (AOA 2004, DHR 2004). 
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One possible explanation is that males are 
more active physically and thus their hips 
are subject to subtle microtraumas that ac-
celerate the degenerative process. Thus, hip 
OA may develop earlier in males. Alterna-
tively, males are less likely to accept physical 
impairment and end up undergoing THA 
earlier than females. Epidemiological stud-
ies provide evidence that physical activity, 
whether through participating in sports or 
having a physically strenuous occupation, 
increases the risk of hip OA (Vingard et al. 
1991, Croft et al. 1992a, Croft et al. 1992b, 
Vingard et al. 1993). However, these stud-
ies have not demonstrated that gender is an 
independent risk factor for hip OA. In study 
III we found that most patients undergoing 
THA for RA were females, which agrees 
with other studies (Creighton et al. 1998, 
Lehtimaki et al. 1999, Keisu et al. 2001).
Females had a higher risk of cup revision 
than males in young patients with primary 
OA (I). To our knowledge, this fi nding has 
not been reported previously. The aetiology 
remains obscure. In young patients with 
RA (III), there was a trend towards poorer 
stem survival in males than in females. In 
two large clinical studies of Charnley LFA, 
males were found to have an increased risk 
of stem revision as compared to females 
(Hozack and Rothman 1990, Lehtimaki et 
al. 1999). Men may apply more powerful 
torque forces to the femoral component, 
leading to aseptic loosening of the stem. 
This may partially explain the difference in 
stem survival between the genders.
10.2.1.2 The effect of age on 
prosthesis survival (I and III)
The poorer survival of prostheses in young 
patients on a nation-wide level has been re-
ported in the literature earlier (Havelin et 
al. 2000, Malchau et al. 2002). The poorer 
survival of THAs in young OA patients in 
the present study seems to be related pri-
marily to the inferior implant types more 
commonly used in their operations rather 
than the age of the patient. In the present 
studies, the younger age group (<46 years) 
had an increased risk of cup revision as 
compared to the older age group (46-54 
years)  in patients with primary OA (I) and 
in patients with RA (III). This is in accord-
ance with that found in a previous study 
(Lehtimaki et al. 1999). Apparently, young 
and active patients put stresses on their hip 
joints more than older patients, a tendency 
that leads eventually to aseptic loosening of 
the cup.
10.2.1.3 Hospital volume (I)
It is unclear whether the revision results 
would improve, if THAs were performed 
in young patients in centralized and spe-
cialized facilities, or if these patients were 
also concentrated in tertiary centres. In this 
study, the results were no better for hos-
pitals performing more than 10 THAs on 
young patients with primary OA than those 
for other hospitals performing fewer than 
10. It is possible that the hospitals in which 
a high number of THAs were performed 
also treated the youngest and most diffi -
cult patients. In retrospect, the hospitals 
working as tertiary referral centres in Fin-
land made some poor choices, using new, 
undocumented uncemented implants that 
were not introduced into smaller hospitals 
until later (Puolakka et al. 1999, Puolakka 
et al. 2001b).
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10.2.1.4 Trends in prosthetic 
components (I and III)
A very wide range of femoral and acetabu-
lar components were used by Finnish or-
thopaedic surgeons for young patients with 
primary OA (I) and RA (III) during the 
study period. Over 50% of all implant de-
signs used in patients with primary OA and 
>70% of all designs used in patients with 
RA were used in fewer than 20 operations. 
A similar pattern of uses has been reported 
in Norway (Havelin et al. 2000). This phe-
nomenon might be attributed to commer-
cial infl uences on orthopaedic surgeons. 
However, the three most commonly used 
stems accounted for 72% of all stems im-
planted in patients with primary OA and 
70% of all stems implanted in patients with 
RA at the end of the study period (2000–
2001 in primary OA, 2002–2003 in RA). A 
similar usage profi le emerged for cups in 
patients with OA (I). The three most com-
monly used cups accounted for 64% of all 
cups. Even so, the situation was still not op-
timal in patients with RA, where the three 
most commonly used cups accounted for 
less than 50% of all cups implanted. This 
fi nding may refl ect the problem of acetabu-
lar component loosening encountered in 
patients with RA; the search for the best 
acetabular solution still goes on.
The proportion of uncemented stems 
and cups used in young patients with either 
primary OA, or with RA rose dramatically 
from the beginning of the study period to 
the early 1990s. This upward trend refl ects 
improvements in uncemented implant de-
signs. However, this trend appears to have 
reversed at the beginning of the 21st century. 
This probably partly refl ects poor experi-
ences associated with the earlier uncement-
ed design concepts. The proportions of 
cemented and uncemented implants used 
nationwide have only been reported on 
data from the Nordic countries’ registers. 
The use of uncemented implants is most 
common in Finland. In Norway, 18% of 
acetabular and 13% of femoral components 
were uncemented in 1988 and 1998 (Have-
lin et al. 2000). In Denmark, 64% of all hip 
prostheses implanted during 1995–1998 
were cemented (Lucht 2000).In Sweden, ce-
mented designs were used in 93% of all hip 
arthroplasties implanted in 2000 (Malchau 
et al. 2002). However, it should be noted 
that the fi ndings from the registers of other 
Nordic countries include all age groups, 
not only young patients. Moreover, not all 
Nordic countries use the same implant de-
signs. Therefore, the results for cemented 
and uncemented implant subgroups can-
not be directly compared between registers. 
Although uncemented implants have been 
used more commonly in Finland, there is 
also wide experience of cemented THA. For 
example, 50% of all cups (n=25 150) and 
39% of all stems (n=19 991) implanted in 
Finland during 1991–2001 (all age and di-
agnosis groups) were cemented (Nevalain-
en 2004).
10.2.1.5 Stem design concepts (I 
and III)
Proximally circumferentially porous-coated 
and HA-coated uncemented stem design 
concepts gave better results than cemented 
stems in young patients with primary OA 
(I). Similarly, proximally circumferentially 
porous-coated stems gave higher long-
term survival rates than cemented stems in 
young patients with RA (III). The results 
of cemented stems implanted with a sec-
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ond-generation cementing technique that 
have been reported in the literature (Bar-
rack et al. 1992, Ballard et al. 1994, Emery 
et al. 1997, Kobayashi et al. 1997, Smith et 
al. 2000) have not been any better than the 
results of fi xation using fi rst-generation 
techniques (Collis 1991, Boeree and Ban-
nister 1993, Joshi et al. 1993, Neumann et al. 
1996, Devitt et al. 1997, Sochart and Porter 
1997b, Sochart and Porter 1997a, Sochart 
and Porter 1998, Keener et al. 2003). Results 
of third-generation cementing techniques in 
younger patients have not been published 
so far. Despite the systematic instruction of 
Finnish orthopaedic trainees and consult-
ants in modern third-generation cementing 
techniques during the 1990s, the results for 
cemented stems did not improve signifi cant-
ly from the 1980s to the 1990s in young pa-
tients with either primary OA or RA. What is 
more, modern uncemented stems implanted 
during the 1990s provided considerably bet-
ter results than cemented stems. The im-
proved performance of uncemented proxi-
mally porous-coated stems implanted in 
young patients with primary OA during the 
1990s is an important fi nding. The results for 
some uncemented stems implanted at spe-
cialized centres have been good (McLaugh-
lin and Lee 2000, Kim et al. 2002, Aldinger 
et al. 2003, Capello et al. 2003, Jacobsen et 
al. 2003, Kim et al. 2003a, Kim et al. 2004). 
Moreover, the results taken from the Swedish 
register also showed a trend towards better 
survival of uncemented implants in young 
patients (Malchau et al. 2002). However, our 
study is the fi rst to confi rm good results for 
modern uncemented stems on a nation-wide 
level in the two largest patient groups among 
young patients. Even though the follow-up 
of proximally HA-coated uncemented stems 
was relatively short in both studies (I and 
III), it is notable, that there is so far only one 
study that has reported long-term results of 
HA-coated stems in young patients (Capello 
et al. 2003).
10.2.1.6 Uncemented stem designs 
(II)
All proximally porous-coated uncemented 
stems studied gave good (>90%) 10 year 
survival rates when either aseptic loosen-
ing or any stem revision was used as the end 
point. Furthermore, the Biomet Bi-Metric 
stem had an excellent 15-year survival rate. 
Good results in younger patients with the 
Bi-Metric stem (Jacobsen et al. 2003) and 
with the Profi le Porous stem have been re-
ported earlier (Kim et al. 2003b) from sin-
gle centres. Now those results are also con-
fi rmed by our nation-wide study (study II). 
Recently, Archibeck et al. (2001) reported a 
100% survival rate at 10 years for an Ana-
tomic Mesh uncemented stem in 78 hips 
(74 patients with a mean age of 52 years 
at the time of arthroplasty. However, our 
data suggest that survival of an Anatomic 
femoral component was clearly poorer than 
those results previously reported by Archi-
beck, and was signifi cantly worse than that 
for the Bi-Metric stem when either aseptic 
loosening or any stem revision served as 
the end point. The reason for this differ-
ence remains unclear. Thanner et al. (1999) 
reported an 84%, 10 year survival rate for 
the PCA Std stem in patients with mean age 
of 50 years. In another series, Bojescul et 
al. (2003) reported a 93% survival rate for 
the PCA Std stem at 15 years. In the present 
study, performance of the PCA Std stem was 
comparable to those previous reports.
Keisu et al. (2001) reviewed the results 
of 114 consecutive THAs with the Lord 
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Madréporique femoral component and 
found a 94% survival rate at 13 years. In an-
other study on 107 hips, the 10-year surviv-
al rate for the Lord Madréporique stem was 
98% using revision as the end point (Mal-
chau et al. 1996). However, the combined 
clinical and radiographical 10 year survival 
rate declined to 81% (Malchau et al. 1996). 
In our study, the extended porous-coated 
Lord Madréporique stem had a good 15-
year survival rate, of 91% with aseptic loos-
ening as the end point. Nevertheless, the 
survival of the Lord Madréporique stem 
overall was signifi cantly worse than that of 
the Bi-Metric stem with revision for aseptic 
loosening of the stem as the end point.
The only proximally HA-coated un-
cemented stem reported on in this study 
(ABG I stem) performed well with an ex-
cellent 10-year survival rate of 97% with 
any stem revision as the end point. Good 
mid-term results have been reported with 
the ABG I stem from single centres (Toni-
no and Rahmy 2000, Giannikas et al. 2002, 
Blacha 2004). However, it is unclear wheth-
er HA-coating improves osseointegration 
in the short-term and resistance to aseptic 
loosening of porous-coated stems in the 
long-term. In their prospective randomized 
trial of 100 hips, Kim et al. (2003a) recently 
compared porous-coated stems with and 
without additional HA-coating; the authors 
concluded, that after mid-term follow-up, 
the HA coating on the porous surfaces did 
not improve or diminish the results of THA 
with the femoral component design used in 
their study. Park et al. (2003) reported on 
the results of 24 patients with bilateral ar-
throplasties, who received a porous-coated 
femoral component in one and a HA-coated 
femoral component in the other hip. These 
authors found no differences between the 
groups in clinical and radiological results at 
a minimum follow-up of 4 years. 
The CLS Spotorno stem, which has a 
completely different design concept from 
the other modern uncemented stem types 
(the only grit-blasted macro-porous tita-
nium stem in the study), gave an excellent 
10 year survival rate. This is in accordance 
with previous reports from single centres 
(Schramm et al. 2000, Aldinger et al. 2003, 
Kim et al. 2004). The double-wedge design 
of the CLS Spotorno stem seems to provide 
good primary stability as well as osseointe-
gration. Although the number of CLS stems 
in study II was rather small (108), these op-
erations were performed in several hospitals 
and by several orthopaedic surgeons. Thus, 
good results of the CLS Spotorno stem seem 
to be reproducible on a nation-wide level. 
The CLS Spotorno stem may offer a good 
option to modern porous- or HA-coated 
uncemented stems.
10.2.1.7 Cup design concepts 
(I and III)
In this study (I), the design concepts of 
press-fi t porous-coated and HA-coated 
uncemented cups performed well among 
young patients with primary OA. The poor 
survival of the uncemented cups implanted 
in the 1980s is tentatively attributed to the 
widespread use of uncemented smooth-
threaded cups (Engh et al. 1990, Tallroth et 
al. 1993, Simank et al. 1997) and uncement-
ed cups with inferior locking mechanisms 
of the PE liner (Chen et al. 1995, Scott et 
al. 2000, Puolakka et al. 2001a, Young et al. 
2002). In the present study (I), survival of 
press-fi t porous-coated uncemented cups 
was better than that of all-poly cemented 
cups with revision for aseptic loosening of 
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the cup as the end point. However, when all 
cup revisions (including exchange of liner), 
were taken into account, there was no more 
difference in survival between these two de-
sign concepts.
Cemented acetabular components are 
considered as the gold standard in THA 
even in younger patients. The 10 year sur-
vival rate of the cup in Charnley LFA has 
exceeded 90% in most of the studies (Joshi 
et al. 1993, Devitt et al. 1997, Kobayashi et 
al. 1997, Sochart and Porter 1997a, Sochart 
and Porter 1998), and >80% survival rates 
have been recorded even at 20 years (Joshi 
et al. 1993, Devitt et al. 1997).
The fi rst generation of press-fi t porous-
coated uncemented cups has generally had 
poor long-term results in younger patients, 
with the 10 year survival rates being gener-
ally <90% (Berger et al. 1997, Duffy et al. 
2001). Long-term results of second-genera-
tion porous-coated cups have been report-
ed only with the Duraloc (DePuy, Warsaw, 
In., U.S.A.) acetabular component (Kim et 
al. 2003a, Kim et al. 2003b). In two clini-
cal studies from the same specialized centre, 
the 10 year survival rate of this cup was re-
ported to exceed >95% in the hands of one 
individual surgeon (Kim et al. 2003a, Kim 
et al. 2003b).
The follow-up of press-fi t HA-coated 
uncemented cups was relatively short in the 
present study (I). Good mid-term results 
have also been reported for these cups in 
younger patients (Giannikas et al. 2002). 
However, long-term results of press-fi t HA-
coated uncemented cups in young patients 
have not been reported so far. Oosterbos 
and colleagues (2004) recently reported 
excellent long-term survival with the press-
fi t HA-coated ABG cup in older patients 
(≥55 years of age), but a high incidence of 
PE wear was a cause of concern even in this 
patient group. Giannikas et al. (2002) re-
ported good medium-term results with the 
ABG hip in younger patients, but expressed 
concern when excessive PE wear of the 
acetabular insert was noted again. Alarm-
ingly, wear and periacetabular osteolysis of 
the ABG I cup has recently been reported 
from another source (Duffy et al. 2004). In a 
recent study of 56 patients with a mean age 
of 44 years, Blacha (2004) reported poor re-
sults with the ABG I cup, the 9-year survival 
rate for the cup being 69% and for the PE 
liner 59%.
10.2.1.8 Uncemented cup designs 
(II)
Of the press-fi t porous-coated uncemented 
cups, only the Biomet Universal and the 
Harris-Galante II showed good endurance 
characteristics against aseptic loosening, 
with over 90% survival rates at 10 years. 
However, 10 year survival rates of all the 
press-fi t porous-coated cup designs declined 
markedly, when all cup revisions were taken 
into account. The Harris-Galante II cup was 
the only cup design with a 10 year survival 
rate of more than 80%. This decline resulted 
from multiple revisions performed mainly 
for excessive wear of the PE liner. For exam-
ple, the 10 year survival rate of the Biomet 
Mallory cup declined from 88% to 61% for 
the same reason.
The cup / liner incongruity of the two-
piece acetabular designs seems to be a com-
mon reason given for failure for most brands 
(Barrack et al. 1997, Malchau et al. 1997, 
Puolakka et al. 2001a, Young et al. 2002, 
Blacha 2004, von Schewelov et al. 2004). 
This problem was emphasized in this study 
(II) due to the large number of Biomet cups 
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used. The critical problems encountered 
with the HexLoc liner found in the Finnish 
Arthroplasty Register have been previously 
reported (Puolakka et al. 1999). The Biomet 
Vision cup, which has a closed metallic shell 
of titanium alloy with plasma-sprayed po-
rous-coating (plugged screw holes) and a 
RingLoc liner, was introduced in Finland 
in 1994. In the present study (II), we found 
excellent short-term results for the Biomet 
Vision cup in young OA patients. Neverthe-
less, a longer follow-up is required to estab-
lish whether the Vision cup with a modern 
uncemented cup design concept and a Rin-
gLoc liner has less wear and osteolysis than 
the fi rst-generation of modular uncemented 
cups. The Morscher Press-Fit uncemented 
cup with titanium fi ber-mesh and mono-
block design gave promising short-term 
results. Again, longer follow-up studies are 
required to see, what the true long-term 
performance of this implant is.
The PCA Pegged acetabular component 
gave poor results in our study (II); 76% sur-
vival rate at 10 years and 64% survival rate 
at 15 years is unacceptably low. The poor 
resistance of this cup to aseptic loosening 
has been reported previously (Heekin et al. 
1993, Malchau et al. 1997, Thanner et al. 
1999).
In the present study (II), the 10 year sur-
vival rate of the ABG I cup was 95% with 
aseptic loosening as the end point, but only 
79% with any cup revision (including ex-
change of liner) as the end point. This is 
in accordance with the fi ndings reported 
earlier (Blacha 2004). The ABG II cup had 
a 99% survival rate at 5 years. However, 
survival of the ABG II cup was not any bet-
ter than that of the ABG I cup over the fi rst 
fi ve years postoperatively. As implant sur-
vival may decline markedly after 7 or 8 years 
(Puolakka et al. 1999, Thanner et al. 1999), 
longer follow-up is needed to see how the 
HA-coated ABG II cup will perform in the 
long-term.
10.2.1.9 Young patients with RA 
– special aspects (III)
Cemented THA has traditionally been 
considered the gold standard for the treat-
ment of end-stage joint disease due to RA 
(Colville and Raunio 1978, Poss et al. 1984). 
However, a high rate of aseptic loosening of 
acetabular components has been associated 
with that concept, and there have also been 
reports of femoral component loosening. 
For example, Poss et al. (1984) recorded a 
78% incidence of increasing radiolucency 
around cemented acetabular components 
in patients with RA at 6 –11 years after sur-
gery, even though none had been revised. 
A greater incidence of both acetabular and 
femoral loosening has been reported in pa-
tients with RA compared with those with 
OA (Ranawat et al. 1980, Poss et al. 1984, 
Lachiewicz et al. 1986). This fi nding may be 
attributed to periarticular osteopenia, which 
has been associated with inactivity, medica-
tion (steroid and antimetabolites), regional 
hyperaemia, and increased bone turnover 
(Bogoch and Moran 1999).
Good results have been reported for both 
uncemented (Keisu et al. 2001, Lyback et al. 
2004) and cemented (Lehtimaki et al. 1997, 
Creighton et al. 1998, Lehtimaki et al. 1999) 
femoral components in young patients 
with RA. Lybäck and colleagues (2004) re-
ported a 100%, 10 year survival rate (with 
aseptic loosening as the end point) for the 
proximally circumferentially porous-coated 
Bi-Metric stem in 55 patients (mean age 
28 years) with juvenile chronic arthritis in 
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Finland. Keisu et al. (2001) reported a 100% 
survival rate for another proximally circum-
ferentially porous-coated uncemented stem 
design (Biomet Taperloc) at a mean follow-
up of 8 years in patients with RA. In a study 
on 1553 consecutive Charnley low-friction 
arthroplasties (LFA) in 1086 patients with 
RA in Finland, Lehtimäki and co-workers 
(1999) reported a 90% survival rate for the 
femoral component at 15 years. In another 
study of Charnley LFA in patients with ju-
venile chronic arthritis, Lehtimäki and col-
leagues (1997) reported a 92% survival rate 
for the femoral component at 15 years. In 
the present nation-wide study (III) the re-
sults for proximally circumferentially po-
rous-coated stems were better than those 
for cemented stems however. It appears 
that modern, proximally porous-coated 
stems achieve good primary stability and 
that osseointegration takes place even in pa-
tients with poorer bone-stock, such as those 
with RA. Thus this design concept provides 
young RA patients with good long-term re-
sults.
Loosening of the acetabular component 
remains the most serious long-term prob-
lem after THA in patients with RA. Åkes-
son and co-workers (1994) demonstrated 
that compared with the femur, the greater 
bone turnover in the acetabulum may con-
tribute to the higher rate of acetabular com-
ponent migration and loosening after THA 
in RA patients. As a possible solution to the 
problem of mechanical loosening, porous-
coated cups were introduced in the mid-
1980s. Morscher (1992) suggested that his 
uncemented hemispheric cups with molded 
PE inlays were superior to cemented cups 
or to other types of uncemented cup, espe-
cially in osteopenic patients with RA. On 
the other hand, Kirk and co-workers (1993) 
found no difference in the clinical outcome 
between cemented and uncemented cups in 
RA patients.
In the present study (III), survival of 
press-fi t porous-coated uncemented cups 
was found to be no better than that of ce-
mented cups with aseptic loosening as the 
end point. Further, when all revisions (in-
cluding exchange of PE liners) were taken 
into account, survival of press-fi t porous-
coated uncemented cups was signifi cantly 
poorer than that of all-poly cemented cups. 
However, press-fi t porous-coated unce-
mented cups were the only design concept 
to demonstrate a positive cohort effect, the 
survival rate for cups implanted during 
1992–2003 being higher than that for cups 
implanted in 1980–1991. The results for 
smooth-threaded uncemented cups were 
catastrophic in patients with RA. Com-
parative results for press-fi t HA-coated un-
cemented cups were not as good as those 
for cemented cups, even in the short term, 
when all revisions were considered. No data 
on HA-coated uncemented implants in 
young patients with RA from either single 
centres or national registers have been re-
ported to date.
In our study, uncemented THR design 
concepts did not perform any better than 
the cemented concept. On the contrary, 
there was a trend towards better results with 
the cemented THR design concept when all 
revisions were taken into account. With the 
press-fi t porous-coated THR design con-
cept, this trend appeared after 7 years of 
follow-up, which can be attributed mainly 
to the increased number of liner revisions. 
What gives cause for concern, is that the 
press-fi t HA-coated concept showed a trend 
towards poorer survival during the fi rst 7 
years of follow-up. Numerous cup (liner) 
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revisions of the HA-coated cups drastically 
worsened the results of the press-fi t HA-
coated design concept. In the light of the re-
sults found here for different stem and cup 
design concepts, one can ask whether a re-
verse hybrid THR (a proximally circumfer-
entially porous-coated stem and an all-poly 
cemented cup) might be the solution for 
young patients with RA. Unfortunately, the 
number of hybrid THRs in our series was 
too small to test this hypothesis. However, 
a prospective randomized controlled study 
might give an answer to this question.
The risk of deep infection in THA is re-
ported to be higher in patients with RA than 
in those with primary OA (Wymenga et al. 
1992). However, it should be noted that in 
the present study the number of revision 
operations due to deep infection in patients 
with RA (III) was no higher than that in pa-
tients with primary OA (I).
10.2.1.10 Summary of register-
based studies (I, II and III)
As survival rates in patients older than 70 
years of age are so good (97%–98% at 15 
years) the focus of concern should be on 
younger and more demanding patients. The 
key issue for successful THA is the selection 
of the right implant. The results of this study 
suggest that the modern second-generation 
uncemented stems, with proximal circum-
ferential porous- or HA-coating, seem to 
be a good choice for young OA patients. 
Furthermore, fi ndings of the present study 
suggest that the modern, second-genera-
tion uncemented stems with proximal cir-
cumferential porous coating are also a good 
choice for young patients with RA.
Based on the results of the present 
study, it seems that press-fi t porous- and 
HA-coated uncemented cups have longer 
endurance against aseptic loosening than 
cemented cups in young osteoarthritic pa-
tients, but excessive PE wear of uncemented 
cups is common and leads to osteolysis and 
liner revisions. Thus, when all revisions are 
taken into account, the survival of modern 
uncemented cups is actually no better than 
that of all-poly cemented cups. In young 
patients with RA, cemented all-poly cups 
should still be regarded as the gold stand-
ard. In the present study their overall per-
formance was found to exceed that of mod-
ern uncemented cups.
In conclusion, the present study showed 
that young patients benefi t from a modern 
uncemented stem implant. However, the 
acetabular site remains a problem from 
aseptic loosening of the cemented cups, and 
also from wear and osteolysis with the unce-
mented modular cups (Harris 2003). There 
are three possible solutions to this problem. 
First, the “reverse hybrid concept” (unce-
mented stem and cemented cup) discussed 
earlier (section 10.2.1.9). Second, unce-
mented modular cups with improved liner 
congruence and diminished wear properties 
(and/or uncemented cups with molded PE 
to avoid the back-side wear or loosening/
breakage of the liner). Third, hard-on-hard 
articulations that have been widely used by 
orthopaedic surgeons in Finland recently. 
The long-term results of these three ap-
proaches in young patients are lacking. 
Certainly, only time will tell us the eagerly 
awaited answer.
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10.2.2 Total hip arthroplasty in 
severely dysplastic hips 
(IV and V)
10.2.2.1 A previous Schanz 
osteotomy
The goal of the Schanz osteotomy was to re-
duce the limp in patients with severe DDH 
(Schanz 1922). In the present study (V), all 
patients had a limp and 76% of them had a 
positive Trendelenburg sign preoperatively, 
despite the previously performed Schanz 
osteotomy. The origin of the pain after a 
Schanz osteotomy seems to result from ne-
oarthrosis in the articulation between the 
Schanz angle and the pelvic wall in hips 
with high dislocation, and secondary oste-
oarthritis in hips with dysplasia or low dis-
location. The untreated hips with high dis-
location seem to become painful later. This 
is supported by the fi ndings in the present 
study by the mean age of the patients with a 
previous Schanz osteotomy undergoing ar-
throplasty, which was six years lower than 
mean age of those patients with untreated 
high hip dislocation (IV and V).
10.2.2.2 Femoral osteotomy
Based on the results of the present study 
(IV and V), it seems that a shortening oste-
otomy of the femur and transposition of the 
greater trochanter are a safe surgical method 
for treating patients with severely dysplastic 
hips. The technique increases both the ab-
ductor lever arm and the functional length 
of the gluteus medius muscle, thus creating 
good abduction strength. The method also 
ensures good and safe exposure for recon-
struction of the acetabulum and femur. In 
the present study segmental shortening os-
teotomy with angular correction, combined 
with the step method for rotational stabil-
ity, was a laborious and time-consuming 
procedure. Moreover, the risk of fracturing 
the proximal fragment is considerable, and 
the magnitude of functional lengthening of 
the leg is limited to only three centimetres 
(Paavilainen et al. 1993). Thus, this method 
was used only in hips treated previously 
with a unilateral low-seated Schanz oste-
otomy, in which it was necessary to perform 
a metaphyseal osteotomy to permit stem in-
sertion and reduction of the hip within the 
range of safe leg lengthening. Recently, with 
the use of a modular femoral component 
with a fl uted distal stem the procedure has 
become much easier and faster to perform, 
as rotational stability is achieved without the 
step method. Thus, this technique could be 
used more frequently nowadays. Although 
the segmental shortening technique gives 
a more anatomical result in radiographs, a 
femoral shortening osteotomy combined 
with distal advancement of the greater 
trochanter seems to give better abductor 
strength and a wider range of movements. 
The results of this study (V) support this 
fi nding, although the differences in limp 
and in range of movements (except exten-
sion) between these two methods lacked 
statistical signifi cance.
10.2.2.3 Abduction strength
In the present series (IV and V), THA in 
conjunction with a femoral shortening os-
teotomy and distal advancement of the 
greater trochanter combined with anatomi-
cal placement of the cup, led to an increase 
in the abduction strength. Confi rmation of 
this was obtained as most of the patients 
walked without a limp, had good active ab-
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duction strength, and displayed a negative 
Trendelenburg sign. However, the largest 
available study on THA on DDH patients 
(Hartofi lakidis and Karachalios 2004) did 
not report the proportion of patients limp-
ing or the presence or absence of the Tren-
delenburg sign postoperatively. Bruce et 
al. (2000) published a small study of con-
genitally dislocated hips on which subtro-
chanteric segmental shortening osteotomy 
with a prosthesis in situ had been performed. 
All osteotomies united, but six of the eight 
patients had a positive Trendelenburg sign 
postoperatively. In a study of 21 total hip ar-
throplasties in severely dysplastic hips, Ma-
sonis et al. (2003) reported that only 17% 
of the patients could walk without a limp 
and 61% walked with a single cane after the 
operation. Other studies on femoral osteot-
omy in THA of severely dysplastic hips have 
included only a small number of patients 
with short-term to mid-term follow-up 
(Yasgur et al. 1997, Chareancholvanich et 
al. 1999a, Perka et al. 2000), and rarely have 
reported anything on abduction strength of 
the operated hips. In the present series the 
Trendelenburg sign was negative in 90% of 
cases, and abduction strength was graded as 
normal or only slightly reduced in 88% of 
cases after the operation.
10.2.2.4 Transposition of the 
greater trochanter
In the present study (IV and V), screw fi xa-
tion of the transposed greater trochanter 
was found to be reliable. There were only 
two fi brous unions (in one patient) with 
slight migration of the greater trochanter. 
Hartofi lakidis and Karachalios (2004) pub-
lished a large study on 229 primary THAs 
in 168 patients with congenital hip disease. 
In that study, osteotomy of the greater tro-
chanter was performed in all hips except for 
three with dysplasia, but femoral shortening 
osteotomy was not used on any hip. Fibrous 
union occurred in 13% of the hips with a 
low dislocation and in 22% of the hips with 
a high dislocation. Furthermore, non-un-
ion with migration of the greater trochanter 
was observed in only three hips (2%). Our 
union rate compares favourably with other 
reports on severely dysplastic hips (Bruce 
et al. 2000, Perka et al. 2000, Masonis et al. 
2003, Hartofi lakidis and Karachalios 2004).
10.2.2.5 Placement of the 
acetabular component
Although some authors advocate placement 
of the acetabular component high on the 
pelvic fl oor (Russotti and Harris 1991, Jasty 
et al. 1995, Pagnano et al. 1996, Dearborn 
and Harris 1999), most advocate placing it 
at the level of the true acetabulum (Linde 
et al. 1988, Yoder et al. 1988, Karachalios 
et al. 1993, Paavilainen 1997, Sener et al. 
2002, Hartofi lakidis and Karachalios 2004, 
Perka et al. 2004). In their study of 90 hips 
with Crowe type III congenital dislocation, 
Stans et al. (1998) reported loosening in 
83% of the cups positioned outside of the 
true acetabular region. A high acetabulum 
clinically perpetuates abductor insuffi cien-
cy, limping and limb-length discrepancy. In 
the present study (IV and V), the cup was 
always seated at the anatomical level or even 
lower, if the anteroposterior diameter of the 
pelvic bone was too small.
It has been reported that, in hips in 
which there is a supero-lateral segmental 
defect but adequate anterior and poste-
rior bone stock (such as that which occurs 
in dysplastic hips), 80% coverage of the 
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acetabular component by host bone is ac-
ceptable (Wolfgang 1990). Some authors 
have suggested that the protrusion socket 
technique originally described by Hess and 
Umber (1978) would be preferable, rather 
than using the femoral head as an autograft 
to augment the superolateral aspect of the 
acetabular rim (Hartofi lakidis et al. 1998). 
This is mainly because a high failure rate 
of up to 46% at 20 years has been reported 
with the latter technique (Mulroy and Har-
ris 1990, Harris 1993). In this study (IV and 
V), reliable fi xation of the cup was always 
achieved without bone grafting. Augmenta-
tion of the superolateral rim with a struc-
tural graft was performed solely to increase 
the bone stock for future revisions. If less 
than 80% host bone coverage of the cup 
was achieved, and the cup could not be reli-
ably fi xed, the protrusion socket technique 
was used. An advantage of this technique 
is that a medialized hip centre shortens the 
body lever arm, and theoretically achieves 
better abduction function. All lateral bulk 
autografts united, and the centralized me-
dial walls healed without complications. If 
an adequate antero-posterior diameter for 
an appropriately sized cup (diameter ≥44 
mm) cannot be achieved at the anatomical 
level, inferior placement of the cup is rec-
ommended.
10.2.2.6 Prosthetic components
In the present study (IV and V), revision of 
the uncemented porous-coated CDH stem 
for aseptic loosening was uncommon, and 
there were no radiographical signs of loos-
ening around these stems in the long-term 
follow-up. In practice, all stem revisions 
were due to technical errors. In this study, 
the 10 year survival rates for revision for any 
reason were 94% (IV) 88% (V), and for re-
vision for aseptic loosening the correspond-
ing fi gures were 98% (IV) and 92% (V) us-
ing the Biomet CDH uncemented femoral 
component. This compares favourably with 
the two earlier reports on severely dysplastic 
hips with long-term follow-up (Hartofi lak-
idis and Karachalios 2004, Lai et al. 2005).
The rate of revisions related to the prob-
lems with the acetabular components was 
unacceptably high in this study (IV and 
V), refl ecting the evolution of the cement-
less method. All threaded uncemented cups 
loosened, which confi rms many reports of 
the poor long-term survival of such cups 
(Engh et al. 1990, Tallroth et al. 1993, Si-
mank et al. 1997). Press-fi t, porous-coated 
acetabular components demonstrated a low 
prevalence of aseptic loosening in our series 
(IV and V). However, excessive wear of the 
PE liner of these cups resulted in numerous 
revisions. Because the acetabular compo-
nents used in the present study were neces-
sarily small and because a 28-mm instead of 
22-mm head was implanted in the majority 
of cases to avoid instability of the hip, the lin-
ers were quite thin. What is more, the lock-
ing mechanism of the Biomet HexLoc liner, 
that was used in all press-fi t, porous-coated 
cups in this study (IV and V), was poor and 
caused excessive back-side wear (Puolakka 
et al. 1999, Puolakka et al. 2001a).
10.2.2.7 Complications
Complications were fairly common in the 
present series (IV and V). Preparation of 
the hard cortical femur was diffi cult and 
resulted in a few fractures during rasping 
or insertion of the prosthesis. Introduction 
of the collarless Biomet CDH stem later on 
reduced this problem, because only power 
108
reamers were subsequently needed to pre-
pare the femur. The majority of neurological 
complications in this series resolved. How-
ever, to avoid neurological injury, intraop-
erative electroneuromyography control is 
recommended when attempting to increase 
leg length in excess of 3 cm. Postoperatively, 
the extremity should be positioned in full 
extension of the hip joint and fl exion of the 
knee joint to reduce tension of the sciatic 
nerve (Morscher 1995). Two to three weeks 
of postoperative bed rest has been recom-
mended for soft-tissue readjustment in or-
der to reduce the risk of dislocations (Har-
tofi lakidis and Karachalios 2004). However, 
the protocol of early mobilization in the 
present study (IV and V) does not appear 
to have increased the rate of dislocation. 
There were no deep infections in this series 
(IV and V). Nevertheless, the complication 
rate is comparable to that reported in other 
studies of THA for severely dysplastic joints 
(Woolson and Harris 1983, Paavilainen et 
al. 1993, Jasty et al. 1995, Hartofi lakidis et 
al. 1998, Anderson and Harris 1999, Harto-
fi lakidis and Karachalios 2004, Perka et al. 
2004).
10.2.2.8 Previous tuberculous 
coxarthritis
In this study (V), there were three patients 
who previously had tuberculosis of the 
hip. All were treated with a shortening os-
teotomy of the femur and transposition of 
the greater trochanter. Two of these hips 
required splitting of the femoral shaft both 
anteriorly and posteriorly to facilitate in-
sertion of the smallest sized stem. None of 
these patients had either wound infection or 
reactivation of the tuberculosis. It has been 
reported previously, that the risk of recur-
rence of tuberculosis is low in such patients 
(Kim et al. 2001, Yoon et al. 2005).
10.2.2.9 Leg-lengthening
Adequate lengthening of the leg is impor-
tant, especially for the patients with unilat-
eral dislocation of the hip joint. Functional 
lengthening is limited by tight soft tissues 
and especially by the sciatic nerve. In many 
patients, it is diffi cult to estimate the opti-
mal amount of lengthening. The method of 
shortening the proximal femur combined 
with distal advancement of the greater tro-
chanter allows functional lengthening up to 
5 cm in cases with untreated high disloca-
tion, but in the cases after Schanz osteoto-
my, it is limited according to the level of the 
Schanz angulation. If insuffi cient lengthen-
ing is obtained by this method, segmental 
shortening osteotomy combined with an-
gular correction is performed. With the lat-
ter method, functional lengthening of up to 
3–4 cm is possible. The choice between these 
two operation methods is always made pr-
eoperatively. The younger the patient, then 
the greater the effort to achieve equal length. 
Patients with fi xed degenerative changes of 
the low back must be carefully tested preop-
eratively with various elevations (Hoikka et 
al. 1993).
10.2.2.10 Summary
In adult patients with severely dysplastic 
hips, independent of the aetiology of the 
hip disease, uncemented THA with distal 
advancement of the greater trochanter, 
femoral shortening osteotomy, and soft-
tissue releases can substantially reduce 
pain and improve hip joint function. For 
the patients with low-seated unilateral 
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Schanz osteotomy, subtrochanteric seg-
mental resection and angular correction 
is recommended because it gives better 
correction of the leg length. In the present 
study (IV and V), these techniques com-
bined with anatomical placement of the 
cup led to an increase in the abduction 
strength, as most of the patients walked 
without a limp, had good active abduc-
tion strength, and displayed a negative 
Trendelenburg sign. Aseptic loosening of 
the threaded uncemented cups was com-
mon. Additionally, press-fi t, porous-coat-
ed uncemented acetabular components 
had good fi xation, but excessive wear of 
the PE liner and periacetabular osteolysis 
resulted in numerous revisions. Revision 
of the uncemented porous-coated CDH 
stem for aseptic loosening was uncom-
mon, and there were no radiographical 
signs of loosening around these stems in 
the mid- to long-term follow-up.
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11. CONCLUSIONS
1. Uncemented proximally circumfer-
entially porous- and HA-coated stem 
design concepts provided young pa-
tients with primary OA with good 
long-term outcomes. On the other 
hand survival of modern uncemented 
cup concepts was no better than that 
of the all-poly cemented cup concept 
in these patients.
2. Modern second-generation unce-
mented stem designs, especially the 
Biomet Bi-Metric, had good long-
term survival in young patients with 
primary OA. However, survival rates 
of uncemented cup designs were un-
satisfactorily low because of multiple 
liner revisions.
3. Uncemented proximally circumfer-
entially porous-coated stems and ce-
mented all-poly cups provided young 
patients with RA the best long-term 
results. These design concepts can 
be recommended for young patients 
with RA.
4. Uncemented THA, with placement 
of the cup at the level of the true 
acetabulum, distal advancement of 
the greater trochanter, and femoral 
shortening osteotomy can be recom-
mended for young patients with high 
congenital hip dislocation, as it gives a 
good functional long-term outcome. 
The uncemented CDH stem had good 
long-term survival. Numerous cup 
revisions were secondary to sub-opti-
mal modular design of the acetabular 
components used in this series.
5. Most of the patients with severely 
dysplastic hips and a previous Schanz 
osteotomy can be successfully treat-
ed with cementless THA, combined 
with transposition of the greater tro-
chanter and femoral shortening oste-
otomy. However, the subtrochanteric 
segmental shortening with angular 
correction gave better leg length cor-
rection for the patients with a previ-
ous low-seated unilateral Schanz os-
teotomy. Both methods gave similar 
functional results.
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